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1. SUMMARY 
Cell state transitions enable the differentiation of stem and progenitor cells into more mature 
and specialized cell types and are, thus, fundamental to the formation of multicellular 
organisms. Developmental progression is largely a unidirectional process. However, 
expression of reprogramming factors is sufficient to de-differentiate mature somatic cells, 
suggesting that cellular plasticity persists even in terminally differentiated cell types. Multiple 
signaling pathways, epigenetic regulators, metabolic sensing cascades and transcription 
factors (TFs) contribute to differentiation and de-differentiation. However, if reprogramming 
requires the reversion of naturally occurring developmental mechanisms remains unknown. 
A suitable model system to study cell state transitions in vitro are lineage-related mouse 
embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs) which are derivatives of the 
pre-implantation blastocyst and the post-implantation epiblast, respectively. Interconvertibility 
of ESCs and EpiSCs provides an experimental model to explore to which extent lineage 
progression and reprogramming overlap mechanistically. 
In a collaborative project, I contributed to the characterization of a novel ESC differentiation 
pathway: in a genome-wide clustered regularly interspaced short palindromic repeats 
(CRISPR)/CRISPR-associated 9 (Cas9) screen we identified multiple components of a 
conserved amino acid signaling pathway as crucial drivers of ESC progression. 
Mechanistically, the lysosome activity, the Ragulator protein complex, and the tumor-
suppressor Folliculin (Flcn) enable the Rag GTPases C and D to bind and seclude the TF Tfe3 
in the cytoplasm. Ectopic nuclear Tfe3 represses specific developmental and activates 
metabolic transcriptional programs which are associated with in vivo development. In 
collaboration with geneticists, we identified point mutations in a Tfe3 domain required for 
cytoplasmic inactivation as a potential cause of a human developmental disorder. This work 
reveals an instructive and biomedically relevant role for metabolic signaling in licensing 
embryonic cell fate transitions. 
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In my main PhD project, we aimed to identify cell state transition regulators which both are 
required for exit from the ESC state and inhibit acquisition of the induced pluripotent cell (iPSC) 
identity upon reprogramming of EpiSCs. We therefore performed a large-scale loss-of-function 
reprogramming screen in sensitized EpiSCs. Comparison with ESC differentiation screens 
revealed the constitutively expressed TF Zfp281 as a unique bidirectional regulator of cell 
state interconversion. We identified the histone methyltransferase Ehmt1 and the zinc finger 
TF Zic2 as differentiation-specific protein interaction partners of Zfp281 and showed that 
subtle chromatin binding changes of Zfp281 during ESC progression translate into activation 
of Ehmt1 and stabilization of Zic2 on promoters and enhancers. Genetic gain- and loss-
of-function experiments confirmed a critical role of Ehmt1 and Zic2 downstream of Zfp281 both 
in driving exit from the ESC state, and in restricting reprogramming of EpiSCs. This study 
reveals that the cell type-invariant chromatin association of Zfp281 provides an interaction 
platform for remodeling the cis-regulatory network underlying cellular plasticity. 
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2. INTRODUCTION 
2.1 Pluripotency in the embryo and in culture  
Pluripotency describes the capacity of a cell to give rise to all somatic lineages and the 
germline. Pluripotency is a transient cellular feature during embryonic development and exists 
only for a few days in vivo. In the past 30 years, culture conditions to capture this property in 
vitro have been developed revealing that distinct pluripotent cell states can be maintained 
which recapitulate the establishment and progression of pluripotency in the embryo. As a 
model system, I used murine pluripotent stem cells and hence this introduction will focus on 
mouse pluripotency in the embryo and in culture. 
 
2.1.1 Pluripotent cell states 
Embryogenesis is the process by which a single cell, the zygote, gives rise to a fully developed 
organism, which is comprised of many different and highly specialized cell types. After oocyte 
fertilization by a mature sperm, the zygote undergoes several rounds of cleavage division 
ultimately giving rise to a spherical blastocyst which occurs at embryonic day (E) 3.5 
(Figure 1). At this developmental stage the embryo is structured into two lineages: the inner 
cell mass (ICM) and the trophectoderm (TE), which surrounds the ICM and later contributes 
in large to the placenta. Pluripotency emerges in the late pre-implantation blastocyst at 
E4.0-4.5 when the ICM segregates into the primitive endoderm (PrE), which will contribute to 
the yolk sac, and the pluripotent epiblast (Figure 1). The latter is comprised of roughly 10-20 
cells each harboring the potential to generate all cell types of the embryo proper: ectoderm, 
endoderm, mesoderm and the germline (Rossant & Tam, 2009). Epiblast cells at this 
developmental stages can be isolated and cultured ex vivo as ESCs (Evans & Kaufman, 1981; 
Martin, 1981) (Figure 1). In vitro, ESCs self-renew to regenerate clones of themselves and 
can be propagated in theory indefinitely while retaining pluripotency: to differentiate into all 
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germ layers and germ cells in vitro, and to generate whole animals when injected back into 
the pre-implantation epiblast (Bradley et al, 1984). 
Upon embryo implantation at around E5.0-5.5, the epiblast transforms into a cup-shaped 
epithelium, the egg cylinder epiblast, and enters gastrulation at E6.5, including formation of 
the primitive streak (PS) (Rossant & Tam, 2009) (Figure 1). Although morphologically different, 
the post-implantation egg cylinder epiblast cells, similar to the pre-implantation epiblast, can 
develop into all lineages of the embryo including germ cells (Lawson et al, 1991). However, at 
this embryonic stage ESCs can no longer be derived but instead EpiSCs can be isolated using 
distinct culture conditions (Brons et al, 2007; Tesar et al, 2007). EpiSCs retain certain features 
of the post-implantation epiblast such as the ability to differentiate into multiple somatic 
lineages in vitro and, upon transplantation into post- but not pre-implantation epiblasts, to 
contribute to embryonic development (Brons et al, 2007; Huang et al, 2012; Tesar et al, 2007). 
In contrast to ESCs, EpiSCs are not capable of inducing primordial germ cell formation, 
suggesting a restricted developmental potential (Hayashi et al, 2011). 
The different pluripotent states of ESCs and EpiSCs corresponding to the E4.5 pre- and E5.5 
post-implantation epiblast have been therefore termed “naïve” and “primed”, respectively   
(Nichols & Smith, 2009) (Figure 1). 
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Figure 1: Pluripotency in vivo and in vitro. 
A schematic overview showing the relationship between in vivo and in vitro pluripotent state 
progression. Pluripotent cells emerge in the inner cell mass (ICM) of the E3.5 blastocyst. Striped ICM 
indicates priming of epiblast (Epi) and primitive endoderm (PrE) identities which segregate into two 
distinct lineages in the E4.5 blastocyst. Upon implantation at around E5.0-5.5, the epiblast transforms 
into a cup-shaped epithelium and further initiates gastrulation, including formation of the primitive streak 
(PS), at E6.5. Conventionally, ESCs were cultured in Serum/LIF resulting in a heterogeneous cell 
population in a metastable state (pink-cyan gradient) which show partial transcriptional similarities to 
the post-implantation epiblast. ESCs cultured in chemically defined conditions, 2i/LIF (pink), maintain a 
more naïve pluripotent state and resemble most closely the E4.5 epiblast. Differentiation of naïve ESCs 
in defined conditions (Fgf2/ActivinA/knockout serum replacement, FAK) results in the transient 
appearance of epiblast like cells (EpiLCs) that most closely resemble the peri-implantation epiblast at 
E5.5, termed as formative pluripotency (cyan). In contrast, primed epiblast stem cells (EpiSCs, green) 
can be isolated from the E5.5-E8.0 post-implantation epiblast and resemble transcriptionally the anterior 
PS at E7.0. EpiSCs can be also derived from ESCs in vitro by continuous exposure to FA via an EpiLC 
state. Bottom graph depicts expression pattern of core pluripotency (purple), naïve pluripotency (pink), 
early post-implantation (cyan) and lineage (green) markers that are characteristic of distinct in vivo and 
in vitro pluripotent cell states. Top: extraembryonic lineages are depicted in gray; dark gray lineages 
are trophectoderm (TE)-derived and light gray lineages PrE-derived. 
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2.1.2 The naïve pluripotency gene regulatory network 
TFs control gene expression by binding to specific deoxyribonucleic acid (DNA) sequences 
and recruiting various co-factors. ESC pluripotency is maintained by a highly interconnected 
gene regulatory network (GRN) of TFs (Martello & Smith, 2014). At its core are the POU 
domain TF Oct4 (Pou5f1) and the SRY box TF Sox2. Both are indispensable for self-renewal 
of ESCs and epiblast development in vivo (Avilion et al, 2003; Masui et al, 2007; Nichols et al, 
1998; Niwa et al, 2000). Oct4 and Sox2 physically interact (Ambrosetti et al, 1997; Pardo et 
al, 2010; van den Berg et al, 2010), bind together on DNA at Oct/Sox elements (Ambrosetti et 
al, 2000; Chen et al, 2008), and positively regulate each other’s transcription (Chew et al, 
2005). Surprisingly, the expression of Oct4 and Sox2 is not restricted to naïve pluripotent cells, 
but is retained in the post-implantation epiblast and in EpiSCs (Avilion et al, 2003; Brons et al, 
2007; Rosner et al, 1990; Scholer et al, 1990; Tesar et al, 2007), where they have subsequent 
roles in further lineage specification (Mulas et al, 2018; Thomson et al, 2011). In contrast, a 
set of naïve TFs are specifically expressed in ESCs and the pre-implantation epiblast and are 
rapidly downregulated in EpiSCs and upon implantation. These include Esrrb, Klf2, Klf4, 
Nanog and Tfcp2l1, which have all been demonstrate to functionally contribute to ESC 
self-renewal (Chambers et al, 2003; Festuccia et al, 2012; Hall et al, 2009; Martello et al, 2013; 
Martello et al, 2012; Niwa et al, 2009; Ye et al, 2013). In contrast, the TF Rex1 (Zfp42) follows 
similar expression kinetics, but it is not required for naïve pluripotency in vitro or in vivo (Masui 
et al, 2008; Pelton et al, 2002). Of note, Nanog although being transcriptionally downregulated 
upon implantation is re-activated in EpiSCs and the post-implantation epiblast, suggesting 
additional regulatory mechanisms (Brons et al, 2007; Hart et al, 2004; Tesar et al, 2007). The 
naïve pluripotent TFs are interconnected with one other and with core factors Oct4 and Sox2 
(Chen et al, 2008; Marson et al, 2008) forming a self-reinforcing GRN to stabilize the ESC 
state (Dunn et al, 2014; Kim et al, 2008; Loh et al, 2006). 
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2.1.3 Metastable and ground state ESCs 
Conventionally, ESCs were derived by cultivating blastocysts in medium supplemented with 
fetal calf serum on a feeder layer containing inactivated fibroblasts (Evans & Kaufman, 1981; 
Martin, 1981). How this culture condition enables faithful derivation of ESCs remained initially 
unknown. The crucial component of fetal calf serum is bone morphogenetic protein (BMP) 4 
which activates Inhibitor of Differentiation (Id) genes via SMAD signaling pathways (Ying et al, 
2003) (Figure 2). Addition of leukemia inhibitory factor (LIF) in ESC cultures can substitute for 
the feeder layer when coating culture dishes with gelatin (Smith et al, 1988; Williams et al, 
1988). Mechanistically, LIF acts primarily via Janus kinase (JAK) which mediates 
phosphorylation of signal transducer and activator of transcription (STAT) 3 and subsequently 
stimulates the expression of naïve pluripotency genes Klf2, Klf4 and Tfcp2l1 (Hall et al, 2009; 
Martello et al, 2013; Niwa et al, 2009; Ye et al, 2013) (Figure 2). This led to the establishment 
of widely used feeder-free Serum/LIF (S/L) culture condition for ESCs. However, this condition 
results in a heterogeneous cell population in regards to expression of naïve pluripotency genes 
such as Rex1, Nanog, Esrrb and Klf4 (Chambers et al, 2007; Hayashi et al, 2008; Toyooka et 
al, 2008; van den Berg et al, 2008). S/L ESCs therefore exist in at least two distinct 
subpopulations corresponding to a naïve state, which recapitulates features of the 
pre-implantation epiblast, and a more advanced state, which is marked by expression of early 
post-implantation genes and reduced self-renewal (Kolodziejczyk et al, 2015). However, cells 
can fluctuate between these two states in culture suggesting a dynamic equilibrium in vitro. 
As a result, S/L ESCs are termed “metastable” (Figure 1).  
The question therefore arose whether it would be possible to develop culture conditions 
capturing a more homogenous ESC population. S/L ESCs produce FGF4 which activates 
extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway 
in an autocrine manner and in turn promotes differentiation (Kunath et al, 2007; Stavridis et 
al, 2007). Paradoxically, Oct4 and Sox2 stimulate expression of Fgf4, suggesting that the 
pluripotent GRN primes its own dismantling (Ambrosetti et al, 1997). LIF and BMP4 signaling 
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do not inhibit the Fgf4 activated pathway resulting in a constant battleground of pro- and 
anti-differentiation signals most likely causing the metastable cell state. In fact, knockout (KO) 
of Fgf4 reduces heterogeneity in ESCs and severely impairs differentiation (Kunath et al, 
2007). Moreover, depletion of Erk2 results in a comparable phenotype implying the 
requirement of FGF/ERK signaling for exit from self-renewal (Stavridis et al, 2007). 
Mechanistically, Erk2 phosphorylates the naïve pluripotency factor KLF2, leading to its 
degradation and therefore destabilization of the pluripotency network (Yeo et al, 2014). 
Additionally, Erk1/2 also reinforce developmental programs by promoting expression of 
differentiation-associated genes (Tee et al, 2014). Indeed, chemical inhibition of 
mitogen-activated protein kinase kinases (MEK) 1 and 2 by PD0325901 (PD03), which blocks 
phosphorylation and therefore activation of Erk1/2, in appropriate culture conditions is 
sufficient to maintain ESCs in an undifferentiated state (Ying et al, 2008) (Figure 2). However, 
PD03 alone is not able to substitute LIF in culture condition. Earlier studies showed that 
suppression of glycogen synthase kinase (GSK) 3 enhances ESC self-renewal (Ogawa et al, 
2006; Sato et al, 2004). Inhibition of GSK3 mimics canonical WNT stimulation and thereby 
stabilizes cytoplasmic β-catenin. In turn, β-catenin translocates to the nucleus where it 
interacts with the transcriptional repressor TCF7L1 and therefore titrates it away from binding 
to and repressing key pluripotency genes (Martello et al, 2012; Wray et al, 2011; Yi et al, 
2011). The combination of the GSK3 inhibitor Chir99021 (Chiron) and PD03, the so called 2i 
culture system, is sufficient to maintain ESCs in a pluripotent state without the requirement of 
Serum and LIF (Ying et al, 2008) (Figure 2). Typically 2i cultures are carried out in feeder- and 
Serum-free medium such as N2B27 with the optional addition of LIF, which further stabilizes 
the pluripotent network (Martello et al, 2013; Ye et al, 2013). 
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Figure 2: Signaling cascades promoting pluripotency and inhibiting differentiation. 
Schematic overview of various signaling pathways that affect ESC self-renewal in metastable S/L (left 
side) and ground state 2i (right side) culture conditions. Clockwise: BMP4 is the crucial component in 
Serum and stimulates SMADs to activate Id genes. LIF acts primarily via JAK/STAT3 and activates 
expression of naïve pluripotency genes Tcfp2l1 and Klf4. Inhibition of GSK3 by Chiron mimics canonical 
WNT signaling which results in stabilization of β-catenin, subsequent inhibition of TCF7L1 (TCF3) and 
induction of Esrrb. Autocrine Fgf signaling activates the MAPK pathway which triggers differentiation. 
PD03 inhibits MEK and therefore maintains ESCs in an undifferentiated state. Figure adapted from 
Hackett & Surani, 2014. (Hackett & Sur ani, 2014 )  
 
Although S/L and 2i conditions are both sufficient to functionally capture pluripotency, ESCs 
cultured in these regimes behave very distinctly and differentially express roughly 3500 genes 
(Marks et al, 2012). This is partially explained by increased homogeneity in the chemically 
defined 2i condition, such as the uniform expression of various naïve pluripotency genes, e.g. 
Rex1, Nanog, Esrrb and Klf4, and the complete silencing of differentiation-associated markers 
(Figure 1). However, the core pluripotency factors Oct4 and Sox2 are expressed at similar 
levels in both culture regimes (Marks et al, 2012). Besides transcriptional differences, a wide 
range of epigenetic features discriminates naïve and metastable pluripotency. DNA 
methylation at CpG dinucleotides is a repressive epigenetic mark usually associated with gene 
silencing. In vivo, the ICM is characterized by a hypomethylated genome, which is 
recapitulated in ESCs in 2i. Upon embryo implantation, DNA methylation rapidly increases, 
which is also observed upon converting ESCs from chemical defined to S/L conditions (Ficz 
et al, 2013; Habibi et al, 2013; Leitch et al, 2013; Monk et al, 1991; Monk et al, 1987). Similar 
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to DNA methylation, the repressive trimethylation of lysine 27 of histone H3 (H3K27me3) is 
prominent in ESCs cultured in S/L, but not in 2i conditions (Marks et al, 2012). 
Consequentially, there are not many bivalent promoters, which are characterized by the 
presence of both repressive H3K27me3 and active trimethylation at lysine 4 of histone H3 
(H3K4me3) histone marks (Azuara et al, 2006; Bernstein et al, 2006; Mikkelsen et al, 2007) 
and associated with rapid gene activation upon developmental progression, in ESCs cultured 
in chemically defined conditions (Marks et al, 2012). The difference between 2i and S/L 
cultured ESCs is even further exemplified by the function of Prdm14. While this TF is required 
to maintain pluripotency in conventional conditions, it is dispensable for self-renewal in 2i 
ESCs (Grabole et al, 2013; Yamaji et al, 2013). Thus, mechanisms controlling pluripotency 
can be context- and culture-dependent. Nevertheless, S/L ESCs converge on a naïve-specific 
transcriptome and hypomethylated genome when switched to 2i/LIF, suggesting high cellular 
plasticity (Ficz et al, 2013; Habibi et al, 2013; Marks et al, 2012). Taken together, two distinct 
culture methods for ESCs have been developed whereby 2i resembles the pre-implantation 
epiblast at E4.5 and S/L ESCs the post-implantation epiblast at E5.5 (Boroviak et al, 2014). 
Given the overall increase in homogeneity and closer resemblance to an early epiblast in vivo, 
ESCs cultured in 2i are therefore termed “ground state” pluripotent. 
 
2.1.4 EpiSCs and primed pluripotency 
EpiSCs can be obtained from a wide range of post-implantation embryonic stages (E5.5-E8.0) 
(Kojima et al, 2014; Osorno et al, 2012) in the presence of Fgf2 and Activin A (FA) on 
fibronectin coated culture dishes (Brons et al, 2007; Tesar et al, 2007). When injected into the 
post-implantation epiblast, EpiSCs most efficiently integrate into the PS of the developing 
embryo and their in vitro transcriptome resembles most closely the anterior PS of the E7.0 
gastrula (Kojima et al, 2014). Similarly to ESCs, EpiSCs express the core pluripotency factors 
Oct4 and Sox2 but not naïve markers such as Rex1, Esrrb or Klf4 (Brons et al, 2007; Tesar et 
al, 2007). Notably, Nanog is detectable in EpiSCs, correlating with its re-activation in the 
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posterior epiblast at around E6.0 (Hart et al, 2004). In contrast, early post-implantation 
markers, e.g. Fgf5, Otx2 and Oct6 (Pou3f1), are expressed and lineage markers such as T/Bra 
and Foxa2 are upregulated but only in a subset of cells (Tsakiridis et al, 2014) (Figure 1). 
Additionally, EpiSCs display significant DNA methylation at promoters of pluripotency genes 
(Veillard et al, 2014). EpiSCs can also be derived from differentiating ESCs in the continuous 
presence of FA, however stable cultures are only obtained after several passages (Guo et al, 
2009). Interestingly, upon neural differentiation, ESCs pass through an epiblast-like stage, 
from which EpiSCs can be derived, before acquiring neuronal identity (Zhang et al, 2010). 
This suggests that differentiation in vitro recapitulates developmental progression in vivo from 
pre- to post-implantation pluripotency before lineage specification.  
 
2.1.5 Formative pluripotency 
Naïve ESCs and primed EpiSCs resemble the E4.5 pre-implantation epiblast and the PS of 
E7.0 post-implantation epiblasts, respectively. Can one capture a cell state representing the 
peri-implantation epiblast? Single cell transcriptome analysis of early post-implantation 
epiblasts at E5.5 revealed a gene expression pattern distinct from the naïve pre-implantation 
and the primed gastrula stage, termed as formative pluripotency, which describes a 
progression phase of pluripotency (Mohammed et al, 2017; Smith, 2017). In vitro, ESCs exit 
the naïve pluripotent state before engaging into lineage specification (Kalkan et al, 2017; 
Mulas et al, 2017). In fact, a transient cell population with transcriptional similarities to the E5.5 
epiblast has been identified upon differentiation of ESCs. These epiblast-like cells (EpiLCs) 
are generated from 2i/LIF ESCs by culturing in EpiSCs condition, FA, supplemented with 
knockout serum replacement (FAK) for 48 hours (h) (Hayashi et al, 2011) (Figure 1). Activin 
seems to be dispensable for the transition to EpiLCs, suggesting that the predominant driver 
of EpiLC differentiation is Fgf signaling (Buecker et al, 2014). EpiLCs, similarly to the 
post-implantation epiblast, do not express naïve pluripotency markers, e.g. Rex1, Esrrb or 
Klf4, but instead early post-implantation genes such as Fgf5, Otx2 and Oct6, while expressing 
12 
 
Oct4 and Sox2 similarly to naïve ESCs. In contrast to primed EpiSCs, EpiLCs do not transcribe 
lineage markers, such as T/Bra or Foxa2. Moreover EpiLCs, unlike primed EpiSCs, can be 
differentiated into primordial germ cells in vitro, recapitulating potency of the early 
post-implantation epiblast in vivo (Hayashi et al, 2011). These findings suggest the existence 
of a continuum of pluripotent states between naïve and primed stem cells.  
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2.2 Exit from and acquisition of pluripotency 
Historically, the Waddington landscape describes a model for normal development as a 
marble rolling downhill to its final differentiated state in which it preferentially resides 
(Waddington, 1957) (Figure 3). While suggestive of continuous lineage restriction and 
irreversible commitment, TF overexpression experiments in vitro and in vivo have significantly 
challenged this view and revealed a profound degree of developmental cell state plasticity 
even in terminally differentiated cell types. Interconvertibility between distinct cell states offers 
the potential to study the dynamics of cell state transitions in a controllable system.  
 
Figure 3: Cell state changes on Waddington’s landscape. 
Waddington’s landscape model describes development as a strictly unidirectional process represented 
as a marble rolling downhill from a pluripotent (yellow, top) to a differentiated cell state (green, bottom) 
via a progenitor state (light blue, middle). Ectopic expression of tissue-specific TFs can convert the fate 
of a lineage-committed cell (green, bottom) to another lineage (pink, bottom), a process known as 
trans-differentiation. Transfer of a somatic nuclei into enucleated oocytes, cell fusion of a somatic with 
a pluripotent cell and ectopic expression of reprogramming factors is sufficient to erase the current cell 
state  (purple, bottom) and to reprogram (rejuvenate) into a pluripotent state (yellow, top), which can 
occur through distinct trajectories (pink arrow). Figure adapted from Ohnuki & Takahashi, 2015. (Ohnuki & Takah ashi, 2015 )  
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2.2.1 ESC differentiation 
Differentiation of ESCs and progression of the pre-implantation epiblast requires the resolution 
of the naïve pluripotent state in order to allow establishment of post-implantation pluripotency 
and eventually lineage specification and gastrulation. Various two- and three-dimensional 
systems have been established to differentiate ESCs in vitro. Embryoid bodies (EBs) are 
cultured as three-dimensional, round spheroids and are able to give rise to all three germ 
layers (Evans & Kaufman, 1981; Martin, 1981). However, EB cultures are heterogeneous and 
pose challenges to directed differentiation, while monolayer cultures are more controllable 
however usually recapitulate only one specific lineage (Keller, 2005). Conventional S/L ESCs 
are heterogeneous in terms of expression of pluripotency and lineage-associated markers. 
For a long time, it was believed that this heterogeneity is required for random exploration of 
available cell states and further lineage commitment (Moris et al, 2016). However, naïve ESCs 
are homogenous, suggesting that heterogeneity is not a property of stem cell pluripotency but 
rather dependent on the applied culture condition (Marks et al, 2012). If lineage specification 
requires priming and progression through a heterogeneous cell state remains, however, to be 
determined. 
To monitor dynamics of ESC progression, various cell lines with fluorescently labeled proteins 
have been established. A particularly powerful system is the knock-in of a destabilized green 
fluorescent protein (GFP) with a half-life of 2h driven by the endogenous Rex1 promoter 
(RGd2) (Wray et al, 2010). Rex1 is homogeneously expressed in naïve 2i ESCs and the 
pre-implantation epiblast and, although Rex1 is not required for developmental progression, 
its expression is rapidly downregulated upon blastocyst implantation and during ESC 
differentiation (Boroviak et al, 2014; Kalkan et al, 2017; Masui et al, 2008; Pelton et al, 2002; 
Wray et al, 2010). Notably, silencing of Rex1 is heterogeneous in vitro (Wray et al, 2011), 
commencing after 24h of release from 2i in a subpopulation, but continuing for another 24h 
until Rex1-GFP expression is extinguished in all cells (Wray et al, 2011). Release of ESCs 
from 2i/LIF prolongs this process for an additional 12h (Dunn et al, 2014). Interestingly, 
15 
 
downregulation of other naïve pluripotency factors, such as Nanog, Klf2 and Tfcp2l1, can be 
observed as early as 4h after removal of 2i (Leeb et al, 2014). Nevertheless, loss of Rex1 
expression strongly correlates with loss of self-renewal indicating that downregulation of Rex1 
marks irreversible cell fate commitment (Kalkan et al, 2017). Therefore, the RGd2 reporter 
enables near real-time tracking of exit from naïve pluripotency and purification of discrete and 
functionally defined cell populations by flow cytometry.  
 
2.2.2 Somatic cell reprogramming 
Reprogramming describes the process of erasing an existing cellular identity and reversion to 
a less differentiated cell state. However, reprogramming events are extremely rare in vivo and 
occur for example during tissue injury to initiate repair (Jessen et al, 2015). The idea of a strict 
unidirectionality during development as postulated by Waddington’s landscape model 
(Waddington, 1957) (Figure 3) was further challenged by somatic nuclear transfer experiments 
in frogs (Gurdon, 1962; Gurdon et al, 1958) and cell fusion experiments (Tada et al, 2001; 
Takagi et al, 1983). These findings suggested the existence of cell-intrinsic factors that can 
erase differentiated cellular programs. The first mechanistic insight into cell fate conversion 
came from studies showing that ectopic expression of myoblast determination protein (MYOD) 
is sufficient to trans-differentiate mouse fibroblasts into myoblasts (Davis et al, 1987) (Figure 
3). However, the breakthrough discovery was made by Shinya Yamanaka and colleagues who 
showed that somatic cells can be reprogrammed into iPSCs by the expression of four TFs, 
OCT4, SOX2, KLF4 and MYC (OSKM; Yamanaka factors) (Takahashi & Yamanaka, 2006). 
Mouse iPSCs are almost identical to ESCs in terms of morphology, gene expression and 
potency upon blastocyst injection (Okita et al, 2007; Takahashi & Yamanaka, 2006; Wernig et 
al, 2007). This discovery put forward the concept of TFs as determinants of mammalian cell 
identity. However, fibroblasts give rise to iPSCs at an efficiency of less than 0.1% (Wernig et 
al, 2007), therefore efforts have been made to identify reprogramming enhancers. 
Surprisingly, all four Yamanaka factors can be replaced by other, mainly related, factors (Heng 
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et al, 2010; Jiang et al, 2008; Nakagawa et al, 2008) and expression of naïve pluripotency TFs 
can further enhance reprogramming efficiency (Takahashi & Yamanaka, 2016). Moreover, 
repressive epigenetic regulators have been identified as roadblocks for somatic 
reprogramming by restricting DNA binding of reprogramming TFs (Ebrahimi, 2015). These 
findings therefore suggest that formation of iPSCs can be achieved via distinct trajectories 
(Takahashi & Yamanaka, 2015) (Figure 3). Reprogramming of fibroblasts is a multistep 
process with an early stochastic and late deterministic phase, which are characterized by 
specific molecular and transcriptional events. Especially the late phase of reprogramming 
recapitulates the reversion of certain developmental programs, e.g. a 
mesenchymal-to-epithelial transition is required for iPSC formation (Li et al, 2010; 
Samavarchi-Tehrani et al, 2010), while the opposite epithelial-to-mesenchymal transition is 
crucial for gastrulation (Acloque et al, 2009). Although it is debated whether a common 
developmental intermediate exists (Raab et al, 2017), these observations suggest that 
differentiation and reprogramming may employ common mechanisms in inverse directions. 
 
2.2.3 Reprogramming of EpiSCs 
As outlined above, conventional reprogramming of somatic cells into iPSCs requires 
overexpression of 4 TFs, proceeds over many days and is associated with cell death, therefore 
hampering mechanistical dissection of this process. EpiSCs are more closely related to iPSCs 
than somatic cells, suggesting that trajectories during EpiSC reprogramming may be less 
complicated and more tractable. Although EpiSCs, when transferred in either conventional S/L 
or chemically defined 2i/LIF culture condition, do not acquire the naïve pluripotent state but in 
fact differentiate and eventually die (Brons et al, 2007; Guo et al, 2009), overexpression of 
only one TF is sufficient for formation of EpiSC-derived iPSCs (Epi-iPSCs) (Guo et al, 2009). 
Specifically, activation of Klf2, Klf4, Nanog, Esrrb, Tfcp2l1 or Gbx3 (Festuccia et al, 2012; Guo 
et al, 2009; Hall et al, 2009; Martello et al, 2013; Silva et al, 2009; Tai & Ying, 2013; Ye et al, 
2013) or hyperactivation of Stat3 (Yang et al, 2010) in EpiSCs generates Epi-iPSCs in the 
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presence of 2i or 2i/LIF. Interestingly, different EpiSC reprogramming regimes proceed along 
distinct transcriptional trajectories before converging on the same naïve endpoint, suggesting 
a remarkable flexibility for the acquisition of cell identity from the same starting population 
(Stuart et al, 2019). Thus, interconvertibility of developmentally related naïve ESCs and primed 
EpiSCs provides an attractive system to identify and characterize regulators of pluripotent cell 
state transitions. 
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2.3 Regulators of cell state transitions 
Cell fate determination is a highly dynamic and coordinated process that requires dissolution 
of the starting cell identity and acquisition of a new cell fate. Previous studies of differentiation, 
trans-differentiation and reprogramming showed a particular importance for TFs in these 
processes. However, many other mechanisms acting on multiple levels such as epigenetic 
regulation, nuclear transport, metabolic sensing and protein stability are also required for cell 
state transitions.  
The introduction of ribonucleic acid interference (RNAi) and later CRISPR/Cas9 offered the 
possibility to perform genome-wide disruption of gene function. RNAi is a highly conserved 
biological process in which binding of small RNA molecules to complementary messenger 
RNA (mRNA) results in degradation of target mRNAs and thus reduction of protein levels (Fire 
et al, 1998). CRISPR/Cas9 is a prokaryotic defense mechanism that provides resistance to 
foreign genetic elements by recognizing and cleaving foreign DNA (Wiedenheft et al, 2012). 
This system was quickly adapted for mammalian cells in which a single guide RNA (sgRNA) 
guides the Cas9 nuclease to complementary DNA to create a site-specific double-strand break 
which can result in error-prone repair and thus frameshift mutations (Cong et al, 2013; Jinek 
et al, 2012; Mali et al, 2013). These tools have been extensively exploited to identify regulators 
of ESC differentiation by loss-of-function screens (Betschinger et al, 2013; Hackett et al, 2018; 
Leeb et al, 2014; Li et al, 2018; MacDougall et al, 2019b; Yang et al, 2012). Overall, more than 
600 protein-coding genes have been implicated in exit from naïve pluripotency however only 
few were studied in detail. Although similar loss-of-function screens have been performed in 
somatic reprogramming (Qin et al, 2014; Yang et al, 2014a), knowledge about regulators of 
EpiSC de-differentiation is still limited. Here I will describe regulators of exit from and 
acquisition of naïve pluripotency that are relevant for the thesis.  
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2.3.1 Guardians of ESC differentiation 
Tcf7l1 is a transcriptional repressor and the main downstream effector of Wnt/GSK3 signaling 
in ESCs. Withdrawal of Chiron from the 2i culture medium leads to the de-repression of 
TCF7L1 and subsequently repression of its direct targets Klf2, Nanog and Esrrb (Martello et 
al, 2012; Pereira et al, 2006). Among these, repression of Esrrb seems to be most critical for 
exit from naïve pluripotency. Thus, depletion of Tcf7l1 inhibits ESC differentiation (Guo et al, 
2011; Pereira et al, 2006) and displays gastrulation defects in vivo (Merrill et al, 2004), while 
overexpression of Esrrb is sufficient to inhibit ESC progression (Martello et al, 2012). The 
important role of Tcf7l1 is highlighted by the fact that it scores as a top hit in most large-scale 
ESC differentiation screens (Betschinger et al, 2013; Hackett et al, 2018; Leeb et al, 2014; Li 
et al, 2018; MacDougall et al, 2019b; Yang et al, 2012).  
Similar to Tcf7l1, the tumor-suppressor Flcn is also required upstream for repression of Esrrb 
during exit from naïve pluripotency (Betschinger et al, 2013). Flcn together with its interaction 
partners Fnip1 and Fnip2 drives ESC progression by cytoplasmic retention of the basic 
helix-loop-helix (bHLH) TF Tfe3. Thus, differentiation is strongly impaired by either depletion 
of Flcn or ectopic expression of nuclear Tfe3. In naïve ESCs, Tfe3 is localized in both the 
nucleus and cytoplasm but upon 2i withdrawal translocates into the cytoplasm. Nuclear 
exclusion of Tfe3 is also observed in the post-implantation epiblast, suggesting that the same 
mechanism operates during development in vivo (Betschinger et al, 2013). The Flcn-Fnip1/2 
complex and the microphthalmia-associated transcription factor (MiTF)/Tfe family member 
Tfeb are known components of the somatic amino acid signaling pathway (Saxton & Sabatini, 
2017). Mechanistically, Flcn activates mechanistic target of rapamycin complex (mTORC) 1 
in response to amino acids, which in turn phosphorylates and inactivates Tfeb via cytoplasmic 
sequestration (Petit et al, 2013; Roczniak-Ferguson et al, 2012). Paradoxically, depletion of 
Flcn or tuberous sclerosis complex (Tsc) 2, an mTORC1 repressor, in naïve ESCs causes 
nuclear retention of Tfe3 and impairs exit of the ESC state (Betschinger et al, 2013). How the 
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subcellular localization of Tfe3 is regulated and to which extent the amino acid signaling 
machinery is involved therefore remains to be explored. 
The zinc finger TF Zfp281 was identified in several screens as a driver of ESC differentiation 
(Betschinger et al, 2013; Hackett et al, 2018; Li et al, 2018). This is in line with abnormal 
embryonic development of Zfp281-null mice, specifically defective activation of Nodal 
signaling and induction of genes associated with the primed pluripotent state, leading to 
embryonic lethality around E8.5 (Huang et al, 2017). Initial studies showed that Zfp281 recruits 
the NuRD complex, a multi-subunit complex which deacetylates H3K27 and thereby facilitates 
H3K27me3 and gene repression, to the Nanog promoter in metastable S/L ESCs to mediate 
Nanog repression (Fidalgo et al, 2012; Fidalgo et al, 2011). Thus, depletion of Zfp281 causes 
increased expression of Nanog and impairs EB differentiation. More recently, it was proposed 
that Zfp281 expression is upregulated upon differentiation of S/L cultured ESCs, which in turn 
destabilizes metastable pluripotency by direct protein interaction with the methylcytosine 
hydroxylase Tet1 and transcriptional repression of Tet2 (Fidalgo et al, 2016). These studies 
suggest various mechanisms for Zfp281 regulated cell state transition in vitro and in vivo. 
However, if these mechanisms also regulate exit from naïve pluripotency downstream of 
Zfp281 is unclear.  
The homeobox TF Otx2 and the zinc finger TF Zic2 were identified as regulators of ESC 
differentiation in a genome-wide loss of function screen (Li et al, 2018). Homozygous mutant 
mice of Otx2 and Zic2 are embryonic lethal around E9.5 and E13.5 with severe defects in 
rostral head and neural crest cell formation, respectively, demonstrating an essential role in 
embryogenesis (Acampora et al, 1995; Elms et al, 2003; Matsuo et al, 1995). Zic2 together 
with the NuRD complex occupies enhancers of bivalent genes in metastable S/L ESCs to 
maintain H3K27me3 and depletion of Zic2 results in impaired upregulation of primed 
pluripotency markers upon EB differentiation (Luo et al, 2015). However, its precise role in exit 
from naïve pluripotency is unknown. Depletion of Otx2 in metastable S/L ESCs results in 
increased self-renewal and homogenous expression of the TF Nanog (Acampora et al, 2013). 
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In contrast, Otx2 is lowly expressed in 2i/LIF condition and its loss does not influence the naïve 
pluripotent state (Buecker et al, 2014). However, Otx2 interacts with Oct4 and is crucial to 
target Oct4 to previously inaccessible enhancer sites during ESC differentiation (Buecker et 
al, 2014; Yang et al, 2014b). Differentiating Otx2 KO ESCs therefore fail to repress naïve and 
induce primed marker genes. Ectopic expression of tagged Otx2 and Zic2 transgenes in 
EpiSCs revealed co-localization of these two TFs at active genomic regions in primed 
pluripotent cells (Matsuda et al, 2017), suggesting that Otx2 and Zic2 functionally act together 
in the exit of pluripotency. 
While various TFs have important roles in safeguarding ESC progression, epigenetic 
modifications are also key to control precise gene expression during this process (Festuccia 
et al, 2017). A well-studied example is the heterodimeric histone methylation complex Ehmt1 
(GLP)/Ehmt2 (G9a) which mediates repressive mono- and dimethylation at histone H3 lysine 
9 (H3K9me1 and H3K9me2) (Shinkai & Tachibana, 2011). Both complex members were 
identified as regulators of exit from naïve pluripotency in a genome-wide loss of function 
screen (Li et al, 2018), which is consistent with increased H3K9me2 and subsequent silencing 
of associated developmental genes observed during embryo implantation and ESC 
differentiation (Zylicz et al, 2015). In fact, disruption of either Ehmt1 or Ehmt2 in mice results 
in widespread loss of H3K9me1 and H3K9me2, growth retardation and embryonic lethality 
around E9.5 (Tachibana et al, 2002; Tachibana et al, 2005). Co-depletion of Ehmt1 and Ehmt2 
does not further reduce H3K9me1 and H3K9me2 levels, suggesting non-redundant functions 
(Tachibana et al, 2005). However, the exact mechanism that stimulates deposition of 
H3K9me2 during development remains unclear. 
 
2.3.2 Roadblocks of EpiSC reprogramming 
While roadblocks of EpiSC reprogramming have not been systematically identified, several 
genes inhibiting formation of Epi-iPSCs have been reported. These include the TFs Otx2 and 
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Zfp281 which also function in exit from naïve pluripotency. Ablation of Otx2 in primed EpiSCs 
leads to acquisition of an ESC-like morphology as well as upregulation of naïve and 
downregulation of primed pluripotency genes, even without reprogramming stimuli. However 
this dramatic phenotype is only apparent after several passages in EpiSC promoting 
conditions, thus suggesting a cellular adaption upon loss of Otx2 (Acampora et al, 2013). In 
contrast, depletion of Zfp281 in EpiSCs in the presence of FA results in destabilization of this 
cell state with proliferation defects and, ultimately, cell death (Fidalgo et al, 2016). However, 
upon shifting to naïve 2i/LIF culture conditions, Zfp281 depletion results in formation of Epi-
iPSCs, potentially via transcriptional upregulation of Tet2. Thus, these examples show that 
exit from and acquisition of naïve pluripotency might be regulated via similar mechanisms.  
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3. AIM OF THIS THESIS 
As outlined above, cell identities are specified by so called “master” or “lineage-determining” 
TFs that are sufficient to even convert terminally differentiated cells into the naïve pluripotent 
state. However, how such TFs are regulated in the context of developmental cell state 
transitions that orchestrate cell type specification in a spatially and temporally controlled 
manner, is unclear. The capture of developmentally related ESCs and EpiSCs provides a 
controllable in vitro setup to systematically annotate mechanisms of cellular plasticity. 
 
Within my PhD project I set out to address the following questions: 
• How is ESC identity silenced during developmental progression? 
• Is reprogramming into iPSCs a reversion of “natural” differentiation? 
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4. RESULTS 
4.1 Lysosomal signaling licenses embryonic stem cell differentiation 
via inactivation of Tfe3 
 
The entire article can be found in the appendix section. 
4.1.1 Contributions 
In this study, a master’s student, Marietta Zinner, designed and performed the genome-wide 
CRISPR/Cas9 screen under my supervision. Additionally, I performed the computational 
analysis of RNA- and chromatin immunoprecipitation coupled to deep sequencing (RNA-seq 
Lysosomal signaling licenses embryonic stem cell differentiation via 
inactivation of Tfe3 
Villegas F*, Lehalle D*, Mayer D*, Rittirsch M, Stadler MB, Zinner M, Olivieri D, Vabres P, 
Duplomb-Jego L, De Bont E, Duffourd Y, Duijkers F, Avila M, Genevieve D, Houcinat N, 
Jouan T, Kuentz P, Lichtenbelt KD, Thauvin-Robinet C, St-Onge J, Thevenon J, 
van Gassen KLI, van Haelst M, van Koningsbruggen S, Hess D, Smallwood SA, 
Riviere JB, Faivre L, Betschinger J 
Cell Stem Cell. 2019 Feb; 24(2):257-270.e8 * Equal contribution 
 
Abstract 
Self-renewal and differentiation of pluripotent murine embryonic stem cells (ESCs) is 
regulated by extrinsic signaling pathways. It is less clear whether cellular metabolism 
instructs developmental progression. In an unbiased genome-wide CRISPR/Cas9 screen, 
we identified components of a conserved aminoacid-sensing pathway as critical drivers of 
ESC differentiation. Functional analysis revealed that lysosome activity, the Ragulator 
protein complex, and the tumor-suppressor protein Folliculin enable the Rag GTPases C 
and D to bind and seclude the bHLH transcription factor Tfe3 in the cytoplasm. In contrast, 
ectopic nuclear Tfe3 represses specific developmental and metabolic transcriptional 
programs that are associated with peri-implantation development. We show differentiation-
specific and non-canonical regulation of Rag GTPase in ESCs and, importantly, identify 
point mutations in a Tfe3 domain required for cytoplasmic inactivation as potentially causal 
for a human developmental disorder. Our work reveals an instructive and biomedically 
relevant role of metabolic signaling in licensing embryonic cell fate transitions. 
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and ChIP-seq) data in collaboration with Michael Stadler and assisted in writing the manuscript 
with Jörg Betschinger. 
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4.2 Zfp281 orchestrates interconversion of pluripotent states by 
engaging Ehmt1 and Zic2 
 
The entire article can be found in the appendix section. 
4.2.1 Contributions 
This work comprises my main PhD project and hence I was developing and performing most 
of the experiments. The large-scale EpiSC reprogramming screen was performed in the lab 
of Frank Buchholz at the technical University in Dresden by Maria Winzi and Jörg Betschinger. 
Melanie Rittirsch assisted in multiple experiments, Daniel Hess performed the mass 
spectrometry analysis and Ilya Lukonin the spheroid image analysis. I performed the 
computational analysis in collaboration with Michael Stadler and assisted in writing the 
manuscript with Jörg Betschinger. 
Zfp281 orchestrates interconversion of pluripotent states by engaging Ehmt1 
and Zic2 
Mayer D, Stadler MB, Rittirsch M, Hess D, Lukonin I, Winzi M, Smith A, Buchholz F, 
Betschinger J 
EMBO Journal. 2019 Nov; 29:e102591 
 
Abstract 
Developmental cell fate specification is a unidirectional process that can be reverted in 
response to injury or experimental reprogramming. Whether differentiation and 
de-differentiation trajectories intersect mechanistically is unclear. Here, we performed 
comparative screening in lineage-related mouse naïve embryonic stem cells (ESCs) and 
primed epiblast stem cells (EpiSCs), and identified the constitutively expressed zinc finger 
transcription factor (TF) Zfp281 as a bi-directional regulator of cell state interconversion. 
We showed that subtle chromatin binding changes in differentiated cells translate into 
activation of the histone H3 lysine 9 (H3K9) methyltransferase Ehmt1 and stabilization of 
the zinc finger TF Zic2 at enhancers and promoters. Genetic gain- and loss-of-function 
experiments confirmed a critical role of Ehmt1 and Zic2 downstream of Zfp281 both in 
driving exit from the ESC state, and in restricting reprogramming of EpiSCs. Our study 
reveals that cell type-invariant chromatin association of Zfp281 provides an interaction 
platform for remodeling the cis-regulatory network underlying cellular plasticity. 
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4.3 Additional Results I: Zfp281 genetically interacts with Otx2 
4.3.1 Screen of selected TFs for genetic interaction with Zfp281 
We showed that transcription and DNA occupancy of Zfp281 remains largely unchanged 
during ESC differentiation (Mayer et al, 2019; Figure 2F, 3E). We therefore hypothesized that 
cell state specific protein interaction partners of Zfp281 might explain differentiation defects 
observed in the absence of Zfp281. This experimental strategy led to the identification of 
Ehmt1 and Zic2 as functional downstream effectors of Zfp281 specifically during ESC 
progression (Mayer et al, 2019; Figure 4A, C).  
In parallel to the above mentioned approach, we screened for genetic interactions of Zfp281 
with candidate lineage-determining TFs with the following characteristics: (1) scored as a hit 
in at least one of the published knockdown ESC differentiation screens (Betschinger et al, 
2013; Leeb et al, 2014; Yang et al, 2012), (2) mRNA is expressed in ESCs (RPKM>1) and (3) 
mRNA is upregulated 32h after 2i withdrawal (> 2 fold). To assess for genetic interactions of 
the 11 TFs passing these three criteria with Zfp281, we depleted each in wildtype (WT) and 
Zfp281 KO RGd2 ESCs, which express a destabilized GFP downstream of the Rex1 promoter 
(Wray et al, 2011), with small interfering RNAs (siRNAs) and differentiated them for 48h 
towards EpiLCs. While depletion of individual TFs in WT cells showed only little to no effect 
compared to control siRNA (neg), in Zfp281 KO cells knockdown of one candidate, the 
homeobox TF Otx2, strongly enhanced retention of self-renewal from 8 to 20% (Figure 4A). 
Otx2 has been identified as an important regulator for induction and maintenance of the EpiSC 
state (Acampora et al, 2013), likely via redirecting Oct4 to previously inaccessible enhancer 
sites during ESC differentiation (Buecker et al, 2014; Yang et al, 2014b). To test whether this 
genetic interaction is also functionally important during reprogramming, we used 796.4 EpiSCs 
which express GFP and Puromycin N-acetyl-transferase under the control of the regulatory 
sequence of the Oct4 gene (Guo et al, 2011; Guo et al, 2009), and a constitutively expressed 
Stat3 activating receptor (GY118F) responsive to granulocyte colony stimulating factor (Gcsf) 
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(Yang et al, 2010). Stimulation of 796.4 EpiSCs with 2i and Gcsf for 4 days (d), followed by 
selection with Puromycin resulted in little to no self-renewing Epi-iPSCs which was strongly 
increased upon depletion of Zfp281 (Mayer et al, 2019; Figure 1D). To ensure unambiguous 
detection of genetic interactions with Zfp281, we reduced treatment duration with Gcsf to 2d. 
Similar to what we observed during ESC differentiation, depletion of selected TFs did not 
enhance EpiSC reprogramming on their own. However, knockdown of Foxp1, Hand1, Jun and 
Otx2 significantly increased the Zfp281-dependent phenotype (Figure 4B, C). Although 
knockdown of Foxp1 showed the strongest increase in formation of Epi-iPSC colonies when 
co-depleted with Zfp281, it did not enhance the Zfp281 KO phenotype in ESC differentiation. 
In fact, Otx2 was the only gene which augmented Zfp281 function in both ESC differentiation 
and reprogramming of EpiSCs, suggesting a genetic interaction of these two TFs during 
pluripotent cell state transitions. 
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Figure 4: Screen for selected lineage-determining TFs downstream of Zfp281. 
(A) Self-renewal of WT (grey) and Zfp281 KO (green) cells transfected with indicated siRNAs after 48h 
of 2i withdrawal with addition of FAK. Dashed line marks self-renewal of Zfp281 cells transfected with 
negative (neg) siRNA. Significance was determined using a Wilcoxon Mann-Whitney rank sum test 
compared to transfection with neg siRNA in Zfp281 cells. (*) <0.05; not significant (n.s.). Average and 
standard deviation (SD) of 2 biological replicates. 
(B) Number of Epi-iPSC colonies derived from 796.4 EpiSCs transfected with indicated siRNAs in 
combination with neg (grey) and Zfp281 (green) siRNAs, stimulated with Gcsf and 2i for 2d, and 
selected with Puromycin. Dashed line marks number of Epi-iPSC colonies transfected with Zfp281 
siRNA. Significance was determined using a Wilcoxon Mann-Whitney rank sum test compared to 
transfection with Zfp281 siRNA. (*) <0.05; not significant (n.s.). Average and SD of 2 biological 
replicates. 
(C) Deconvolution of Otx2 siRNA pool: Epi-iPSC colonies derived from 796.4 EpiSCs transfected with 
Otx2 siRNAs (individual siRNAs or pool) together with Zfp281 siRNA pool, stimulated for 2d with Gcsf 
and 2i, and selected with Puromycin. Average and SD of 2 biological replicates. 
 
4.3.2 Otx2 genetically but not physically interacts with Zfp281 in pluripotent cell 
state transition 
Deletion of Zfp281 causes deficient ESC differentiation and subsequent deregulation of 
several naïve pluripotency and early lineage markers during this process (Mayer et al, 2019; 
Figure 2A, EV3A). Transcriptional upregulation of Otx2 upon exit from naïve pluripotency is 
required and sufficient for ESC progression (Buecker et al, 2014). To investigate mRNA levels 
of Otx2 in the absence of Zfp281, we made use of RNA-seq data from WT and Zfp281 KO 
ESC differentiation (Mayer et al, 2019; Table EV2). Otx2 mRNA is more than 5-fold induced 
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after 32h of 2i withdrawal in WT cells and is almost unaffected in Zfp281 deficient cells 
(Figure 5A). To further characterize the interaction of Zfp281 with Otx2, we generated Otx2 
individual and Zfp281/Otx2 compound KO RGd2 ESCs (Figure 5B). GFP is uniformly 
expressed in WT naïve ESCs (Rex1-GFPhigh) and progressively downregulated during 
differentiation (Rex1-GFPlow). Reporter expression of two independent Otx2 and Zfp281/Otx2 
KO clones was similar to parental WT cells and one untargeted sibling clone (Otx2 WT) in 2i 
(Figure 5C). 24h after 2i withdrawal, 90% of Otx2 KO cells were GFPhigh compared to 56% in 
WT cells. However, this phenotype only persisted moderately as at 72h after release from 2i 
and at 48h of EpiLC differentiation, less than 1% and 3% of WT cells were GFPhigh, while 2% 
and 9% of Otx2 KO cells maintained high GFP expression, respectively. Correspondingly, 
Otx2 KO cells did not show any retention of self-renewal at 72h of differentiation and at 48h of 
EpiLC differentiation only 3% of Otx2 deficient cells compared to 1% of WT cells could still 
self-renew (Figure 5D). This therefore indicates that Otx2 depletion on its own induces 
predominantly a transient ESC differentiation phenotype. In contrast, a larger proportion of 
Zfp281/Otx2 KO cells were Rex1-GFPhigh after 72h of 2i withdrawal (43%) and EpiLC 
differentiation (49%) compared to Zfp281 KO cells (14% and 31%, respectively) (Figure 5C). 
Inability to repress Rex-GFP was also reflected by retention of self-renewal in 17% and 34% 
of Zfp281/Otx2 KO cells compared to 10% and 15% of Zfp281 KO cells after 72h of 2i 
withdrawal and 48h EpiLC differentiation, respectively (Figure 5D). We therefore conclude that 
although individual Otx2 KO cells only have a transient phenotype in ESC progression, 
co-depletion with Zfp281 strongly enhances the single mutant phenotypes, indicating a 
synergistic rather than additive interaction. 
The genetic interaction of Zfp281 and Otx2 was not restricted to ESC differentiation but was 
also evident in reprogramming of 796.4 EpiSCs (Figure 4B). To exclude a cell-line and/or 
Stat3-dependent effect, we used an independent O4GIPGY118F EpiSC line as well as O4GIP 
EpiSCs conditionally expressing Esrrb or Klf4 via addition of Doxycycline (Dox) to induce 
reprogramming (Mayer et al, 2019). Surprisingly, co-depletion of Otx2 with Zfp281 in these 
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EpiSC lines did not increase the number of derived Epi-iPSCs when compared to Zfp281 
knockdown (Figure 5E, F). These results suggest that the synergy of Otx2 and Zfp281 only 
augmented Zfp281 in restricting reprogramming is cell line- and/or context-dependent. 
  
Figure 5: Otx2 genetically interacts with Zfp281 in pluripotent cell state transition. 
(A) Otx2 mRNA fold change (FC) in WT and Zfp281 naïve ESCs and 32h after 2i withdrawal. mRNA 
levels were extracted from RNA-seq datasets and normalized to WT ESCs (Mayer et al, 2019). 
(B) Absence of proteins in indicated KO cells. 
(C) Representative flow cytometry profiles of RGd2 cells of indicated genotypes in 2i, and after 24h and 
72h of 2i withdrawal (left) and 48h of 2i withdrawal with addition of FAK (right). Dashed line indicates 
cut-off for Rex1-GFPhigh and Rex1-GFPlow cells. Numbers are the average and SD of Rex1-GFPhigh cells 
in 2 biological replicates. 
(D) Self-renewal of cells with specified genotype after differentiation in indicated conditions. Average 
and SD of 2 biological replicates. 
(E, F) Number of Epi-iPSC colonies derived from O4GIPGY118F (E) and O4GIP EpiSCs containing 
Dox-inducible Esrrb or Klf4 transgenes (F) after transfection with indicated siRNA combinations, 
stimulated for 2d with Gcsf and 2i (E) or with Dox and 2i for 2d (F), and selection with Puromycin. 
Average and SD of 3 (O4GIPind. Klf4) or 2 (O4GIPGY118F and O4GIPind. Esrrb) biological replicates. 
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Although we obtained non-conclusive results for a genetic interaction of Otx2 and Zfp281 
during reprogramming of EpiSCs, increased resistance to ESC differentiation in compound 
KO cells was robust. To test whether this is due to co-binding of these two TFs to chromatin, 
we performed ChIP-seq of Otx2 in naïve ESCs (WT2i) as well as 32h after 2i withdrawal 
(WT32h). As described before (Buecker et al, 2014; Yang et al, 2014b), Otx2 binds dynamically 
to chromatin during ESC differentiation resulting in a weak correlation between these two cell 
states (Figure 6A). However, overlap of Otx2 ChIP peaks with Zfp281 ChIP peaks (Mayer et 
al, 2019) was very sparse, and observed at only 15% of all Otx2 and 11% of all Zfp281 peaks 
respectively (Figure 6B). Additionally, Zfp281 immunoprecipitation coupled to 
semi-quantitative mass spectrometry (IP-MS) in nuclear extracts of WT2i and WT40h cells did 
not reveal a direct protein interaction of Zfp281 with Otx2 (Mayer et al, 2019; Table EV3). 
Together, these data suggest that although not physically interacting, Zfp281 and Otx2 seem 
to synergistically regulate ESC progression in vitro, potentially by acting in parallel pathways. 
  
Figure 6: Comparison of DNA occupancy of Zfp281 and Otx2. 
(A) Scatter plot comparing Otx2 log2 ChIP enrichment relative to matched inputs in WT2i and WT32h 
cells. (R) Pearson’s correlation coefficient. 
(B) Overlap of Zfp281 and Otx2 ChIP peaks.  
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4.4 Additional Results II: Similarities and differences between Zfp281 
and Tfe3 regulated cell differentiation 
4.4.1 No mechanistic overlap of Zfp281 and Tfe3 in pluripotent cell state 
transitions 
Transitions of pluripotent cell states are controlled on different molecular levels including 
signaling pathways and metabolic sensing which ultimately lead to transcriptional changes 
ensuring stem cell progression. We have previously shown that the Ragulator protein complex, 
Tsc1/2 and Flcn together with Fnip1/2 enable the Rag GTPases C and D to bind and retain 
the bHLH TF Tfe3 in the cytoplasm, therefore enabling exit from the naïve pluripotent state 
(Villegas et al, 2019). In contrast, Zfp281 orchestrates pluripotent cell fate transition via 
recruitment and activation of the TF Zic2 and the methyltransferase Ehmt1 to chromatin albeit 
Zfp281 itself is relatively static during this process (Mayer et al, 2019). In both studies we 
showed that depletion of either Flcn, Lamtor1 or Zfp281 resulted in long-term maintenance of 
self-renewal in differentiation-promoting conditions (Villegas et al, 2019; Figure 1F) (Mayer et 
al, 2019; Figure 2A, EV2B), suggesting key roles in ESC progression. However, whether the 
Flcn-Lamtor-Tfe3 and Zfp281-Ehmt1-Zic2 axes converge on shared downstream targets 
remained to be determined. 
In contrast to Zfp281, none of the Tfe3 upstream regulators scored positively in our EpiSC 
reprogramming screen (Mayer et al, 2019; Table EV1), nor did ectopic nuclear Tfe3 increased 
EpiSC de-differentiation efficiency (Betschinger et al, 2013). To validate these observations, 
we transfected three independent GY118F expressing EpiSC lines with siRNAs against Flcn, 
Fnip1/2, Lamtor3 and Tsc2 and induced reprogramming. As a negative control we included 
siRNAs targeting Tcf7l1, a differentiation-specific regulator (Pereira et al, 2006) with no 
described function in reprogramming of EpiSCs (Mayer et al, 2019; Figure 1D), and as a 
positive control Zfp281. In all cell lines, depletion of none of the Tfe3 regulators increased the 
number of Epi-iPSCs compared to control transfection (Figure 7A), demonstrating distinct 
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functions of the Flcn-Lamtor-Tfe3 and Zfp281-Ehmt1-Zic2 axes in stabilizing EpiSCs against 
reprogramming. 
To test whether Zfp281 function in ESC differentiation depends on Tfe3, we made use of an 
independent differentiation assay using O4GIP ESCs (Betschinger et al, 2013). Knockdown 
of Tcf7l1, Zfp281 and Tfe3 upstream regulators caused resistance to differentiation 
(Figure 7B). Co-depletion of Tfe3 but not related MiTF/Tfe family member Tfeb reverted the 
differentiation phenotype of Flcn, Fnip1/2, Lamtor3 and Tsc2 but not Tcf7l1 or Zfp281, 
suggesting that Zfp281 acts independently of Tfe3 in ESC progression (Figure 7B). In line with 
these results, knockdown of Flcn but not Zfp281 or Tcf7l1 induced nuclear Tfe3 accumulation 
in naïve ESCs (Figure 7C). Taken together these results suggest that Zfp281 acts 
independently of the Flcn-Lamtor-Tfe3 axis in pluripotent cell state transitions.  
  
Figure 7: Zfp281 and Tfe3 regulate pluripotent cell state transitions independently from each 
other. 
(A) Number of Epi-iPSC colonies derived from specified EpiSC lines after transfection with indicated 
siRNAs, stimulated with Gcsf and 2i for 4d, and selection with Puromycin. Average and SD of 3 
(TNGAGY118F) and 2 (OGIPGY118F and 796.4) technical replicates.  
(B) Resistance to differentiation of O4GIP ESCs transfected with indicated siRNAs in combination with 
neg (grey), Tfe3 (red) or Tfeb (white) siRNAs after 72h of 2i withdrawal. Results were normalized to neg 
siRNA and are shown on a log10-scaled axis. Average and SD of 2 biological replicates. 
(C) Tfe3 localization (top) and log2 nucleo-cytoplasmic Tfe3 ratios (bottom) in O4GIP ESCs transfected 
with indicated siRNAs. Scale bar is 20μm. 
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4.4.2 Genome-wide comparison of impaired differentiation in Zfp281 and Flcn 
deficient cells 
Although functionally independent, depletion of Zfp281 or activation of Tfe3 induce 
pronounced resistance to differentiation. To investigate whether these TFs control a similar 
set of target genes we compared their genome-wide DNA occupancy in naïve ESCs 
(Betschinger et al, 2013; Mayer et al, 2019) and observed very little overlap on chromatin, 
specifically at 9% of Tfe3 and 5% of Zfp281 peaks, respectively (Figure 8A). Consistently, we 
were not able to detect a direct protein interaction between these TFs in IP-MS experiments 
(Mayer et al, 2019; Table EV3) (Villegas et al, 2019; Table S1). Zfp281 (67%) and Tfe3 (84%) 
bind preferentially distal to transcription start sites (TSSs) (Mayer et al, 2019; Figure EV3G) 
(Villegas et al, 2019; Figure S2D, E) however, the 1290 Zfp281/Tfe3 co-bound peaks are 
almost equally distributed between proximal (49%) and distal genomic regions (51%) (Figure 
8B). We showed that promoter-bound Tfe3 associates with coordinated lysosomal expression 
and regulation (CLEAR) target genes (Sardiello et al, 2009) (Villegas et al, 2019; Figure 2D, 
S2F). Genes mapped by proximity to ChIP binding sites revealed that proximal but not distal 
Zfp281/Tfe3 co-bound peaks enrich more than expected by chance at CLEAR target genes 
however to a lesser extent than proximal Tfe3-only bound peaks (Figure 8C). In contrast, 
proximal Zfp281-peaks are depleted for this gene set. In summary, overlap of Zfp281 and Tfe3 
on chromatin is very sparse, but proximal Zfp281/Tfe3 co-bound genomic regions are enriched 
to a certain extent at CLEAR target genes. 
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Figure 8: Comparison of DNA occupancy of Zfp281 and Tfe3. 
(A) Overlap of Zfp281 and Tfe3 ChIP peaks. Zfp281-only (pink), Tfe3-only (blue) and Zfp281/Tfe3 co-
bound peaks (yellow). 
(B) Density plot showing log10 distance in base pairs (bp) of Zfp281-only (pink), Zic2-only (blue) and 
Zfp281/Zic2 co-bound peaks (yellow) to nearest transcription start site (TSS). Dashed line (2000 bp) 
indicates cut-off for proximal and distal peaks.  
(C) Enrichment and depletion (standardized residuals) of CLEAR genes (Sardiello et al, 2009) in 
indicated proximal and distal peak selections. 
 
Despite strong experimental and computational evidence that Zfp281 and Tfe3 independently 
regulate ESC differentiation, we considered the possibility that they control a generic 
transcriptional cell state progression program. We therefore, first, compared genes 
differentially expressed between Zfp281 KO and WT (Zfp2812i), and Flcn KO and WT (Flcn2i) 
ESCs (Figure 9A). k-means clustering of this combined gene set (total: 1704 genes) revealed 
shared up- and down-regulated transcripts (clusters 1 and 2), as well as Zfp281- and 
Flcn-specific target genes (clusters 3 and 4, and clusters 5 and 6, respectively). Consistent 
with previous analysis (Mayer et al, 2019; Figure 3B, C), Zfp281 target genes in ESCs remain 
deregulated to a similar extent during Zfp281 KO differentiation (Zfp281diff). These genes are 
mostly unaffected after 32h of WT differentiation (WT32h), however are differentially expressed 
in EpiSCs, notably with inverse directionality to Zfp281 deficient cells (Figure 9A). Surprisingly, 
Flcn target genes in ESCs (clusters 1, 2, 5 and 6) behave similarly, raising the possibility that 
this might be a common mechanism for cell state transition regulators to prime forthcoming 
developmental progression already at an early developmental stage. While shared and 
Zfp281-specific deregulated transcripts (clusters 1-4) are mainly enriched for generic 
developmental terms using gene ontology (GO) analysis, Flcn-specific up-regulated genes 
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(cluster 5) enrich strongly for lysosomal terms (Figure 9B). To assess whether co-binding of 
Zfp281 and Tfe3 on chromatin could account for common transcriptional targets, Zfp281/Tfe3 
co-bound, Zfp281- and Tfe3-only peaks were mapped by proximity to genes in clusters 1-6 
(Figure 9C). Zfp281-only peaks were enriched for genes in clusters 2 and 4 which are 
transcriptionally down-regulated either common for Zfp281 and Tfe3 or specifically for Zfp281 
deficient cells, respectively, suggesting that Zfp281 might act predominantly as a 
transcriptional activator. In contrast, Tfe3-only peaks map preferentially to genes in cluster 5 
which are up-regulated specifically in Flcn KO cells. Since these genes associate with 
lysosomal GO terms, CLEAR target genes were also strongly enriched in this gene cluster 
(Figure 9C). Surprisingly, Zfp281/Tfe3 co-bound peaks associate equally with genes in 
clusters 4 and 5, which are mainly deregulated in either Zfp281 or Flcn deficient cells, 
respectively, but not in the shared target gene clusters 1 and 2. Zfp281 and Flcn therefore 
control a common set of target genes in naïve ESCs, but independent of co-localizing on 
chromatin, suggesting discrete regulation. 
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Figure 9: Transcriptional comparison of Zfp281 and Flcn KO ESCs. 
(A) Heatmap of mRNA log2 fold changes (log2FC) of Zfp281 and Flcn KO ESCs and differentiated cells 
relative to respective WT controls, and WT32h relative to WT2i and EpiSCs relative to WT2iL (Buecker et 
al, 2014; Factor et al, 2014) for genes significantly deregulated in Zfp2812i and Flcn2i (total: 1704 genes). 
Zfp2812i and Flcn2i samples were used for k-means clustering (black line on top of heatmap). 
(B) Top 3 enriched GO terms for biological processes (grey) and cellular components (green) in 
heatmap clusters 1-6. 
(C) Enrichment and depletion (standardized residuals) of genes associated with specified peak 
selections and CLEAR genes (Sardiello et al, 2009) in heatmap clusters 1-6. 
 
 
39 
 
To compare the function of Zfp281 and Tfe3 during early lineage progression, we used a 
similar approach however considering this time only genes which are significantly deregulated 
during WT differentiation (total: 1450 genes) (Figure 10A). k-means clustering of genes limited 
to samples specific for Zfp281 and Flcn KO differentiation (Zfp281diff and Flcndiff, respectively) 
revealed 7 gene clusters (clusters 7-13) (Figure 10A). Cluster 7 contains genes which are both 
up- and down-regulated in WT32h however remain unchanged in Zfp281diff and Flcndiff. Clusters 
8 and 9 are deregulated similarly between Zfp281diff and Flcndiff, while clusters 10 and 11, and 
clusters 12 and 13 are specific for either Zfp281diff or Flcndiff, respectively. In all cases these 
clusters are comprised of genes both up- and down-regulated in WT32h, which show consistent 
regulation in EpiSCs (Figure 10A). In line with previous analysis (Mayer et al, 2019; 
Figure 3B, C), differentiation specific deregulated transcripts of Zfp281 (clusters 8-11) showed 
minor mis-expression in Zfp2812i that became predominant only during differentiation. A 
similar pattern is observed in Flcn KO cells in clusters 8 and 9, and 12 and 13 (Figure 10A), 
suggesting differentiation-specific gene regulation. Most gene clusters in differentiation 
(clusters 7, 9, 11, 12 and 13) are enriched for developmental associated GO terms, however 
clusters 8 and 12 are also enriched for vacuolar terms, which includes the lysosome 
(Figure 10B). Proximal Zfp281/Tfe3 co-bound peaks are enriched at CLEAR target genes 
(Figure 8C), suggesting that co-binding of these two TFs could explain shared transcriptional 
targets in cluster 8. Target genes mapped by proximity to Tfe3-only ChIP peaks revealed 
strong enrichment for clusters 8 and 12 genes, and weaker enrichment for genes belonging 
to cluster 10. Zfp281/Tfe3 co-bound peaks as well as CLEAR target genes associate 
predominantly with cluster 12 and CLEAR target genes to a lesser extent with cluster 8 
(Figure 10C). In contrast, Zfp281-only peaks were not more enriched at any gene clusters as 
expected by chance. This analysis therefore suggests that Zfp281 and Flcn share a set of 
common target genes during ESC differentiation, that includes lysosomal targets in cluster 8 
which are strongly associated with Tfe3 binding to chromatin. However, Zfp281 and Flcn also 
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regulate independent transcriptional targets which in the case of Flcn contain additional 
lysosomal genes (cluster 12) and are likely direct targets of Tfe3.  
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Figure 10: Transcriptional comparison of Zfp281 and Flcn KO differentiation. 
(A) Heatmap of mRNA log2FC of Zfp281 and Flcn KO ESCs and differentiated cells relative to 
respective WT controls, and WT32h relative to WT2i and EpiSCs relative to WT2iL (Buecker et al, 2014; 
Factor et al, 2014) for genes significantly deregulated in WT32h relative to WT2i (total: 1450 genes). 
Zfp281diff and Flcndiff samples were used for k-means clustering (black line on top of heatmap). 
(B) Top 3 enriched GO terms for biological processes (grey) and cellular components (green) in 
heatmap clusters 7-13. 
(C) Enrichment and depletion (standardized residuals) of genes associated with specified peak 
selections and CLEAR genes (Sardiello et al, 2009) in heatmap clusters 7-13. 
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4.5 Material and methods for additional results 
Mouse ESCs and EpiSCs 
Female RGd2 cells contain a Rex1:GFPd2-IRES-Blasticidin (Wray et al, 2011), male O4GIP 
ESCs contain a GFP-IRES-Puromycin transgene under control of an Oct4 regulatory element 
(Betschinger et al, 2013) and Zfp281 KO.1 cells are in female RGd2 background (Mayer et al, 
2019). 
O4GIPGY118F (Mayer et al, 2019) and 796.4 (Yang et al, 2010) EpiSCs contain a 
GFP-IRES-Puromycin transgene under control of an Oct4 regulatory element (Guo et al, 2009) 
and express constitutively Stat3 activating receptor (GY118F) responsive to Gcsf (Yang et al, 
2010). TNGA EpiSCs contain a GFP-IRES-Puromycin transgene under control of regulatory 
sequences of endogenous Nanog (Chambers et al, 2007). O4GIPind. Esrrb and O4GIPind. Klf4 
EpiSCs contain a conditionally expressed Esrrb or Klf4 transgene through addition of Dox 
(Mayer et al, 2019). 
 
Cell Culture  
Culturing of ESCs and EpiSCs, ESC differentiation, EpiSC reprogramming and siRNA 
transfection were performed as described (Mayer et al, 2019; Villegas et al, 2019). Following 
siRNAs (Qiagen) were used: 
gene/control catalog number  gene/control catalog number 
Alx1 GS216285  Nkd2 GS72293 
En2 GS13799  Oct6 GS18991 
Flcn GS216805  Otx2 GS18424 
Fnip1 GS216742  Sox1 GS20664 
Fnip2 GS329679  Tcf7l1 GS21415 
Foxd3 GS15221  Tfe3 GS209446 
Foxp1 GS108655  Tfeb GS21425 
Hand1 GS15110  Tsc2 GS22084 
Jun GS16476  Utf1 GS22286 
Lamtor3 GS56692  Zfp281 GS226442 
negative control 1027281    
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Genome editing 
CRISPR/Cas9 genome editing in RGd2 WT and Zfp281 KO.1 ESCs was performed as 
described (Mayer et al, 2019). For generation of Otx2 deficient cell lines, two independent KO 
clones (specified in Figure 5B) and, in the case of Otx2 targeting in WT cells, one untargeted 
wildtype sibling clone were kept for further analysis. Following sgRNA sequences for deleting 
Exon 2 of Otx2 were used: 
sgRNA 1 (PAM) - targeting Otx2 Intron 1 sgRNA 2 (PAM) - targeting Otx2 Intron 2 
ATTTGTAGCTGGCGTCGGGGGG GAACCAGGGTCTTTTAGCCTGG 
 
 
Molecular biology 
pPB-CAG-GY118F-pgk-hph (Yang et al, 2010) was stably integrated into TNGA EpiSCs after 
co-transfection with pBASE (Betschinger et al, 2013) and selection in the presence of 
150µg/ml HygromycinB (Thermo Fisher). 
 
Immunostaining 
Immunostaining was performed as described (Villegas et al, 2019) using anti-Tfe3 (Sigma, 
HPA023881, 1:1000) antibody. DNA was visualized with Hoechst33342 (Life Technologies) 
and quantification of nucleo-cytoplasmic Tfe3 ratios was performed as described (Betschinger 
et al, 2013) for Flcn (97 cells), neg (198 cells), Tcf7l1 (208 cells) and Zfp281 (376 cells) siRNA 
transfected O4GIP ESCs. 
 
Protein methods 
Western blotting was performed as described (Mayer et al, 2019) using primary antibodies for 
anti-GAPDH (Sigma, G8795, 1:5000), anti-Otx2 (Abcam, ab21990, 1:500) and anti-Zfp281 
(Bethyl Laboratories, A303-118A, 1:500). 
 
ChIP and library preparation 
ChIP for Otx2 (Abcam, ab21990, 2µg) and subsequent library preparation was performed as 
described (Mayer et al, 2019). 
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RNA-seq analysis 
Published RNA-seq from Zfp281 KO and corresponding WT ESCs in 2i and 32h after 2i 
withdrawal (Mayer et al, 2019), Flcn KO and corresponding WT ESCs in 2i and 34h after 2i 
withdrawal (Villegas et al, 2019), ESCs cultured in 2i/LIF (Buecker et al, 2014) and EpiSCs 
(Factor et al, 2014) were used. RNA-seq reads were aligned and quantified as described 
(Mayer et al, 2019; Villegas et al, 2019). 
Transcripts were considered as expressed with at least 3 counts per million in at least two 
biological samples from Zfp281 KO and corresponding WT cells (total: 13071 genes). 
Significantly deregulated genes were identified using edgeR (Robinson & Oshlack, 2010) 
(package version 3.24.0) and fitted to following generalized linear models: 
~ time + genotype + time:genotype 
This model was used separately for Zfp281 and Flcn KO datasets including their 
corresponding WT samples. time refers to genes with a significant coefficient between WT2i 
and WT32h or WT34h cells, genes with a significant genotype coefficient are differentially 
expressed between Zfp2812i or Flcn2i and WT2i cells, and genes with a significant interaction 
term time:genotype are deregulated in Zfp281 or Flcn KO cells specifically during 
differentiation. 
Raw P values were corrected for multiple testing by calculating false discovery rates (FDR). 
Significant genes were identified as genes with an absolute log2FC greater than 1.0 and an 
FDR of less than 0.01. 
Log2FC values obtained from edgeR were used for heatmap visualization. For ESC heatmap 
in Figure 9A, only significantly deregulated genes in either Zfp2812i (781 genes) or Flcn2i 
(1167 genes) were considered (total: 1704 genes). For differentiation heatmap in Figure 10A, 
only significantly deregulated genes between WT2i and WT32h were considered (total: 1450 
genes). Heatmaps were generated using aheatmap function from the Bioconductor package 
NMF (Gaujoux & Seoighe, 2010) (package version 0.21.0). Analyses of enriched gene sets 
(Figure 9B, 10B) were performed using DAVID (Huang da et al, 2009) for GO terms of 
biological processes and cellular components. Differentially expressed genes upon transient 
TFEB overexpression in HeLa cells (CLEAR genes) (Sardiello et al, 2009) were converted to 
mouse homologs using HomoloGene (Geer et al, 2010) allowing only 1:1 mapping of genes.  
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ChIP-seq analysis 
Published Zfp281 ChIP-seq data (Mayer et al, 2019) and Tfe3 ChIP-seq data (Betschinger et 
al, 2013) as well as one replicate each for Otx2 ChIP-seq in WT2i and WT32h were aligned, 
quantified and normalized as described (Mayer et al, 2019).  
Zfp281, Otx2 and Tfe3 ChIP peaks were called using two replicates each of Zfp281 ChIP-seq 
reads in WT2i and WT32h, one replicate each of Otx2 ChIP-seq reads in WT2i and WT32h and 
one replicate each of Tfe3 ctrl and shFlcn ChIP-seq in WT2i, respectively, using Macs2 (Zhang 
et al, 2008) (version 2.1.1.20160309) with default parameters. Peaks that were at least 2-fold 
enriched (IP over respective input for Zfp281 and Otx2 or IP over IgG for Tfe3 ChIP) in at least 
one of the four replicates for Zfp281 or in at least one of the two replicates for Otx2 or Tfe3 
were considered (Zfp281: 23757 peaks, Otx2: 18207 peaks, Tfe3: 13513 peaks). To 
quantitatively compare Zfp281 and Otx2 chromatin binding, both peak sets were combined 
and overlapping peak regions were merged using the function reduce from Bioconductor 
package GenomicRanges (Lawrence et al, 2013) (package version 1.34.0). Combined peaks 
were classified into single- or co-bound as follows: Peaks that were enriched at least 2-fold 
(IP over respective input) in at least one of the four Zfp281 ChIP samples and in at least one 
of the two Otx2 ChIP samples were considered as co-bound (total: 2632 peaks), while if 
detected only in Zfp281 ChIP or only in Otx2 ChIP samples were considered as Zfp281-only 
(total: 20924 peaks) or Otx2-only (total: 15848 peaks), respectively. The same approach was 
used to determine overlapping chromatin binding of Zfp281 and Tfe3, revealing 1290 
co-bound, 22323 Zfp281-only and 12643 Tfe3-only bound peaks.  
Zfp281-only, Tfe3-only and Zfp281/Tfe3 co-bound peaks were assigned to genes by 
calculating the distance of the peak mid to nearest TSS using a set of non-redundant TSSs 
with a single start site randomly selected for each gene. Peaks were classified as proximal if 
the distance to the nearest TSS was less than 2000bp (Zfp281-only: 7052 peaks, Tfe3-only: 
1645 peaks, Zfp281/Tfe3 co-bound: 633 peaks) and as distal otherwise (Zfp281-only: 15270 
peaks, Tfe3-only: 10997 peaks, Zfp281/Tfe3 co-bound: 657 peaks). 
Enrichment or depletion of CLEAR target genes (Sardiello et al, 2009) in proximal or distal 
Zfp281-only, Tfe3-only and Zfp281/Tfe3 co-bound peaks (Figure 8C) and CLEAR target 
genes, Zfp281-only, Tfe3-only and Zfp281/Tfe3 co-bound peaks in gene clusters 
(Figure 9C, 10C) were quantified as standardized residuals by using the chisq.test function in 
R. 
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5. DISCUSSION 
Developmental progression is an intrinsic and hard-wired cellular program which relies on 
stem and progenitor cells being able to sense external cues and accordingly activate 
differentiation programs. We have shown that metabolic signaling at the lysosomal membrane 
is essential for ESC progression by inactivating the TF Tfe3, which allows activation of 
differentiation and repression of pluripotency-associated transcriptional programs. 
Identification of TFE3 gain-of-function mutations in patients with a novel developmental 
disorders suggests that the ability of Tfe3 to repress lineage progression is operational 
throughout development (Villegas et al, 2019). Reversal of cellular specification can be 
achieved in vivo upon injury or in vitro via TF overexpression. We identified the bidirectionally 
acting TF Zfp281 to be required for the exit from and to inhibit the acquisition of naïve 
pluripotency, suggesting reversibility of developmental mechanisms. In contrast to classic 
lineage-instructive TFs, Zfp281 chromatin accessibility remains largely unchanged during this 
process and instead mediates the activation and recruitment of the histone methyltransferase 
Ehmt1 and the TF Zic2, respectively (Mayer et al, 2019). Detailed discussions for both studies 
can be found in the manuscripts in the appendix section. 
In this discussion, I will focus first on additional results regarding a synergistic genetic 
interaction of Zfp281 with the homeobox TF Otx2 during pluripotent cell state transitions and 
how this could enhance our current understanding of the GRN acting during this process. In 
the second part, I will discuss the similarities and differences in the mode-of-action for the 
stem cell progression regulators Tfe3 and Zfp281. Finally, I will bring into perspective the role 
of TFs in regulating cellular plasticity to enable pluripotent cell state transition. 
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5.1 TF interplay in pluripotent cell state transitions 
5.1.1 Otx2 synergistically interacts with Zfp281 in ESC differentiation and 
partially in reprogramming of EpiSCs 
Given that the chromatin occupancy of Zfp281 remains largely static during ESC 
differentiation, we hypothesized that Zfp281 may interact with lineage-determining TFs which 
are usually characterized by upon activation, transcriptionally or via protein modification, 
instructing lineage progression. We therefore selected based on transcriptional activation and 
putative function in ESC differentiation (Betschinger et al, 2013; Leeb et al, 2014; Yang et al, 
2012), 11 candidate lineage-determining TFs. Surprisingly, depletion of only one of those, the 
homeobox TF Otx2, strongly enhanced phenotypes induced by loss of Zfp281 in both ESC 
differentiation and EpiSC de-differentiation, but had little impact on its own. Otx2 has been 
identified as a regulator of EpiSC induction and maintenance (Acampora et al, 2013) by 
recruiting Oct4 to new enhancer sites (Buecker et al, 2014; Yang et al, 2014b). In fact, 
transcriptional induction of Otx2 during ESC differentiation is mediated by Oct4 itself (Williams 
et al, 2016; Yang et al, 2014b), suggesting a positive feedforward loop for robust cell fate 
transition. In the meantime, several other genome-wide loss-of-function screens for ESC 
progression have been performed (Hackett et al, 2018; Li et al, 2018; MacDougall et al, 2019a; 
Villegas et al, 2019). Including genes identified in these screens, such as Zfp217 or Zic3, into 
our candidate list of Zfp281 interactors may identify additional factors synergizing with Zfp281 
in ESC differentiation and EpiSC reprogramming.  
Loss of Otx2 in EpiSCs does not only lead to a destabilization of this cell state, manifested by 
derepression of Sox1 and neural differentiation, but also acquisition of naïve pluripotency 
features, such as an ESC-like morphology and upregulation of Nanog (Acampora et al, 2013), 
highlighting a putative function in reprogramming of EpiSCs. In our large-scale EpiSC 
de-differentiation screen, Otx2 scored just below the significant threshold (average 
Z-score: 1.98) and thus did not classify as a primary screen hit (Mayer et al, 2019; Table EV1). 
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However, depletion of Otx2 alone did not enhance reprogramming of EpiSCs 
(Figure 4B, 5D, E) which is likely due to the less potent reprogramming setup (2 instead of 4d 
of Gcsf treatment) that we employed in this experiments to detect alterations of the strong 
Zfp281 phenotype. Moreover, acquisition of pluripotency features in EpiSCs upon loss of Otx2 
is only achieved after several passages and increases over time (Acampora et al, 2013). In 
contrast, our reprogramming setup involves acute siRNA knockdown. More specific 
experiments will be required to elucidate if and how Otx2 regulates reprogramming of EpiSCs. 
In contrast to validations in two independent ESC differentiation regimes, synergistic 
interaction of Zfp281 and Otx2 only persisted in one out of four tested EpiSC 
lines/reprogramming setups (Figure 4B, 5D, E). Whether this phenotypic discrepancy is due 
to the experimental setting, which might not allow us to see an enhancement of Zfp281 
phenotype, or a cell-line dependent effect remains to be determined. Supporting the latter, 
depletion of Foxp1, which showed the strongest increase in Epi-iPSC colonies upon 
co-depletion with Zfp281 in 796.4 EpiSCs (Figure 4B), in independent O4GIPGY118F EpiSCs 
under the same condition used in Figure 5E did indeed enhance Zfp281 reprogramming 
phenotype (data not shown).  
 
5.1.2 Potential mechanisms of Zfp281 and Otx2 interaction 
Removal of Otx2 on its own induces only minor defects in ESC differentiation, while 
co-depletion with Zfp281 showed a strong increase in retention of self-renewal, particularly in 
EpiLC differentiation (Figure 4A, 5C). This is consistent with the relatively mild transcriptional 
changes seen in differentiating Otx2 KO cells (Buecker et al, 2014), suggesting a synergistic 
rather than additive interaction between Zfp281 and Otx2. This can be either achieved by 
co-regulating a common set of target genes, which are especially sensitive to the absence of 
both proteins, or by acting in independent pathways. Supporting the latter hypothesis, we do 
not detect a direct protein interaction of Zfp281 with Otx2 in WT2i or WT40h (Mayer et al, 2019; 
Table EV3) or in a published Zfp281 protein interactome in metastable S/L ESCs (Fidalgo et 
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al, 2016). Moreover, ChIP-seq of these two TFs revealed only 15% overlap in chromatin 
localization (Figure 6B). Fgf5, a bona fide early differentiation marker, is a well described 
downstream target gene of Otx2 with 5 binding sites in close proximity to its TSS (Buecker et 
al, 2014). While differentiation-induced transcriptional upregulation of Fgf5 is strongly 
perturbed in the absence of Otx2 (Acampora et al, 2013; Buecker et al, 2014), Fgf5 expression 
remains almost unaffected during Zfp281 KO cell differentiation (Mayer et al, 2019; Figure 
EV3A, Table EV2). However, to validate a synergistic interaction of Zfp281 with Otx2, a 
comparison of transcriptional changes in individual and compound mutant cells would be 
required. Interestingly, for Ehmt1/Zic2 compound KO cells, which also show increased 
resistance to differentiation compared to the individual mutants, transcriptional analysis 
revealed rather a reinforcement of already deregulated genes rather than two independent 
genetic programs (Mayer et al, 2019; Figure 6D, EV4E).  
 
5.1.3 Zfp281 and Otx2 as part of a larger GRN 
Otx2 is required to redirect Oct4 to new enhancer sites during ESC differentiation (Buecker et 
al, 2014; Yang et al, 2014b). In cell state specific IP-MS for Oct4 not only Otx2 was identified 
to preferentially interact with Oct4 in the EpiLC state but surprisingly also Zfp281 and Zic2/3 
(Buecker et al, 2014). Indeed, we also recovered a direct protein interaction between Zfp281 
with Oct4 however without a preference for naïve ESCs or differentiated cells (Mayer et al, 
2019; Table EV3). Although we only observed little co-binding of Zfp281 and Otx2 on 
chromatin, it is appealing to speculate that this could be achieved via Oct4 as a common 
protein interactor. Careful comparison of ChIP-seq data of these three TFs will allow to 
address this question. It has been shown that overexpression of Otx2 in naïve 2i/LIF condition 
is sufficient to induce differentiation and redirect Oct4 chromatin binding (Buecker et al, 2014; 
Yang et al, 2014b). However, absence of a strong differentiation phenotype in Otx2 mutant 
cells suggests that other TFs can compensate for loss of Otx2. In light of these results, it would 
be interesting to investigate whether overexpression of Zfp281, which similarly to Otx2 induces 
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ESC differentiation (Mayer et al, 2019; Figure 2D), is also sufficient to redirect Oct4 chromatin 
binding. 
Where can we place Zic2 into this ESC differentiation specific GRN? Zic2 directly interacts 
with Zfp281 and Oct4 preferentially during differentiation (Buecker et al, 2014; Mayer et al, 
2019). We showed that Zic2 is partially required for Zfp281-induced differentiation and that 
Zfp281 recruits and stabilizes Zic2 on chromatin during ESC progression. Similar to Otx2 and 
Zfp281, overexpression of Zic2 induces ESC differentiation even under highly restrictive naïve 
culture conditions (Mayer et al, 2019; Figure EV4D), however loss of Zic2 only had minor 
effects on gene expression during differentiation (Mayer et al, 2019; Figure 6). Furthermore, 
de novo DNA motif analysis of top EpiLC specific Otx2 peaks revealed the Zic binding motif 
as the second most common one following only the Otx2 motif itself (Buecker et al, 2014). 
Although there is currently no IP-MS data in pluripotent cells available to validate a direct 
interaction of Otx2 and Zic2, one can speculate about a common mechanism of these two 
TFs. Indeed, transient expression of tagged Otx2, Zic2 and Oct4 in EpiSCs followed by 
ChIP-seq revealed preferential co-binding of Otx2 to chromatin with Zic2 rather than Oct4 in 
this developmentally more advanced cell state (Matsuda et al, 2017). Similarly to Otx2, Zic2 
also binds all five enhancer sites in close proximity to the TSS of Fgf5 in EpiSCs (Matsuda et 
al, 2017) and expression of Fgf5 is drastically reduced upon Zic2 KO differentiation (Mayer et 
al, 2019; Table EV2). Although the transient transfection of tagged transgenes by Matsuda et 
al. may reveal chromatin binding features that are distinct to the endogenous TFs, these data 
suggest further dynamic changes in the GRN responsible for EpiSC progression. It would be 
interesting to compare ChIP-seq binding sites of Otx2 and Zic2 during ESC differentiation or 
assay potential changes in Oct4 binding upon Zic2 overexpression.  
Taken together, these observations suggest a potential link between Zfp281, Otx2, Oct4 and 
Zic2 during ESC differentiation. However, more data, e.g. transcriptional consequences and 
effects on Oct4 chromatin binding upon combinatorial depletion of Otx2 and Zic2, are required 
to elucidate the dynamics of the GRN responsible for developmental progression. While Oct4, 
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Otx2 and Zic2 dynamically change their DNA occupancy during ESC differentiation, this is not 
the case for Zfp281 whose binding remains relatively static, suggesting that Zfp281 might act 
as a molecular platform on DNA for other TFs and epigenetic regulators to enable fast and 
efficient remodeling of the chromatin landscape during development. 
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5.2 Transcriptional programs regulating ESC progression 
We have identified and characterized the two TFs Tfe3 and Zfp281 as having key roles in 
transcriptional remodeling during ESC differentiation. While Flcn depletion results in a 
gain-of-function phenotype induced by nuclear Tfe3 accumulation, Zfp281 loss-of-function 
impairs exit from naïve pluripotency. Notably, Zfp281 regulates ESC progression 
independently from Tfe3 (Figure 7B, C) and we did not detect peptides corresponding to the 
respective other TF in Zfp281 or Tfe3 IP-MS (Mayer et al, 2019; Table EV3) (Villegas et al, 
2019; Table S1), suggesting no direct physical interaction. Absence of a protein interaction is 
also supported by low overlap of these two TFs on chromatin. Interestingly, roughly 50% of 
these Zfp281/Tfe3 co-bound peaks reside proximal to TSSs and show partial enrichment for 
CLEAR target genes (Figure 8B, C). This is quite surprising since in general both TFs bind 
preferentially to distal genomic regions (Zfp281: 32% proximal and 68% distal, Tfe3: 15% 
proximal and 85% distal). Additionally, the binding motifs of Zfp281, CCCCTCCCCC (Mayer 
et al, 2019; Figure EV3C) and of Tfe3, TCACGTGAT (Betschinger et al, 2013), do not share 
any sequence similarities, therefore raising the possibility that co-binding at promoters could 
be rather by chance than dependent on each other. Together, these data strongly suggest 
that Zfp281 and the Flcn-Lamtor-Tfe3 axis impact ESC progression via two independent 
pathways, that may, however, converge on the same target genes. Indeed, in both naïve 
Zfp281 and Flcn mutant ESCs and early differentiation conditions, we observe a commonly 
deregulated gene set but also an equally large fraction of pathway-specific targets 
(Figure 9A, 10A), suggesting overlapping and independent functions. 
In naïve ESCs, we showed that loss of Zfp281 results in strong transcriptional deregulation 
which persists throughout differentiation. Interestingly, these genes remain largely unchanged 
during early WT differentiation but show inverse deregulation in developmentally more 
advanced EpiSCs (Mayer et al, 2019; Figure 3B). Surprisingly, we observed a similar behavior 
for the ESC-specific target genes of Tfe3 (Figure 9A), suggesting that this might be a common 
mechanism of cell fate regulators to stabilize advanced developmental progression already at 
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an earlier developmental stage. It would be interesting to investigate whether this hypothesis 
also applies to other differentiation-promoting pathways by re-analyzing published RNA-seq 
datasets for e.g. Foxd3 (Krishnakumar et al, 2016; Respuela et al, 2016), Otx2 (Buecker et al, 
2014) or Tcf7l1 (Yi et al, 2011) deficient ESCs.  
While in ESCs CLEAR target genes as well as GO terms for lysosomal/vacuolar function are 
enriched specifically in the Zfp281-independent/Flcn-dependent cluster 5, two separate 
clusters, 8 and 12, which are Zfp281-dependent and Zfp281-independent/Flcn-dependent, 
respectively, are enriched during differentiation (Figure 10C). Zfp281 may therefore control 
cluster 8 lysosomal gene transcription during ESC progression. Absence of Flcn in ESCs does 
not only cause upregulation of lysosomal genes but also increased lysosomal proteolytic 
activity (Villegas et al, 2019; Figure 2A, S3C). It is therefore appealing to speculate that loss 
of Zfp281 might cause a similar phenotype. In contrast to Tfe3, Zfp281 chromatin binding is 
not enriched at cluster 8 genes, indicating that this effect is consequential to deficient exit from 
pluripotency rather than directly mediated by Zfp281. Whether activation of lysosomal genes 
is a common and general consequence of impaired ESC differentiation remains to be 
determined. 
Besides lysosomal genes, we also found several naïve pluripotency factors in cluster 8, e.g. 
Esrrb, Tbx3, Tfcp2l1 and Rex1, which are not efficiently repressed during differentiation in 
Zfp281 and Flcn mutant cells. With the exception of Tbx3, Zfp281 and Tfe3 bind to the TSS of 
these genes. Cluster 9 genes, which show inefficient transcriptional upregulation in Zfp281 
and Flcn KO differentiation, are comprised of several differentiation-associated genes e.g. 
Oct6, Dnmt3b, Sox11 and Zic1. While Zfp281 binds close to the TSS of all these genes, Tfe3 
binding is completely absent. This is consistent with depleted Tfe3 chromatin association at 
cluster 9 genes and enrichment for Zfp281 binding (Figure 10C). Although we find several 
prominent genes being commonly deregulated between Zfp281 and Flcn KO cells, it is rather 
unlikely that only a handful of genes cause such a strong differentiation defect. More likely an 
interplay between a larger set of factors, maybe only showing moderate deregulation, will 
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regulate such a complex process. However, more transcriptional analysis comparing different 
lineage deficient mutants is required to draw stronger conclusion regarding a relevant 
transcriptional program for ESC progression.  
While depletion of Zfp281 causes not only a deficiency in the exit from but also enhances the 
acquisition of naïve pluripotency (Mayer et al, 2019), neither ectopic nuclear Tfe3 (Betschinger 
et al, 2013) nor depletion of Flcn, Fnip1/2, Lamtor3 or Tsc2 resulted in increased numbers of 
Epi-iPSC colonies (Figure 7A). In line with these results, none of the components of the 
Flcn-Lamtor-Tfe3 axis scored positively in our EpiSC reprogramming screen (Mayer et al, 
2019; Table EV1). What discriminates Zfp281 from Tfe3? Nuclear induction of Tfe3 after exit 
from naïve pluripotency impaired proper acquisition of neuronal cell fates (Villegas et al, 2019; 
Figure S7G) which is consistent with gain-of-function mutations in human TFE3 causing a 
pleiotropic disorder with severe developmental defects (Villegas et al, 2019; Figure 7D, E, F), 
suggesting that Tfe3 function is not limited to early development. Ectopic induction of nuclear 
Tfe3 enables binding of this TF to DNA, however whether Tfe3 has the capacity to bind to 
inaccessible chromatin in EpiSCs e.g. at pluripotency genes Esrrb, Tfcp2l1 and Rex1, remains 
unknown. It has been shown that Zfp281 depletion in EpiSCs results in cell cycle arrest and 
apoptosis (Fidalgo et al, 2016), suggesting a destabilization of the EpiSC state, thus making 
cells more vulnerable to external cues such as reprogramming stimuli. Depletion of Zfp281 
will not only cause loss of associated binding partners, e.g. Zic2, but potentially also changes 
the cell-state specific chromatin environment.  
Taken together, thorough computational comparison of two important pluripotent cell fate 
regulators, Zfp281 and Flcn, allowed us to speculate about general mechanisms of ESC 
progression, e.g. inverse transcriptional deregulation of late developmental genes already in 
ESCs and the lysosome as a potential central organelle in the exit from naïve pluripotency. 
Obviously, more data are required to validate these hypotheses and to further investigate their 
functional robustness and importance. 
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5.3 Conclusion and future perspective 
Within this thesis, I discovered a bidirectional function for the TF Zfp281 in the exit from and 
acquisition of the naïve pluripotent state via recruitment and activation of the TF Zic2 and the 
histone methyltransferase Ehmt1. Moreover, I identified a synergistic genetic interaction of 
Zfp281 with the TF Otx2 most likely via Oct4. Although Zfp281 acts independent of the 
Flcn-Lamtor-Tfe3 axis during ESC differentiation, similarities in transcriptional deregulation 
indicate a general role for the lysosome as a check-point for developmental progression. 
This combined study highlights the importance of TFs as key modulators of cell state 
transitions and underlines their diverse mechanisms that ensure robust and precise cellular 
programs. We can therefore classify them in: (a) lineage-instructive TFs characterized by 
enhanced activity or expression during cell state conversion e.g. Otx2, (b) lineage-repressive 
TFs which have to be inactivated to allow lineage progression e.g. Tfe3 and (c) 
lineage-permissive TFs that serve as stable molecular platforms on chromatin without 
changing their own activity e.g. Zfp281.  
We know that there is a highly interconnected pluripotency GRN stabilizing the ESC state 
(Boyer et al, 2005; Kim et al, 2008; Loh et al, 2006), which needs to be dissolved and 
remodeled to allow developmental progression. While some components of this network are 
functionally required in both pluripotent and differentiated cells, e.g. Oct4 and Sox2, others 
only act cell state specifically, e.g. Tfe3 and Otx2. To further dissect and also better 
understand individual contributions to this network, combinatorial perturbations of different 
components have to be analyzed and computationally modelled (Dunn et al, 2014). Moreover, 
technical advances in single cell RNA-seq have enabled first insights in co-expression and 
co-regulation of key network genes in ESCs (Kolodziejczyk et al, 2015). Importantly, this GRN 
is not only a static construct but changes dynamically upon developmental progression. First 
attempts have been made to apply single cell analysis during ESC differentiation proposing a 
stochastic process of cell state transitions (Stumpf et al, 2017). 
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Can we ultimately use the knowledge of the GRN during developmental progression to 
enhance our understanding of cellular reprogramming? While ESC differentiation is a highly 
efficient process, de-differentiation is usually characterized by low reprogramming efficiency 
and accompanied by high cell death. Zfp281, as a novel bidirectional regulator of these 
processes, could serve as a prime examples to study the relationship of network dynamics in 
differentiation and de-differentiation. 
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8. APPENDICES 
8.1 Abbreviations 
bHLH  basic helix-loop-helix 
Bmp  bone morphogenetic protein 
bp  base pairs 
Cas9  clustered regularly interspaced short palindromic repeats-associated 9  
ChIP  chromatin immunoprecipitation 
Chiron  Chir99021 
CLEAR coordinated lysosomal expression and regulation 
CRISPR clustered regularly interspaced short palindromic repeats 
d  days 
DNA  deoxyribonucleic acid 
dox  doxycycline 
E  embryonic day 
EB  embryoid body 
Epi  epiblast 
Epi-iPSC epiblast stem cell derived induced pluripotent stem cell 
EpiLC  epiblast-like cell 
EpiSC  epiblast stem cell 
Erk  extracellular signal-regulated kinase 
ESC  embryonic stem cell 
FA  bFGF and ActivinA 
FAK  bFGF, ActivinA and knockout serum replacement 
FC  fold change 
Flcn  Folliculin 
Gcsf  granulocyte colony stimulating factor 
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GFP  green fluorescent protein 
GO  gene ontology 
GRN   gene regulatory network 
Gsk  glycogen synthase kinase 
h  hours 
H3K4me3 trimethylation at histone H3 lysine 4  
H3K9me1 monomethylation at histone H3 lysine 9 
H3K9me2 dimethylation at histone H3 lysine 9 
H3K27me3 trimethylation at histone H3 lysine 27  
ICM  inner cell mass 
Id  Inhibitor of Differentiation 
IP-MS  immunoprecipitation coupled to semi-quantitative mass spectrometry 
iPSC  induced pluripotent stem cell 
Jak  Janus kinase 
KO  knockout 
LIF  leukemia inhibitory factor 
Mapk  mitogen-activated protein kinase 
Mek  mitogen-activated protein kinase kinases  
MiTF  microphthalmia-associated transcription factor 
mTORC mechanistic target of rapamycin complex 
mRNA  messenger ribonucleic acid 
Myod  myoblast determination protein 
neg  negative 
n.s.  not significant 
OSKM  Oct3/4, Sox2, Klf4 and Myc 
PD03  PD0325901 
PrE  primitive endoderm 
PS  primitive streak 
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R  Pearson’s correlation 
RGd2  Rex1:GFPd2-IRES-Blasticidin 
RNA  ribonucleic acid 
RNAi  ribonucleic acid interference 
SD  standard deviation 
seq  sequencing 
sgRNA  single guide ribonucleic acid 
siRNA  small interfering ribonucleic acid 
S/L  Serum/Lif 
Stat  signal transducer and activator of transcription 
TE  trophectoderm 
TF  transcriptiona factor 
Tsc  tuberous sclerosis complex 
TSS  transcription start site 
WT  wildtype 
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SUMMARY
Self-renewal and differentiation of pluripotent murine
embryonic stem cells (ESCs) is regulated by extrinsic
signaling pathways. It is less clear whether cellular
metabolism instructs developmental progression.
In an unbiased genome-wide CRISPR/Cas9 screen,
we identified components of a conserved amino-
acid-sensing pathway as critical drivers of ESC dif-
ferentiation. Functional analysis revealed that lyso-
some activity, the Ragulator protein complex, and
the tumor-suppressor protein Folliculin enable the
Rag GTPases C and D to bind and seclude the
bHLH transcription factor Tfe3 in the cytoplasm. In
contrast, ectopic nuclear Tfe3 represses specific
developmental and metabolic transcriptional pro-
grams that are associated with peri-implantation
development. We show differentiation-specific and
non-canonical regulation of Rag GTPase in ESCs
and, importantly, identify point mutations in a Tfe3
domain required for cytoplasmic inactivation as
potentially causal for a human developmental disor-
der. Our work reveals an instructive and biomedically
relevant role of metabolic signaling in licensing em-
bryonic cell fate transitions.
INTRODUCTION
Pluripotency emerges in the mouse blastocyst at embryonic day
(E) 3.75 and declines upon implantation. Pausing developmental
progression of the pre-implantation epiblast by chemical inhibi-
tionof glycogensynthetasekinase3 (GSK3)andfibroblastgrowth
factor (FGF) signaling (2i) allows stabilizationof naive pluripotency
in self-renewing embryonic stem cells (ESCs) in vitro (Smith,
2017). Besides FGF4-elicited mitogen-activated protein kinase
signaling andGSK3-dependent disinhibition of the transcriptional
repressor Tcf7l1, multiple additional transcriptional and post-
transcriptional mechanisms enforce loss of ESC identity (Bet-
schinger, 2017). Among those are metabolic pathways that pro-
vide cofactors for chromatin-modifying enzymes and contribute
to differentiation-associated epigenetic changes (Zhang et al.,
2018). Whether these instruct or permissively facilitate extinction
of the ESC state is unclear. Furthermore, perturbation of respec-
tive metabolites delays differentiation (Hwang et al., 2016; Mous-
saieff et al., 2015), suggestingafinebalancing function rather than
an essential requirement. In contrast, depletion of the tumor sup-
pressors Folliculin (Flcn) and Tuberous sclerosis complex 1 or 2
(Tsc1/2) impairs exit from ESC self-renewal upstream of nucleo-
cytoplasmic distribution of the basic-helix-loop-helix transcrip-
tion factor (TF) Tfe3 (Betschinger et al., 2013). Flcn, Tsc, and
Tfe3 also function in signaling of the mechanistic target of rapa-
mycin (mTOR) complex 1 (mTORC1), indicating that metabolism
controls developmental progression of ESCs.
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The mTORC1 protein kinase complex coordinates cellular
growth in response to environmental conditions (Saxton and Sa-
batini, 2017; Figure S1A). Besides enabling protein, lipid, and
nucleotide synthesis, mTORC1 suppresses catabolic processes
such as autophagy. This is done in part by phosphorylating
members of the MiTF/Tfe family of TFs to which Tfe3 belongs
(Raben and Puertollano, 2016). Phosphorylation induces binding
to 14-3-3 proteins, leading to cytoplasmic sequestration and
inactivation. When mTORC1 is inactive, these TFs translocate
into the nucleus and induce both autophagy and lysosome target
genes. This provides a transcriptional feedback mechanism dur-
ing cellular starvation that enhances the production of biosyn-
thetic precursors through protein degradation.
Flcn and Tsc proteins act in pathways that signal nutritional
stimuli to mTORC1 (Saxton and Sabatini, 2017). Tsc1 and 2
are part of the heterotrimeric tuberous sclerosis protein com-
plex, which is inhibited by extrinsic growth factors and acts as
a negative regulator of themTORC1 activator Rheb (Figure S1A).
Flcn functions in a parallel signaling branch that conveys amino
acid (aa) levels to Rag guanosine triphosphatases (GTPases).
Rag GTPases form obligate heterodimers in which RagA or
RagB pairs with RagC or RagD subunits and that are recruited
to the lysosomal membrane by the pentameric Ragulator protein
complex (Bar-Peled et al., 2012; Sancak et al., 2010). Binding of
guanosine triphosphate (GTP) by the RagA/B subunit and of gua-
nosine diphosphate (GDP) by the RagC/D subunit induces a
conformation that interacts with and activates mTORC1 at lyso-
somes (Saxton and Sabatini, 2017). The nucleotide state of Rag
GTPases is controlled by GTPase-activating proteins (GAPs)
and guanine nucleotide exchange factors (GEFs) that act down-
stream of aa-sensing protein complexes; sensors of cytosolic
aas converge on inhibition of the RagA/B GAP complex
GATOR1, whereas Slc38a9 and the RagA/B GEF activity of
Ragulator are downstream of intralysosomal aas (Saxton and
Sabatini, 2017). Flcn, in contrast, interacts with Flcn-interacting
proteins (Fnip) 1 and 2 and is a RagC/D GAP that facilitates acti-
vation of the Rag heterodimer and, consequentially, mTORC1 in
response to aas (Meng and Ferguson, 2018; Petit et al., 2013;
Tsun et al., 2013).
The function of Flcn and Tsc in ESC differentiation therefore
poses a conundrum; Flcn is an activator and Tsc an inhibitor of
mTORC1, but depletion of either protein impairs exit from self-
renewal upstream of nuclear Tfe3 (Betschinger et al., 2013; Li
et al., 2018). Canonical mTORC1 signaling is therefore unlikely
to instruct differentiation. Consistent with this, chemical inhibi-
tion of mTORC1 in ESCs compromises proliferation and transla-
tional regulation but not extinction of naive pluripotency (Bet-
schinger et al., 2013; Gangloff et al., 2004; Murakami et al.,
2004; Sampath et al., 2008). It is therefore unclear how Flcn
and Tsc drive ESC differentiation. Furthermore, it remains to
be determined how Tfe3 prevents resolution of the pluripotent
transcriptional circuitry and whether its anti-differentiation func-
tion is restricted to murine pluripotent stem cells.
Here we apply a genome-wide functional CRISPR/Cas9
screen to identify genes that are essential for exit from ESC
self-renewal. We show that the majority of these, including
Flcn, are part of a signaling pathway that activates RagC/D at
the lysosome, which, in turn, induces cytoplasmic Tfe3 inactiva-
tion. In contrast to canonical aa sensing, this function of Rag
GTPases is mTORC-independent. In fact, mTORC1 antagonizes
RagC/D activation in ESCs, providing a mechanistic explanation
for why Flcn and Tsc proteins act antonymously in mTORC1
regulation but synonymously in differentiation. We demonstrate
that the catabolic activity of lysosomes controls differentiation
throughRagC/D and Tfe3, providing a directmechanistic link be-
tween ESC catabolism and transcriptional control of develop-
mental progression. Furthermore, we identify a Tfe3 protein re-
gion that is essential for lysosome-mediated inactivation. This
part of the protein is frequently deleted in TFE3 translocation-
induced human renal cell carcinomas and mutated in a human
mosaic developmental disorder, indicating a conserved role of
lysosomal signaling in cell state transitions.
RESULTS
Ragulator Drives ESC Differentiation Upstream of
Subcellular Tfe3 Localization
Release from 2i induces exit from ESC self-renewal and terminal
differentiation (Kalkan et al., 2017). To identify the molecular
mechanisms essential for this process, we screened for genes
whose deletion would block differentiation. Toward this goal,
we infected Cas9-expressing RGd2 ESCs with a genome-wide
lentiviral guide RNA (gRNA) library (Koike-Yusa et al., 2014)
and continuously passaged these cells in the absence of 2i. To
enrich for differentiation-resistant mutant cells, we concomi-
tantly selected for expression of the Rex1 (Zfp42) reporter in
RGd2 cells, which marks self-renewing ESCs (Kalkan et al.,
2017; Figure 1A). This screen was performed independently in
two female ESC clones and identified 19 high-confidence target
genes, including Flcn (Figure 1B; Table S1). We validated the dif-
ferentiation resistance phenotype for 15 of those in a male RGd2
ESC line that was transiently transfected with Cas9 and individ-
ual gRNAs (Table S3). To determine genes that act upstream of
subcellular Tfe3 distribution, we analyzed Tfe3 localization in
these (Figure 1C). Similar to differentiated wild-type cells (Fig-
ure S1H), seven of the differentiation-resistant mutants showed
cytoplasmic Tfe3 accumulation. These contained members of
the pathways inhibited by 2i: the GSK3-signaling components
APC and Tcf7l1 and the FGF receptor signal transducers
Ptpn11 and Grb2. In contrast, Tfe3 was nuclear in the absence
of Flcn and the Ragulator subunits Lamtor1, 2, 4, and 5 and nu-
cleo-cytoplasmic in the absence of Tsc1 and 2. Consistent with a
predominant role of Tfe3 distribution in exit from ESC self-
renewal, we also identified two gRNAs targeting exon 4 of Tfe3
that generated Tfe3 alleles with ectopic nuclear localization.
Similar roles in differentiation and aa sensing suggest that Ragu-
lator and Flcn function together in exit from self-renewal.
We first confirmed the role of Lamtor1, 2, and 3 in an indepen-
dentassay (Betschingeret al., 2013). Their knockdown inOct4GIP
ESCs by small interfering RNA (siRNA) transfection induced
nuclear enrichment of Tfe3 and impaired differentiation, similar
to absence of Flcn and the redundantly acting Folliculin-interact-
ing proteins Fnip1 and 2 (Figures S1B–S1D; Betschinger et al.,
2013). To test for Tfe3 dependency, we co-depleted MiTF/Tfe
family members expressed in ESCs (Figure S1E). Removal of
Tfe3, but not Tfeb or MiTF, reverted differentiation defects
caused by knockdown of Flcn and Lamtor1 and 2 but not Tcf7l1
(Figure 1D), demonstrating a specific requirement for Tfe3
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downstream of these genes. For further analysis, we generated
isogenic Flcn and Lamtor1 knockout (KO) ESC clones (Figures
S1F and S1G). These maintained nuclear Tfe3 localization (Fig-
ure S1H) and failed to exit self-renewal under two different dif-
ferentiation regimes: removal of 2i and the strongly inductive
epiblast-like cell (EpiLC) differentiation (Hayashi et al., 2011;
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Figure 1. Identification of Differentiation Drivers in a Genome-wide CRISPR/Cas9 Screen
(A) Schematic outline of the screening procedure. Green indicates undifferentiated cells.
(B) Screen results ordered by statistical significance. Genes labeled in red were retested, of which genes annotated in black were validated.
(C) Tfe3 localization in RGd2 cells transiently transfected with Cas9 and gRNAs targeting the indicated genes after 3–5 passages in the absence of 2i. Note that
control cells are lost as expected during the procedure because of terminal differentiation. Scale bar is 20 mm.
(D) Resistance to differentiation of O4GIP ESCs transfected with the indicated siRNA combinations after 3 days of 2i withdrawal. Results were normalized to
negative (neg) siRNA cells and are shown on a log(10)-scaled axis. Average and standard deviation (SD) of 2 technical replicates are shown.
(E) Retention of self-renewal after 2 days of 2i withdrawal under the indicated conditions. Average and SD of 3 biological replicates are shown.
(F) Alkaline phosphatase composition of colonies derived from the indicated long-term differentiated cell lines subjected to clonal self-renewal in 2i. Average and
SD of 2 biological replicates are shown.
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Figure 1E). Both phenotypes were rescued by Flcn and Lamtor1
transgene expression in the respective mutants (Figures 3B and
3C). Long-term culture of Flcn and Lamtor1 KO ESCs in the
absence of 2i gave rise to cell populations retaining self-renewal,
which is similar to induction of ectopic nuclear Tfe3 in 4-hydroxy-
tamoxifen (Tam)-treated Tfe3-ERT2 expressing cells (Figure 1F;
Betschinger et al., 2013). In summary,Ragulator andFlcn function
upstream of Tfe3 and are required for ESC differentiation.
The Flcn-Ragulator-Tfe3 Axis Regulates Lysosomal and
Developmental Transcription
To gain insight into Flcn and Ragulator function in ESCs, we
compared the transcriptomes of two independent Flcn and
Lamtor1 KO cell lines and their respective controls (Table S1).
Transcriptional deregulation in mutant ESCs was strongly corre-
lated (Pearson correlation coefficient [R] = 0.70) (Figure S2A),
suggesting that both genes act in the same pathway. To explore
the relation with Tfe3 activity, we also profiled Tfe3-ERT2-ex-
pressing ESCs after 3 hr and 34 hr of Tam induction. k-means
clustering (Figures 2A and S2B) of deregulated transcripts iden-
tified groups of early (cluster 1), late, and indirect Tfe3 target
genes (clusters 2–6) and Tfe3-independent alterations in estab-
lished Flcn and Lamtor1 KO cell lines (clusters 7 and 8). Compar-
ison with published datasets of blastocyst development (Boro-
viak et al., 2015) showed, in particular upon 34 hr Tfe3
activation in Tfe3-ERT2 ESCs, a correlation with induction of
diapause, an embryonic state of suspended development (Fig-
ure S2A). Although this correlation is not strong (R = 0.22), it is
comparable with reported diapause—mimicking ESC regimes
using chemical inhibitors (Bulut-Karslioglu et al., 2016; Scogna-
miglio et al., 2016).
To directly explore the role of Tfe3 in differentiation, we
sequenced RNA of control, Flcn KO, and Tam-induced Tfe3-
ERT2 cells after release from 2i (Table S1). Principal-compo-
nent analysis (PCA) separated control ESCs and the E4.5
epiblast (Boroviak et al., 2015) from 34-hr differentiated control
cells, EpiLCs (Buecker et al., 2014), and the E5.5 epiblast along
PC2 (Figure 2B). In contrast, 34-hr differentiated Flcn KO and
Tfe3-induced cells as well as their long-term differentiated
progeny, including Lamtor1 KO cells, clustered close to wild-
type ESCs, suggesting transcriptome-wide impairment of
peri-implantation programs. k-means clustering (Figure 2C) of
differentiation-specific transcriptional changes identified insen-
sitive genes (clusters 9 and 10), transiently induced Tfe3 targets
(cluster 11) and two clusters of genes (clusters 12 and 13)
whose dynamic behavior during differentiation was significantly
(data not shown) dampened by genetic perturbations. Gene
ontology (GO) analysis revealed enrichment of developmental
and lysosomal regulators in clusters 12 and 13, respectively
(Figure 2C; Table S1). Deregulation of these two clusters was
already detectable in Flcn and Lamtor1 KO ESCs and Tfe3-
ERT2 ESCs induced for 34 hr. This is, however, not causal to
aberrant transcription during differentiation because Tam was
added to Tfe3-ERT2 cells only upon release from 2i. To test
whether the induction of lysosomal regulators has a functional
consequence, we exposed ESCs to DQ-BSA, a substrate that
fluoresces after proteolysis in lysosomes (Figure S2C). This re-
vealed an increase in lysosomal proteolytic activity in Flcn
(+40%) and Lamtor1 (+57%) KO and Tfe3-ERT2 Tam-treated
(+61%) cells. The opposite was observed in the presence of
Vacuolin-1 (33%), a compound that compromises delivery
and maturation of lysosomal enzymes (Sano et al., 2016).
When Tfe3 was acutely induced, we also observed an expan-
sion of the LysoTracker-labeled endolysosomal compartment.
Tfe3 overactivation therefore increases the activity of lyso-
somes in Flcn- and Lamtor1-mutant ESCs.
Alterations of mRNA levels in clusters 12 and 13 were by and
large undiscernible in Tfe3-ERT2 ESCs induced for 3 hr (Fig-
ure 2C), indicating that they are late or indirect Tfe3 targets. To
discriminate between these possibilities, we analyzed genome-
wide Tfe3 occupancy in ESCs (Betschinger et al., 2013). Tfe3
binds predominantly distal of transcriptional start sites (TSSs),
but the overlap with enhancer features is scarce (2,387 putative
enhancer within 11,459 total peaks) (Figures S2D and S2E).
Target genes mapped by proximity to all distal binding sites
(3,996 genes) or the 2,387 putative enhancers (1,440 genes)
are predominantly enriched at Tfe3-insensitive genes in cluster
10 (Figure 2D). In contrast, the majority of Tfe3-bound proximal
sites are associated with marks of active transcription and en-
riched at Tfe3-sensitive genes in clusters 11 and 13 (Figures
2D and S2E). Tfe3, thus, antagonizes differentiation-specific
transcription by directly activating promoters of cluster 13 tar-
gets and indirectly repressing expression of cluster 12 genes.
Promoter-driven induction of lysosomal regulators is reminiscent
of MiTF/Tfe family TFs driving the CLEAR (coordinated lyso-
somal expression and regulation) gene network in somatic cells
(Sardiello et al., 2009). CLEAR genes are indeed enriched in
clusters 11 and 13 and also mirror the Tfe3 binding preference
to promoters of genes in clusters 1–8 (Figures 2D and S2F).
This suggests that upregulation of at least a subset of direct
metabolic targets in ESCs is a cell-type-independent response
to Tfe3 activation. Taken together these findings indicate that
disinhibition of Tfe3 in the absence of Flcn and the Ragulator
subunit Lamtor1 triggers a specific transcriptional cascade that
simultaneously augments cellular catabolism and inhibits forth-
coming developmental transcription.
Flcn-Dependent RagC/D Activation Controls Exit from
ESC Self-Renewal
Ragulator and Flcn-Fnip are required for activation of RagA/B
and RagC/D, respectively (Figure S1A). As has been described
for somatic cells, RagC, Lamtor1 (Sancak et al., 2010), and a sub-
fraction of endogenously tagged Flcn (Martina et al., 2014) coloc-
alize with lysosome-associated membrane protein 1 (LAMP1)
in ESCs (Figure 3A). Lysosomal RagC localization requires
Lamtor1, 2, and 3 but not Flcn (Figure S3A), corroborating the
previously reported Ragulator-dependent Rag GTPase recruit-
ment (Sancak et al., 2010). To probe their role in exit from self-
renewal, we depleted Rag GTPases in O4GIP ESCs by siRNA
transfection (Figure S3B). The combinatorial knockdown of
RagA/B or RagC/D caused nuclear Tfe3 accumulation and
Tfe3-dependent differentiation impairment (Figures 1D and
S1B–S1D). Rag GTPases therefore act redundantly and, similar
to Ragulator and Flcn, drive developmental progression up-
stream of Tfe3. We note that our primary screen identified
RagC (Figure 1B) and that individual knockdownofRagC induced
resistance to differentiation, although less pronounced than
together with RagD (Figure S1B). Although we did not observe
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significant nuclear Tfe3 enrichment in cellswithoutRagC (Figures
1CandS1D), co-depletion of Tfe3 restored exit fromself-renewal
(Figure S3C), suggesting subtle but functionally relevant Tfe3
mislocalization.
We next tested whether Flcn and Ragulator act upstream of
Rag GTPases by using mutants preferentially binding GDP
(RagB/C/DGDP) or encoding for GTPase-inactive alleles (RagB/
C/DGTP) (Tsun et al., 2013). Overexpression of RagC/DGDP re-
verted nuclear Tfe3 localization and differentiation impairment
in Flcn KO cells (Figures S3D and S3E), whereas RagC/DGTP or
any nucleotide-loading RagB mutant did not, suggesting that
Flcn acts as a GAP for RagC/D in ESCs. To determine the role
of Ragulator in activating RagA/B, we exploited the notion that
Lamtor1 anchors the Ragulator-Rag GTPase complex at the
lysosome (Bar-Peled et al., 2012; Nada et al., 2009). We
reasoned that cytoplasmic delocalization of Rag GTPases in
the absence of Lamtor1 (Figure S3A) would allow us to assemble
lysosomal signaling by targeting Rag GTPases ectopically to
the lysosomal membrane. We therefore engineered hybrid pro-
teins in which the N-terminal lysosomal targeting sequence of
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Lamtor1 (Nada et al., 2009) was fused to RagB and C
(lysRagB/C) and that colocalized with LAMP1 in Lamtor1 KO
ESCs (Figures S3F–S3H). Importantly, lysRagC but not lysRagB
reverted nuclear Tfe3 localization and differentiation resistance
(Figures 3B and 3C) in Lamtor1 KO ESCs. Although we cannot
exclude that the lysRagB hybrid protein is non-functional, this
suggests that lysosomal targeting of RagC is sufficient for exit
from self-renewal in the absence of Ragulator. Consistent with
the notion that Flcn acts upstream of the RagC/D nucleotide
state and independent of lysosomal recruitment (Figure S3A),
lysRagCGDP rescued Flcn KO phenotypes whereas lysRagC
did not (Figures 3B and 3C). Conversely, lysRagCGTP dominantly
induced nuclear Tfe3 localization and Tfe3-dependent differenti-
ation impairment in wild-type cells (Figures 3D, S3I, and S3J).
These results suggest that the principal role of Ragulator in exit
from ESC self-renewal is lysosomal recruitment of RagC/D.
Non-canonical RagGTPase Regulation and Signaling
in ESCs
The RagA/B nucleotide state depends on the GATOR1 GAP
complex, which is antagonized by GATOR2 (Bar-Peled et al.,
2013; Figure S1A). To probe their role in differentiation, we
generated Depdc5 (a GATOR1 subunit) and Wdr24 (a GATOR2
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Figure 3. Lysosomal Rag GTPases Drive ESC
Differentiation
(A) Colocalization of Lamtor1, RagC, and tagged
Flcn with LAMP1 (arrowheads) in ESCs. Scale bars,
20 mm and 10 mm (inset).
(B and C) Tfe3 localization (B) and retention of self-
renewal relative to empty vector-transfected cells
after 3 days of 2i withdrawal (C) in cells of the indi-
cated genotypes expressing the indicated Rag
transgenes. Average and SD of 2 biological repli-
cates are shown. Scale bar, 20 mm.
(D) Retention of self-renewal after 3 days of 2i
withdrawal in wild-type cells expressing indicated
RagC transgenes. Average and SD of 2 biological
replicates.
subunit) KO ESCs (Figure S4A). Neither
featured nuclear Tfe3 enrichment or resis-
tance to differentiation (Figures 4A and
4B), suggesting that RagA/B regulation is
dispensable. This is surprising because
activation of the Rag heterodimer by aas
in somatic cells critically depends on the
RagA/B nucleotide state (Saxton and Sa-
batini, 2017). We therefore tested whether
ESCs are at all able to transduce changes
in aa levels to mTORC1 by monitoring
phosphorylation of the mTORC1 sub-
strates S6 kinase (S6K) and 4EBP1. Aa
deprivation in ESCs caused Depdc5-
dependent mTORC1 inactivation, whereas
readdition led to its reactivation, whichwas
blunted in Wdr24 and severely impaired in
Lamtor1 KO ESCs (Figure 4C). These ob-
servations are consistent with canonical
aa sensing in ESCs. In contrast, mTORC1
regulation was unperturbed in Flcn KO ESCs. Although unex-
pected, Flcn- and Fnip1/2-independent mTORC1 activation in
response to aas has been described before in other cell types
(Nagashima et al., 2017; Wada et al., 2016). We conclude that
GATOR-dependent regulation of RagA/B mediates mTORC1
activation by aas but not differentiation of non-starved ESCs.
Consistent with decoupling of RagGTPase regulation and
mTORC1 in steady-state ESCs, phosphorylation of mTORC1
substrates was not significantly altered in Flcn and Lamtor1
KO cells (Figure S4B), and transcriptional deregulation in Flcn
and Lamtor1 KO ESCs does not correlate with mTOR inhibition
(Bulut-Karslioglu et al., 2016; Figure S2A).
This may explain why exit from self-renewal is unperturbed in
the presence of the allosteric mTORC1 inhibitor rapamycin
(Rapa) (Betschinger et al., 2013). To show that this is not because
of Rapa-insensitive mTORC1 activity (Saxton and Sabatini,
2017), we treated ESCs with the catalytic mTOR inhibitor
AZD8055 and knocked down the mTORC1 subunit Raptor by
siRNA transfection. Similar to Rapa treatment, this did not
induce nuclear Tfe3 translocation or retention of self-renewal
(Figures S4C–S4E), demonstrating that Rag GTPases drive
differentiation independent of activating mTORC1. How, then,
does mTORC1 hyperactivation upon depletion of Tsc1 and
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Tsc2 impair ESC differentiation upstream of nuclear Tfe3 (Bet-
schinger et al., 2013; Figures 1B–1D, S1D, S4C, and S4D)? We
first compared transcriptional changes in Flcn and Lamtor1 KO
ESCs with recently published alterations in Tsc2 KO ESCs (Li
et al., 2018). This revealed a similar, although weaker, deregula-
tion of Tfe3 target genes, particularly in clusters 5 and 6 (Fig-
ure S2B). The Tsc2 and Flcn-Ragulator pathways thus overlap
significantly at the level of Tfe3 regulation. We reasoned that
Rag GTPases are a potential intersection point of both path-
ways. To functionally test this, we generated Tsc2 KO ESCs
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Figure 4. Non-canonical Rag GTPase Regulation in Steady-State ESCs
(A and B) Tfe3 localization (A) and retention of self-renewal after 3 days of 2i withdrawal (B) of the indicated genotypes. Average and SD of 2 biological replicates
are shown. Scale bar, 20 mm.
(C) mTORC1 activity in ESCs in response to amino acids. Arrows mark fast-migrating (unphosphorylated) and slow-migrating (phosphorylated) 4EBP1.
(D) Retention of self-renewal after 3 days of 2i withdrawal in the indicated cell lines in the absence or presence of 20 nM rapamycin. Average and SD of 2 biological
replicates are shown.
(E and G) Tfe3 subcellular localization in the indicated ESCs with or without 20 nM rapamycin (E) and Tsc2 KO.1 ESCs expressing the indicated Rag constructs (G).
Scale bar, 20 mm.
(F) Retention of self-renewal relative to empty vector-transfected cells in Tsc2KO.1 cells expressing the indicated transgenes after 3 days of 2i withdrawal. Average
and SD of 2 biological replicates are shown.
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(Figures S4A and S4F). These cells featured hyperactive
mTORC1, nuclear Tfe3, and impaired differentiation, which
was reversed by addition of Rapa (Figures 4D, 4E, and S4G).
Remarkably, expression of RagCGDP or RagDGDP specifically
rescued these phenotypes (Figures 4F and 4G), which is similar
to Flcn KO cells (Figures S3D and S3E). This suggests that Tsc-
dependent mTORC1 inhibition and Flcn-Ragulator function
converge on lysosomal RagC/D to sequester Tfe3 in the cytosol
and promote exit from self-renewal.
Lysosomal Catabolism Drives ESC Differentiation
Our results indicate that Flcn specifies differentiation-specific
RagGTPase signaling. To characterize upstream signals, we
tested the role of aas and glucose in this pathway. Removal of
essential aas or glucose from the ESC culture medium induced
nuclear Tfe3 localization and impaired exit from self-renewal
(Figures 5A andS5A). This was accompanied by inhibition of pro-
liferation (data not shown), which was not observed in Flcn or
Lamtor1 KO ESCs. Consistent with a Rag GTPase-independent
response, resistance to differentiation was not reverted by
lysRagCGDP expression or in Tfe3 KO ESCs (Figures 5A and
S5B-S5D). Although these observations do not rule out nutri-
tional control of RagC/D activation, they likely reflect a multitude
of stress-related responses in starving ESCs.
Lysosomes degrade proteins, lipids, carbohydrates, and or-
ganelles to generate aas that signal to Rag GTPases (Saxton
and Sabatini, 2017). We therefore decided to specifically probe
the role of lysosomal catabolism in ESC differentiation. Addition
of the vacuolar H+ ATPase (v-ATPase) inhibitors bafilomycin A
(Baf A) and concanamycin A (Con A), the lysosomotropic com-
pound chloroquine, or Vacuolin-1 impaired exit from self-renewal
(Figures 5B and S5E). Because Baf A, Con A, and chloroquine
also triggered dose-dependent cell lethality (data not shown),
we focused our experiments on Vacuolin-1. Treatment with
Vacuolin-1 induced nuclear Tfe3 translocation (Figure 5C), but
expression of lysRagCGDP or KO of Tfe3 rescued Vacuolin-1-
elicited resistance to differentiation (Figures 5D and 5E). Com-
pound treatment altered lysosomal morphology, but RagC still
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Figure 5. Lysosomes License ESC Differentiation
(A) Retention of self-renewal after 2 days of 2i withdrawal in the absence of essential amino acids (aa) and/or glucose (glc) in the indicated genotypes. Average and
SD of 2 biological replicates are shown.
(B) Self-renewal of wild-type cells in 2i after 24 hr treatment with 40 nM rapamycin, 100 nM AZD8055, 20 nM Con A, 100 nM Vacuolin-1, or 10 mM chloroquine
under 2i or differentiation conditions. Average and SD of two technical replicates are shown.
(C) Tfe3, RagC, and LAMP1 localization in wild-type ESCs treated for 24 hr with 100 nM Vacuolin-1. Arrowheads indicate colocalization of RagC and LAMP1.
Scale bar, 20 mm.
(D and E) Retention of self-renewal in wild-type cells expressing the indicated Rag transgenes (D) and in the indicated cell lines (E) differentiated for 3 days in the
absence or presence of 100 nM Vacuolin-1. Average and SD of 2 technical replicates are shown.
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colocalized with LAMP1 (Figure 5C). In the presence of
Vacuolin-1, the Ragulator-RagC complex, despite localizing to
lysosomes, is thus not able to sequester Tfe3 in the cytoplasm.
This suggests that lysosomal catabolism per se activates Flcn
and RagC/D to drive Tfe3 inactivation and exit from ESC
self-renewal.
Binding to RagC/D Is Required for Phosphorylation and
Inactivation of Tfe3
To explore how Rag GTPase signaling in ESCs regulates Tfe3,
we determined the Tfe3 interactome using label-free quantitative
mass spectrometry (Table S1). Tfe3 in RagC/DGDP-overexpress-
ing ESCs specifically interacted with the Ragulator-Rag GTPase
protein complex, v-ATPase subunits, and members of the
14-3-3 protein family compared with nuclear Tfe3-specific bind-
ing partners in Flcn and Lamtor1 KO cells (Figure 6A). Pull-down
of Tfeb by the RagA/BGTP-RagC/DGDP heterodimer in human cell
lines has been reported before (Martina and Puertollano, 2013),
but Tfe3 failed to interact with any RagB nucleotide-loading
mutant in ESCs (Figure S6A), demonstrating RagC/DGDP speci-
ficity. We also noted that RagDGDP co-immunoprecipitated
more Tfe3 than RagCGDP and that both induced Tfe3 protein sta-
bilization. Association of Tfe3 with Rag GTPases was undetect-
able in wild-type ESCs (Figure 6B) and ESCs overexpressing
wild-type RagC/D proteins (Figure S6A), suggesting transient
and nucleotide-dependent binding. To test the necessity of
this interaction in the context of the endogenous Rag nucleotide
cycle, we expressed, in Tfe3KOESCs, inducible Tfe3 alleles with
mutations in residues homologous to the ones required for inter-
action of Tfeb with the active Rag heterodimer (Martina and
Puertollano, 2013). In contrast to wild-type Tfe3, Tfe3(S111A,
R112A) and Tfe3(Q118A, L119A) localized to the nucleus (Fig-
ure 6C) and impaired exit from self-renewal (Figure 6D), indi-
cating that association of Tfe3 with endogenous RagC/DGDP is
required for cytoplasmic localization and ESC differentiation.
Phosphorylation by mTORC1 induces interaction of MiTF/Tfe
TFs with 14-3-3 proteins in response to aas (Raben and Puertol-
lano, 2016). To test whether association of cytoplasmic Tfe3 with
14-3-3 proteins in ESCs requires phosphorylation of the same
sites, we generated Tfe3 alleles with Ala mutations in conserved
mTORC1 substrate residues. This revealed that Tfe3(S245A)
(Settembre et al., 2012) and Tfe3(S320A) (Roczniak-Ferguson
et al., 2012) were partially and Tfe3(S245,S320A) exclusively
nuclear compared with wild-type Tfe3 and Tfe3(10xA) (Pen˜a-
Llopis et al., 2011; Figure 6C). Single and double Tfe3 mutants
also impaired ESC differentiation (Figure 6D). These findings
suggest that mTORC1-independent S245 and S320 phosphory-
lation downstream of RagC/DGDP is necessary for 14-3-3 pro-
tein-mediated cytoplasmic Tfe3 retention.
Point Mutations in Tfe3 Associated with a Human
Developmental Disorder
Taken together, these findings demonstrate non-canonical Rag
GTPase signaling in differentiation. This may not be unique to
ESCs because Tsc1/2 and Flcn loss-of-function mutations, hy-
peractive mTOR alleles, and deletion of Tfe3 exons 1–3 by
DC
A B
Figure 6. Association with Rag GTPases Drives Phosphorylation-Dependent Tfe3 Inactivation
(A and B) Tfe3 interactome comparison between RagC/DGDP-expressing and Flcn and Lamtor1 KO ESCs (A) and wild-type and Tfe3 KO ESCs (B). Redmarks the
Ragulator-Rag GTPase complex, blue 14-3-3 protein family members, and yellow v-ATPase subunits. Quantification is based on 3 biological replicates.
(C and D) Tfe3 localization (C) and retention of self-renewal after 3 days of 2i withdrawal (D) in Tfe3KO.6 cells conditionally expressing the indicated Tfe3 alleles.
Average and SD of 2 biological replicates are shown. Scale bar, 20 mm.
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translocation to distinct partner genes are frequently detected in
renal cell carcinoma (Grabiner et al., 2014; Kauffman et al., 2014).
Themolecular consequences of these Tfe3 alterations are poorly
understood (Kauffman et al., 2014), but the results presented
here suggest that they behave as nuclear gain-of-function
alleles. We therefore conditionally expressed corresponding
Tfe3 deletions in Tfe3 KO ESCs (Figure 7A). Inclusion of exon 3
(exon 3-end) recapitulated cytoplasmic localization of wild-
type Tfe3, whereas removal (exon 4-end) induced nuclear trans-
location and impaired differentiation (Figures 7B and 7C), indi-
cating that the absence of exon 3 and not the presence of fusion
partners may underly oncogenic activity of chromosomal Tfe3
rearrangements. Surprisingly, transcript sequencing of gain-of-
function Tfe3 alleles recovered in our screen (Figures 1B and
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Figure 7. Disease-Associated Tfe3 Alter-
ations Produce Ectopic Nuclear Gain-of-
Function Alleles
(A) Tfe3 domain and exon structure and Tfe3 dele-
tion constructs used in (B) and (C). Exons 3 and 4
and the MiTF/Tfe TF family-specific homology
stretch are indicated.
(B, C, E, and F) Tfe3 localization (B and E) and
retention of self-renewal after 3 days of 2i withdrawal
(C and F) in Tfe3KO.6 cell lines conditionally express-
ing the indicated Tfe3 alleles. Average and SD of
2 biological replicates are shown. Scale bar, 20 mm.
(D) Clinical phenotype of patients and molecular
details of corresponding Tfe3 mutations. I–IV: facial
features of patients 1 (I), 2 (II), 3 (III), and 5 (IV). Note
the coarse features, facial hypertrichosis, and full
cheeks common to the individuals. V–VIII: cuta-
neous phenotype of patients 1 (V), 2 (VI and VII),
and 3 (VIII). Note the whorls and streak hypo-
pigmentation along Blaschko’s line. IX: body
asymmetry and umbilical hernia in patient 4.
(G) Model of lysosomal signaling in ESCs. The
Rag heterodimer equilibrium under steady-state
ESCs is shifted toward the di-GDP conformation.
RagC/DGDP interacts with the Rag binding fold
(RBF) in Tfe3, catalyzing its phosphorylation and
consequential cytoplasmic sequestration by 14-3-3
proteins. Unphosphorylated Tfe3 translocates into
the nucleus to induce metabolic targets and stabi-
lize the pluripotent transcriptional circuitry.
1C) revealed small in-frame-deletions
around T180–P185 and loss of the entire
exon 4 (Figure S7A). Nuclear localization
of the Tfe3Dexon4 protein and resistance
to differentiation were validated in a Tfe3
exon 4-skipping mutant ESC clone gener-
ated by an independent gRNA (Figures
S5B, S5D, and S7B) and in Tfe3 KO cells
harboring inducible Tfe3Dexon4 transgenes
(Figures 7A–7C). Both exon 3 and exon 4
are therefore required for Tfe3 inactivation.
Alterations in exon 4, however, have not
been associated with disease as of now.
In a programdesigned to identify genetic
causalities of hypomelanosis of Ito (HI,
OMIM: 300337), we identified four de
novogermlinemutations (female patient 1,Q119P; female patient
2, Q201P; female patient 3, T187M; female patient 5, P186L) and
one de novo mosaic mutation (male patient 4, T187R) in TFE3
(Figure 7D; Table S2; Data S1). HI and pigmentary mosaicism
are unspecific terms encompassing a heterogeneous group of
disorders characterized by hypopigmented whorls and streaks
along Blaschko’s lines and variable extracutaneous features
affecting the musculoskeletal and nervous systems (Sybert,
1994). Phenotypes of patients with TFE3mutations included hy-
popigmentation on Blaschko’s lines, severe intellectual disability
(ID), coarse facial features, frontonasal dysplasia, obesity, epi-
lepsy, andgrowth retardation (Table S2), suggesting apleiotropic
developmental disorder. All five TFE3 variants affect conserved
aas (FigureS7C), and themissense variants are in silicopredicted
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to be pathogenic (Table S2). TheQ119Pmutation resides in exon
3 and affects an aa implicated in RagGTPase interaction (Figures
6C and 6D; Martina and Puertollano, 2013), whereas the remain-
ing fourmutations (P186L, T187M, T187R, andQ201P) induce aa
changes in exon 4. Nuclear localization and resistance to differ-
entiation were validated in Tfe3 KO ESCs expressing murine
Tfe3 alleles (Q118P and P185L) (Figures 7E and 7F). Secondary
structure analysis of Tfe3 using I-Tasser (Yang et al., 2015) pre-
dicts residues 110–215, encoded by exon 3 and exon 4, to form
a domain of two stable a helices (Figure S7C). The Q-to-P muta-
tions at positions 119 and 201 likely disrupt helix formation. The
two helices are connected by a short loop and an induced a helix
that contains the residues P186 and T187, which may be crucial
for interaction with the Rag heterodimer. These observations
suggest that exon 3 and exon 4 form a Rag binding fold
whose structural integrity is indispensable for cytoplasmic Tfe3
inactivation.
Tfe3 Impairs Neuronal Progenitor Differentiation
Subcellular Tfe3 distribution is associated with developmental
progression of human pluripotent stem cells (Gafni et al.,
2013). It is therefore surprising that Tfe3 gain-of-function muta-
tions do not induce lethality in humans. This is probably a
consequence of mosaicism because TFE3 is an X chromo-
some-linked gene. We indeed observed genetic mosaicism
by postzygotic TFE3 mutation in the only male patient, likely
functional mosaicism by random X chromosome inactivation
in three female patients (demonstrated for one patient), and
skewed X inactivation in one patient without hypopigmentation
(patient 5). Emergence of ectopic nuclear Tfe3 mutations in
somatic but not pluripotent cells is, thus, likely causal for the
disorder.
Although patient data did not allow us to infer when or where
mutations emerged, defects in nervous system development
would be consistent with some of the disease phenotypes.
We therefore used the neural lineage as a proxy to test whether
Tfe3 gain of function, similar to ESCs, induces differentiation
defects in somatic cells. When released from self-renewal,
ESCs recapitulate hallmarks of neural development in vitro,
including expression of the neural progenitor markers Ascl1,
Chrdl1, Lrp2, Hes5, Pax3, Sox1, and Zic1 by day 4, followed
by a gradual increase in the neuronal differentiation markers
Dcx and Tubb3 (Figure S7D; Abranches et al., 2009). Nuclear
Tfe3 impaired exit from self-renewal and downregulation of
the pluripotency TFs Esrrb, Nanog, and Oct4 only when
induced on day 0 or day 1 but not day 2 of differentiation (Bet-
schinger et al., 2013; Figures S7E and S7F), providing an
experimental setup to study Tfe3 independent of its role in
pluripotency. We induced Tfe3 daily from day 4 onward and
observed a decrease in expression of Dcx and Tubb3 on day
10 compared with uninduced cells (Figure S7G). Notably, the
magnitude of repression scaled with the timing of Tfe3 induc-
tion and was mirrored by an increase in the neural progenitor
markers Lrp2, Chrdl1, and Zic1 but not Sox1, Ascl1, or Pax3.
The lysosomal ESC Tfe3 targets Cd63, Ctsd, Hexa, and
Uppl1 were upregulated to similar levels irrespective of the
timing of Tfe3 induction, confirming that lysosomal gene tran-
scription is a cell-type-invariant Tfe3 response. These findings
suggest that nuclear Tfe3, similar to its function in blocking
exit from the ESC state, impairs developmental progression
of somatic progenitor cells.
DISCUSSION
Blastocyst development and ESC differentiation are associated
with shifts in metabolic pathways, but the cause-and-effect rela-
tions are mostly unclear (Zhang et al., 2018). Here we show that
lysosomal Rag GTPases instruct exit from ESC self-renewal.
Rag GTPases have an evolutionarily conserved role in conveying
aa signals to cellular metabolism through activation of mTORC1
(Saxton and Sabatini, 2017). Using genetic and biochemical
approaches, we demonstrate a distinct mechanism in ESCs (Fig-
ure 7G): differentiation requires an alternate Rag heterodimer
conformation that, instead of activating mTORC1, physically
interacts with Tfe3 and induces its phosphorylation. Subsequent
binding to 14-3-3 proteins sequesters Tfe3 in the cytoplasm,
consequentially licensing downregulation ofmetabolic and upre-
gulation of developmental transcription. Non-canonical regula-
tion of Rag GTPases explains why Flcn and Tsc drive ESC differ-
entiation but have opposite roles in mTORC1 activation. We
identify mosaic TFE3 gain-of-function mutations in a pleiotropic
human developmental disorder that are located in a protein
domain essential for this lysosome-dependent inactivation. Our
findings reveal that metabolic signaling at the lysosomal mem-
brane, in addition to regulating cellular homeostasis, controls
embryonic cell fate transitions.
How are mTORC1-dependent and -independent Rag
GTPase functions coordinated in ESCs? Our findings suggest
two mutually non-exclusive possibilities. First, activation of
mTORC1 by aas occurs within minutes and depends on prior
aa starvation, whereas exit from the non-starved ESC state re-
quires at least 24 hr (Kalkan et al., 2017). The difference in
timing and environmental conditions may alter mTORC1 regu-
lation; e.g., because of compensatory mechanisms or cellular
stress responses. Depletion of the Ragulator subunit Lamtor1,
which is crucial for Rag GTPase signaling in aa sensing and dif-
ferentiation, supports this possibility. Lamtor1 KO cells are defi-
cient in activating mTORC1 upon aa refeeding but proficiently
do so under non-starved steady-state conditions, demon-
strating that mTORC1 regulation depends on the cellular
context. Second, Rag GTPase GAPs have distinct functions in
aa sensing and differentiation. We showed that the RagA/B
GAP GATOR1 and its inhibitor GATOR2, but not the RagC/D
GAP Flcn, control mTORC1 activation in response to aas.
Conversely, Flcn, but not the GATORs, drives Tfe3 inactivation
and exit from self-renewal. Ragulator is required for both, likely
because it recruits Rag GTPases to the lysosomal membrane.
This indicates that extrinsic regulation of the RagC/D but
not RagA/B nucleotide state specifies mTORC1-independent
signaling in non-starved ESCs.
How is Tfe3 inactivation instructed by the Rag heterodimer?
Rag heterodimers cycle between stable mTORC1-activating
RagA/BGTP-RagC/DGDP and inactive RagA/BGDP-RagC/DGTP
conformations via a di-GDP state (Shen et al., 2017).We propose
that these conformations co-exist at an equilibrium in steady-
state ESCs that is shifted toward the di-GDP state, which
catalyzes differentiation (Figure 7G). First, the di-GDP conforma-
tion is unable to interact with mTORC1 (Sancak et al., 2008),
Cell Stem Cell 24, 257–270, February 7, 2019 267
which is in line with the expandability of mTORC1 activation for
exit from self-renewal. Second, the limited contribution of lyso-
somal Rag GTPases to mTORC1 activity in non-starved ESCs
(Figure S4B) and the persistence of differentiation-competent
Rag GTPases upon GATOR1 KO is consistent with low amounts
of the RagA/BGTP-RagC/DGDP heterodimer under steady-state
conditions. We showed that the RagC/DGDP subunit specifies
interaction and inactivation of Tfe3. This depends on a Rag
GTPase binding fold encoded by exons 3 and 4 and phosphor-
ylation of serine residues that induce binding to 14-3-3 proteins.
The same domain and phosphorylation sites are required for
mTORC1-dependent cytoplasmic sequestration of MiTF/Tfe
TFs in somatic cells (Martina and Puertollano, 2013), suggesting
that the RagA/BGDP moiety in the di-GDP heterodimer recruits a
yet to be identified kinase. Alternatively, inability to recruit
mTORC1 may allow lysosome-associated kinases to phosphor-
ylate Tfe3 in ESCs.
It is therefore surprising that hyperactive mTORC1 in Tsc2
KO ESCs is an upstream inhibitor of RagC/D and antagonizes
Flcn. mTORC1 in wild-type cells may have a similar activity
because its chemical inhibition causes lysosomal Tfe3 recruit-
ment (Figure S4E), indicating strengthening of the RagC/
D-Tfe3 complex. mTORC1 has indeed been shown to induce
phosphorylation (Piao et al., 2009) and reduce lysosomal local-
ization (Martina et al., 2014; Meng and Ferguson, 2018) of Flcn,
suggesting that hyperactive mTORC1 directly antagonizes
Flcn. mTORC1 overactivation alone is, however, not sufficient
to explain why Tsc2 KO ESCs inefficiently exit self-renewal
because absence of GATOR1 similarly induces mTORC1 but
accelerates differentiation (Li et al., 2018) without perturbing
the transcription of Tfe3 target genes (Figure S2B). The conflict-
ing roles of these two mTORC1-inhibiting protein complexes
may arise because they impose different quantitative and/or
qualitative restrictions on mTORC1 substrate selection (Li
et al., 2018). Alternatively, an additional, mTORC1 activation-in-
dependent function of Tsc2, such as its physical interaction
with Rag heterodimers (Demetriades et al., 2014), may
contribute to stabilization of RagC/DGDP. We suspect that the
consequences of mTORC1 hyperactivation are not cell type
specific because MTORC1 gain-of-function alleles, similar to
TFE3, are associated with kidney cancer (Grabiner et al.,
2014) and pigmentary mosaicism (Mirzaa et al., 2016), and pa-
tients with TFE3 point mutations present classical features of
hyperactive mTORC1 pathway-related disorders (Parrini et al.,
2016) (epilepsy, frequently associated with cortical malforma-
tions) (Table S2).
We surmise that independent regulation of Tfe3 and mTORC1
in ESCs allows differential control of ESC proliferation (Gangloff
et al., 2004; Murakami et al., 2004), exit from self-renewal, and
translation (Sampath et al., 2008) in response to intra- and
extracellular cues. Lysosome activity, Flcn-Fnip, and Tsc, which
are all directly associated with cellular nutrition (Nagashima
et al., 2017; Saxton and Sabatini, 2017), inactivate RagC/D
and Tfe3 in ESCs. It is therefore conceivable that the quantita-
tive and qualitative integration of multiple nutritional signals
forms a metabolic differentiation checkpoint that anticipates
energy requirements faced during developmental progression.
This may not be unique to pluripotent stem cells because in-
duction of Tfe3 in neural progenitor cells also delays differenti-
ation while sustaining progenitor-specific transcription. Activa-
tion of lysosomal genes is a direct and generic catabolic
function of Tfe3 (Martina et al., 2014) that could contribute to
lysosomal storage disorder-related phenotypes in most individ-
uals harboring TFE3 mutations (coarse facial features, umbilical
hernia, postnatal growth retardation, obesity, hepatomegaly,
and hypoglycemia) (Table S2). Inhibition of differentiation, in
contrast, is most likely caused by the concomitant repression
of developmental genes, which, at least in ESCs, are predomi-
nantly indirect Tfe3 targets in cluster 12 (Figure 2C). Our
genomic and proteomic analyses suggest two mechanisms
for this cell-type-specific response to Tfe3 activation: Tfe3
may directly stabilize the ESC state by interacting with the
pluripotent transcription factor network post-transcriptionally
by physical association with, e.g., Sall4 and Sox2 (Figure 6B)
and transcriptionally by binding to promoters of, e.g., the cluster
13 TFs Rex1 and Esrrb (Table S1; Betschinger et al., 2013).
Mutually non-exclusive, direct metabolic targets may perpet-
uate ESC self-renewal by programing a metabolic state refrac-
tory to differentiation. Consistent with this possibility, MiTF/Tfe
TFs have been reported to control cell type specification in
brown adipose tissue (Wada et al., 2016) and the endoderm
(Young et al., 2016) through metabolic target genes. How devel-
opmental defects in patients with somatic Tfe3 gain-of-function
mutations relate to the protein’s function in lysosomal biogen-
esis, cell-type-specific transcription, and exit from progenitor
cell states remains to be determined. Clinically, the association
of cutaneous pigmentary mosaicism, coarse facial features, and
ID is recognizable, and broadening of the phenotypic spectrum
by identification of more patients appears likely. In addition to
regulating embryogenesis, mosaic TFE3 mutations may thus
be considered causative of syndromic ID.
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FLAG Sigma Cat#F1804; RRID:AB_262044
LAMP1 DSHB Cat#1D4B; RRID:AB_2134500
Lamtor1 Cell Signaling Cat#8975S; RRID:AB_10860252
RagB Cell Signaling Cat#8150S; RRID:AB_11178806
RagC Cell Signaling Cat#9480S; RRID:AB_10614716
Tfe3 Sigma Cat#HPA023881; RRID:AB_1857931
GAPDH Sigma Cat#G8795; RRID:AB_1078991
4EBP1 Cell Signaling Cat#9452S; RRID:AB_331692
S6 Cell Signaling Cat#2217; RRID:AB_331355
S6K1 Cell Signaling Cat#9202S; RRID:AB_331676
pS6 Cell Signaling Cat#2211; RRID:AB_331679
pS6K1 Cell Signaling Cat#9205; RRID:AB_330944
Flcn Baba et al., 2006 N/A
Tsc2 Cell Signaling Cat#4308S; RRID:AB_10547134
Biological Samples
Skin and blood samples from 26 affected patients
and their parents.
Centre Hospitalier Universitaire Dijon et
Universite´ de Bourgogne, France
N/A
Chemicals, Peptides, and Recombinant Proteins
CHIR99021 Steward lab, Dresden N/A
PD0325901 Steward lab, Dresden N/A
FGF Smith lab, Cambridge N/A
ActivinA Smith lab, Cambridge N/A
KO serum replacement Thermo Fisher Cat#10828028
Rapa Cell Signaling Cat# 9904
AZD8055 Santa Cruz Cat#sc-364424
BafilomycinA Merck Cat#19-148
ConcanamycinA Santa Cruz Cat#sc-202111
Vacuolin-1 Santa Cruz Cat#sc-216045
Chloroquine Sigma Cat#C6628
Puromycin GIBCO Cat#A1113803
Blasticidin GIBCO Cat#A1113903
HygromycinB Thermo Fisher Cat#10687010
G418 Thermo Fisher Cat#G8168
Paraformaldehyde Electron Microscopy Sciences Cat#15710
Lipofectamin RNAiMAX Thermo Fisher Cat#13778075
Lipofectamin 2000 Thermo Fisher Cat#11668019
Dynabeads Protein G for Immunoprecipitation Thermo Fisher Cat#10004D
Lysyl Endopeptidase WAKO Cat#129-02541
Sequencing Grade Modified Trypsin Promega Cat#V5111
Critical Commercial Assays
Alkaline phosphatase kit Sigma Cat#86R-1KT
Golden Gate TALEN and TAL Effector Kit 2.0 Addgene Cat#1000000024
Gateway BP Clonase II Enzyme mix Thermo Fisher Cat#11789020
Gateway LR Clonase II Enzyme mix Thermo Fisher Cat#11791020
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TruSeq Stranded mRNA Library Prep Illumina Cat#20020594
SureSelect Human All Exon V5 Agilent discontinued
SureSelect XT Human All Exon V6 kit Agilent discontinued
SeqCap EZ MedExome Roche Cat#07676581001
Nextera XT DNA Sample Preparation kit Illumina Cat#FC-131-1024
Deposited Data
RNaseq this paper; GEO:GSE108057 GEO: GSE108057
Experimental Models: Cell Lines
Male RGd2 mouse embryonic stem cells gift from T.Kalkan (Stem Cell Centre,
Cambridge, UK); Kalkan et al., 2017
N/A
Male RGd2 mouse embryonic stem cells (mutant
and transgenic lines)
this paper N/A
Female RGd2 mouse embryonic stem cells gift from M. Leeb (Max Perutz
laboratories, Vienna)
N/A
Male O4GIP mouse embryonic stem cells Betschinger et al., 2013 N/A
Male E14 mouse embryonic stem cells gift from M. Leeb (Max Perutz
laboratories, Vienna)
N/A
Male E14 mouse embryonic stem cells (endogenous
3xFLAG Flcn knockin)
this paper N/A
HEK293 gift from B. Hemmings (FMI, Basel) N/A
Oligonucleotides
Primers used for qPCR, see Table S3 this paper N/A
siRNAs, see Table S3 this paper N/A
gRNA sequences, see Table S3 this paper N/A
Flcn tagging template for genome editing: gtcc
accgtccgaagccccacagctacagagtcacggagcGAC
TACAAAGACCATGACGGTGATTATAAAGATCA
TGACATCGATTACAAGGATGACGATGACAAGt
gactccgagaactccttctggaaggtggtgtacagacca
this paper N/A
UMI containing oligo nucleotide for CRISPR/Cas9
screen gRNA sequencing: 50-TCCCTACACGACG
CTCTTCCGATCTN(5-9)TCTTGTGGAAAGGACGA
AACACC-30
this paper N/A
Forward primer for CRISPR/Cas9 screen gRNA
amplification: 50-TCCCTACACGACGCTCTTCC
GATCT-30
this paper N/A
Reverse primer for CRISPR/Cas9 screen gRNA
amplification: 50-GTTCAGACGTGTGCTCTTCC
GATCTCTTGTGTAGCGCCAAGTGCC-30
this paper N/A
Recombinant DNA
Genome-wide mouse pooled gRNA library Addgene; Koike-Yusa et al., 2014 Cat#50947
pPB-LR5.1-EF1a-hph2ACas this paper N/A
hCas9 Addgene; Mali et al., 2013 Cat#41815
U6-gRNA Addgene; Mali et al., 2013 Cat#41824
SV40-ELD Flemr and B€uhler, 2015 N/A
SV40-KKR Flemr and B€uhler, 2015 N/A
pBase Betschinger et al., 2013 N/A
pPB-CAG-dsRed-pgk-hph this paper N/A
pDONR221-Tfe3 (WT and mutant) this paper N/A
pDONR221-Flcn this paper N/A
pDONR221-Lamtor1 this paper N/A
pDONR221-RagB/C/D (WT and mutant) this paper N/A
(Continued on next page)
e2 Cell Stem Cell 24, 257–270.e1–e8, February 7, 2019
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to the Lead Contact, Joerg Betschinger (joerg.
betschinger@fmi.ch).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse ESCs
Male RGd2 mouse embryonic stem cells (ESCs) containing a Rex1:GFPd2-IRES-Blasticidin reporter (Kalkan et al., 2017) are a gift
from T.Kalkan (Stem Cell Centre, Cambridge, UK) and female RGd2 cells a gift from M. Leeb (Max Perutz laboratories, Vienna).
Male O4GIP ESCs contain a GFP-IRES-Puromycin transgene under control of an Oct4 regulatory element (Betschinger et al.,
2013). Male E14 ESCs are a gift from M.Leeb.
Patients
We performed 26 trios whole exome sequencing on patient’s affected skin-derived DNA and parental blood sample. The study was
approved by the ethics committee of Dijon University Hospital and written informed consent from all subjects or their legal represen-
tatives was obtained.
METHOD DETAILS
Cell Culture
ESCs were cultured on plastic coated with gelatin or laminin (Sigma) in N2B27 medium (DMEM/F12 (Life Technologies), Neurobasal
(GIBCO) supplemented with N2 (homemade) and B-27 Serum-Free Supplement (GIBCO), 1mM sodium pyruvate (GIBCO), 2mM
L-glutamine (GIBCO), 0.1 mM 2-mercaptoethanol (Sigma)), and, where indicated, with 2i (3mM CHIR99021 and 1mM PD0325901
(Steward lab, Dresden)), KO serum replacement (Thermo Fisher), Rapa (Cell Signaling), AZD8055 (Santa Cruz), BafilomycinA (Merck),
ConcanamycinA (Santa Cruz), Vacuolin-1 (Santa Cruz), Chloroquine (Sigma), 4-Hydroxytamoxifen (0.1mM, Sigma), Doxycycline
(0.1mg/ml, Sigma), FGF and ActivinA (Smith lab, Cambridge). For differentiation, ESCs were plated on gelatin-coated plates at
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
pDONR221-lysRagB/C (WT and mutant) this paper N/A
pPB-CAG-DEST-pgk-hph Betschinger et al., 2013 N/A
pPB-CAG-3xFLAG-DEST-pgk-hph Betschinger et al., 2013 N/A
pPB-TRE-DEST-rTA-HSV-neo this paper N/A
pPB-TRE-DEST-rTA-pgk-hph this paper N/A
Software and Algorithms
oligo https://bioconductor.org/packages/
devel/bioc/manuals/oligo/man/oligo.pdf
package version 1.40.0
limma https://www.bioconductor.org/packages/
release/bioc/vignettes/limma/inst/doc/
usersguide.pdf
package version 3.32.0
QuasR Gaidatzis et al., 2015 package version 1.16.0
edgeR https://www.bioconductor.org/packages/
release/bioc/vignettes/edgeR/inst/doc/
edgeRUsersGuide.pdf
package version 3.18.0
Bowtie Langmead et al., 2009 version 4.4.7
MACS2 Zhang et al., 2008 package version 2.1.1.20160309
ComplexHeatmap https://bioconductor.org/packages/release/
bioc/manuals/ComplexHeatmap/man/
ComplexHeatmap.pdf
package version 1.18.1
MaxQuant http://www.coxdocs.org/doku.php?id=
maxquant:start
version 1.5.3.8
FlowJo FlowJo version 9.9.6
Fiji Fiji version 1.0
ZEN Zeiss Version 14.0.12.201
Photoshop Adobe CS6
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1.53 104 cells/cm2 and, the following day, 2i was withdrawn. For EpiLC differentiation (Hayashi et al., 2011), KO serum replacement
(1%), FGF (12ng/ml) and ActivinA (20ng/ml) were additionally added. For differentiation of starved cells, ESCs grown on plastic or
glass plates were incubated in R-N2B27 (amino-acid and glucose free RPMI (homemade), with B27 and N2), and, as indicated,
supplemented with 3.8mg/ml glucose (BioConcept), aas (GIBCO, MEM non-essential aas, MEM essential aas, 2mM L-glutamine),
and differentiation was induced by 2i removal. For aa refeeding experiments, ESCs were incubated for 30 minutes in HBSS (Thermo
Fisher) containing 3.8mg/ml glucose and then switched to N2B27 for another 30minutes. For lysosomal activity assays, cells were
incubated for 1 hour with 5mg/ml DQ-BSA (DQ Red BSA, Life Technologies, D12051) and Lysotracker (LysoTracker Deep Red, Life
Technologies, L12492) diluted 1:10000 in 2i medium. After washing in PBS, fluorescence was measured on a LSRII SORP Analyzer
(Becton Dickinson) and quantified using FlowJo (FlowJo, LLC). siRNA (detailed in Table S3) and plasmid transfections using Lipofec-
tamin RNAiMAX and 2000 (Thermo Fisher), respectively, and exit from self-renewal of O4GIP and RGd2 ESCs was performed as
described before (Betschinger et al., 2013). Briefly, differentiating O4GIP cells were treated with 2i medium plus 1mg/ml Puromycin
(GIBCO) and uncommitted cells quantified after 3 days by adding Alamar Blue (Invitrogen), diluted 1:10 in 2i medium, which was
subsequently read out on a SpectraMax Gemini EM (Molecular Devices) microplate reader. Self-renewal of differentiating RGd2 cells
was quantified by plating single cells on laminin (Sigma)-coated plates, with resulting clones stained for alkaline phosphatase activity
(Sigma) according to the manufacturer’s instruction and counted.
Immunostaining
Cell were seeded on laminin-coated 96well glass plates (Greiner Bio-One), fixed with 4% paraformaldehyde (Electron Microscopy
Sciences) and immunostained as described (Betschinger et al., 2013). Images were captured using a LSM 710 scanning head
confocal microscope (Zeiss) and handled using Fiji and Adobe Photoshop. Primary antibodies used were anti-FLAG (Sigma,
F1804, 1:1000), anti-LAMP1 (DSHB, 1D4B, 1:500), anti-Lamtor1 (Cell Signaling, 8975S, 1:500), anti-RagB (Cell Signaling, 8150S,
1:100), anti-RagC (Cell Signaling, 9480S, 1:100) and anti-Tfe3 (Sigma, HPA023881, 1:1000). DNA was visualized with Hoechst33342
(Life Technologies). Quantification of nucleo-cytoplasmic Tfe3 ratios using CellProfiler (Broad Institute) was performed as described
(Betschinger et al., 2013). Briefly, nuclei and cells were identified and the average fluorescence of nuclei and cytoplasm (cell-nuclei)
determined. For the data presented in Figure S1D, 198 (negative siRNA), 208 (Tcf7l1 siRNAs), 165 (Tsc2 siRNAs), 97 (Flcn siRNAs),
116 (Fnip1/2 siRNAs), 153 (Lamtor1 siRNAs), 148 (Lamtor2 siRNAs), 272 (Lamtor3 siRNAs), 195 (RagA siRNAs), 257 (RagB siRNAs),
133 (RagA/B siRNAs), 264 (RagC siRNAs), 236 (RagD siRNAs), and 360 (RagC/D siRNAs) cells were quantified.
CRISPR/Cas9 screen
Lentiviral gRNA libraries (Addgene 50947) (Koike-Yusa et al., 2014) were generated in HEK293 cells. Stable Cas9 expressing female
RGd2 ESC (gift from Martin Leeb, Max Perutz laboratories, Vienna) clones were derived by transfecting with pPB-LR5.1-EF1a-
hph2ACas9 (derived from pPB-LR5.1-EF1a-puro2ACas9, gift of Kosuke Yusa, Wellcome Trust Sanger Institute) and 7.2x106 cells
of two independent clones were infected with the lentiviral gRNA library at a 20-fold coverage and multiplicity of infection of 0.25.
Stable integrations were selected for 6d in the presence of 0.1 mg/ml Puromycin (GIBCO) and 107 cells for each clone were plated
on Laminin-coated dishes in the absence of 2i, while 2x107 were used for generation of input sequencing libraries. After 3d of differ-
entiation, 2x107 cells were passaged in N2B27 containing 1mg/ml Blasticidin (GIBCO) to select for Rex1 expression, and cells at
passage 4 and 5 taken for generation of experimental sequencing libraries. Uninfected control cells were lost after the second
passage. Genomic DNA was isolated using Proteinase K (Roche) digestion and phenol-chloroform extraction (Sigma).
GENOME EDITING
For C-terminal 3xFLAG Flcn tagging, the TALENwas assembled usingGoldenGate TALEN cloning kit (Cermak et al., 2011) (Addgene
1000000024) into acceptor vectors SV40-ELD and SV40-KKR (Flemr and B€uhler, 2015) (FlcnC_F-Q3ELD: HDHDNNNI NI NNHDHD
HDHDNI HDNI NNHDNG, FlcnC_R-Q3KKR: HDHDNI NNNI NI NNNNNI NNNGNGHDNGHDNNNNNI NNNG). Male E14 ESCs
were transiently transfected with a recombination reporter (Flemr and B€uhler, 2015), TALENs and Flcn tagging template
(gtccaccgtccgaagccccacagctacagagtcacggagcGACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGAT
GACGATGACAAGtgactccgagaactccttctggaaggtggtgtacagacca) and derivative cloneswere genotype for successful recombination.
CRISPR/Cas9 genome editing was performed by transient transfection of hCas9 and U6-gRNA plasmids (Mali et al., 2013) (Addgene
plasmids 41815 and 41824) into male RGd2 ESCs. Target gRNA sequences are detailed in Table S3. For KO ESC clone generation, a
dsRed expression plasmid was cotransfected and single dsRed expressing cells were deposited into 96well plates 2d later. For
screen validation, transfected cell pools were differentiated by 2i withdrawal after 2d and serially passaged in N2B27 containing
1mg/ml Blasticidin.
Molecular biology
Coding sequences were amplified from ESC cDNA and recombined into pDONR221 using Gateway technology (Thermo Fisher). The
lysosomal targeting sequence of Lamtor1 (aas 1-39) (Nada et al., 2009) was inserted by In-Fusion cloning (Clontech) and point
mutations (RagGDP (RagB: T54N, RagC: S75N, RagD: S77L), RagGTP (RagB: Q99L, RagC:Q120L, RagD:Q121L), otherwise indi-
cated) were introduced by polymerase chain reaction (PCR). In Tfe3(10xA), S545,S550,S551,S553,S557,S560,S561,S564,S565
and S567 are mutated to alanine residues. Expression destination vectors were pPB-CAG-DEST-pgk-hph (Betschinger et al.,
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2013), pPB-CAG-3xFLAG-DEST-pgk-hph (Betschinger et al., 2013), pPB-TRE-DEST-rTA-HSV-neo and pPB-TRE-DEST-rTA-pgk-
hph, and were selected for stable integration after co-transfection with pBASE (Betschinger et al., 2013) into ESCs in the presence
of 150 mg/ml HygromycinB (Thermo Fisher) or 200 mg/ml G418 (Thermo Fisher). For mRNA quantification, total cellular RNA was iso-
lated using RNeasy Mini kit (QIAGEN), complementary DNA generated using SuperScript III reverse transcriptase (Invitrogen), and
quantitative PCR performed using TaqMan Fast Universal PCR master mix (Applied Biosystems) with gene specific primers and a
GAPDH probe (Applied Biosystems) for normalization. We used the universal probe library (UPL, Roche) and Taqman system
(Applied Biosystems). Oligonucleotide sequences and probes are specified in Table S3.
Protein methods
Immunoprecipitations using FLAG antibodies (Sigma, F1804) of wild-type ESCs expressing 3xFLAG-tagged Rag GTPase mutants,
and Tfe3 antibodies (Sigma, HPA023881) in three biological replicates of Tfe3WT, Lamtor1WT, Tfe3KO.6, Lamtor1KO.1, FlcnKO.1 and
wild-type ESCs expressing empty vector, RagCGDP and RagDGDP were performed as described before (Betschinger et al., 2013)
using Dynabeads (Thermo Fisher). Proteins were digested on the beads first with 0.2mg LysC (WAKO) for 6h at 37C in 2.5M
Guanidin-HCl, containing 20mM EPPS pH8.5, 10mM CAA and 5mM TCEP in a total volume of 6ml. Then, samples were diluted
with 18ml 50mM HEPES pH 8.5 containing 0.2mg modified porcine Trypsin (Promega) and cleaved overnight at 37C. Another
0.2mg Trypsin was added and the cleavage continued for 4 hours. The generated peptides were acidified with 1ml of 20% TFA
and analyzed by capillary liquid chromatography tandem mass spectrometry with an EASY-nLC 1000 using the two-column set
up (Thermo Fisher). The peptides were loaded with 0.1% formic acid, 2% acetonitrile in H2O onto a peptide trap (Acclaim PepMap
100, 75um x 2cm, C18, 3mm, 100A˚) at a constant pressure of 800 bar. Peptides were separated, at a flow rate of 150 nl/min with a
linear gradient of 2%–6% buffer B in buffer A in 3 minutes followed by a linear increase from 6 to 22% in 40 minutes, 22%–28% in
9 min, 28%–36% in 8min, 36%–80% in 1 min and the column was finally washed for 14 min at 80% B (Buffer A: 0.1% formic acid,
buffer B: 0.1% formic acid in acetonitrile) on a 50mm x 15cm ES801 C18, 2mm, 100A˚ column mounted on a DPV ion source (New
Objective) connected to a Orbitrap Fusion (Thermo Fisher). The data were acquired using 120000 resolution for the peptide measure-
ments in the Orbitrap and a top T (3 s) method with HCD fragmentation for each precursor and fragment measurement in the LTQ
according the recommendation of the manufacturer (Thermo Fisher).
Cell lysates for western blotting were generated in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Tx-100, 0.1%
SDS). Primary antibodies were anti-FLAG (Sigma, F1804, 1:100), anti-GAPDH (Sigma, G8795, 1:1000), anti-4EBP1 (Cell Signaling,
9452S, 1:100), anti-S6 (Cell Signaling, 2217, 1:100), anti-S6K1 (Cell Signaling, 9202S, 1:100), anti-pS6 (S235/236) (Cell Signaling,
2211, 1:100), anti-pS6K1 (T389) (Cell Signaling, 9205, 1:100), anti-Lamtor1 (Cell Signaling, 8975S, 1:500), anti-Flcn (Baba et al.,
2006), anti-Tfe3 (Sigma, HPA023881, 1:1000) and anti-Tsc2 (Cell Signaling, 4308S, 1:1000).
QUANTIFICATION AND STATISTICAL ANALYSIS
CRISPR/Cas9 screen quantification
For gRNA quantification, we developed an approach using uniquemolecular identifiers (UMIs). Biological replicates were divided into
aliquots of 500ng genomic DNA (input samples: 8mg total; selected samples: 2mg total). An oligo nucleotide containing UMIs and the
30 part of the Illumina P5 sequence (50-TCCCTACACGACGCTCTTCCGATCTN(5-9)TCTTGTGGAAAGGACGAAACACC-30) was inte-
grated using Phusion DNA polymerase (Thermo Fisher) in a single round of denaturation, annealing (62C) and extension. Then 2ml of
exonuclease I (NEB) were added and incubated at 37C for 45min, followed by heat inactivation and purification using AMPure XP
beads (Agencourt) with a 1:1 ratio. gRNAs were amplified using Phusion DNA polymerase for 25 cycles (Fwd: 50-TCCCTACAC
GACGCTCTTCCGATCT-30; Rev: 50-GTTCAGACGTGTGCTCTTCCGATCTCTTGTGTAGCGCCAAGTGCC-30; annealing temperature
of 64C)) and purified using AMPure XP beads (1:1 ratio, elution in 22ml). 5ml were used in an Illumina indexing PCR reaction using
Phusion DNA polymerase (6cycles) and NEBnext multiplex oligos set 1 (NEB). Samples were purified using AMPure XP beads
(1:1 ratio) and sequenced on one lane of HiSeq2500 (high output mode, 50bp single-end reads). UMI and gRNA sequences were
extracted from individual reads by searching for exact matches to the vector backbone sequence at expected offsets (more than
76% of all reads). About 95% of extracted gRNA sequences corresponded to one of the expected sequences from the gRNA library
(Koike-Yusa et al., 2014), and the number of UMIs was counted for each gRNA. Counts of UMIs were 2.8 to 7.7-fold lower than read
counts, indicating a low to moderate level of PCR duplication. As read versus UMI counts displayed a linear relationship, no correc-
tion for saturation of highly abundant gRNAs was applied. gRNAs with at least one non-zero count in any sample were selected for
further analysis (84,471 gRNAs, 96.6% of the library). Counts from individual replicates for each of the six libraries (2 input, 4 exper-
imental) were summed and analyzed by MAGeCK (version 0.5.4) (Li et al., 2014) using parameters ‘‘–norm-method total–gene-test-
fdr-threshold 0.25–adjust-method fdr–sort-criteria pos–remove-zero none’’ to identify gRNAs and genes significantly enriched in the
experimental compared to the input libraries.
Protein identification and quantification
Relative quantification of mass-spec data was performed with MaxQuant version 1.5.3.8 using Andromeda as search engine and
label free quantification as described (Ostapcuk et al., 2018). The mouse subset of the UniProt version 2015_01 combined with
the contaminant DB from MaxQuant was searched and the protein and peptide FDR were set to 0.01. Only proteins identified
with at least three peptides were plotted in Figures 6A and 6B.
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Microarray data analysis
Raw data (CEL files) were downloaded (all publicly available sequencing data used in this study are indicated in Table S3), back-
ground corrected and normalized using rma from oligo (https://bioconductor.org/packages/devel/bioc/manuals/oligo/man/oligo.
pdf) (package version 1.40.0). A single probeset was selected per gene using annotation from the Bioconductor package
mouse4302.db (package version 3.2.3), selecting the probeset with the largest interquartile range for each gene. Differentially ex-
pressed genes between Myc inhibition and DMSO samples were identified using limma (https://www.bioconductor.org/
packages/release/bioc/vignettes/limma/inst/doc/usersguide.pdf) (package version 3.32.0) with default parameters. Genes were
considered as significantly deregulated with a minimum absolute fold-change of 2 and a p value smaller than 0.01.
RNaseq and GROseq data analysis
Cellular RNA from ESCs, cells 34h after 2i withdrawal, and long-term differentiated cells sorted for Rex1 expressing cells was purified
using RNAeasy (QIAGEN), strand-specific RNA-seq libraries were generated using TruSeq mRNA Library preparation kit (Illumina),
and libraries sequenced on an Illumina HiSeq2500 machine (50bp single-end reads). Reads were aligned using qAlign from the Bio-
conductor package QuasR (Gaidatzis et al., 2015) (package version 1.16.0) to mouse GRCm38/mm10 genome with default param-
eters except for splicedAlignment = TRUE. EpiLC datawere sequenced as 36bp reads (Buecker et al., 2014), and therefore no spliced
alignment could be performed. Tsc2 KO and Nprl2 KO ESC data (Li et al., 2018) as well as global run-on sequencing (GROseq) in
ESCs (Dorighi et al., 2017) were sequenced as 75bp and 50bp paired end reads respectively, and therefore paired = ’’fr’’ was
used. For in vivo embryo data (Boroviak et al., 2015) pre-existing alignments to mouse GRCm38/mm10 genome downloaded
from ArrayExpress (E-MTAB-2958) were used. Alignments were quantified with qCount from the Bioconductor package QuasR (Gai-
datzis et al., 2015) (package version 1.16.0) for known UCSC genes obtained from the TxDb.Mmusculus.UCSC.mm10.knownGene
package (package version 3.4.0) using default parameters (Table S1).
For identification of genes specifically regulated in either ESCs or during differentiation, we used generalized linear models. Only
genes with at least 3 counts per million in at least two biological samples were considered (ESCs: 12,478 genes; differentiation:
12,709 genes). Statistically significantly deregulated genes were identified using edgeR (https://www.bioconductor.org/packages/
release/bioc/vignettes/edgeR/inst/doc/edgeRUsersGuide.pdf) (package version 3.18.0) and these genes were fitted to five separate
generalized linear models for different sets of samples:
a) genotype: Flcn KO or Lamtor1 KO ESCs compared to respective control FlcnWT and Lamtor1WT ESCs.
b) treatment: 3h Tam or 34h Tam-treated Tfe3-ERT2 ESCs compared to 3h or 34h ethanol-treated Tfe3-ERT2 ESCs.
c) time: FlcnWT and Ethanol-treated Tfe3-ERT2 ESCs and 34h differentiated progeny
d) time + treatment: 34h Tam-treated differentiated Tfe3-ERT2 cells compared to ethanol-treated Tfe3-ERT2 ESCs and 34h
differentiated progeny. treatment therefore identifies differentiation-specific nuclear Tfe3 targets.
e) time + genotype + time:genotype: FlcnKO.1 ESCs and differentiated progeny compared to FlcnWT ESCs and differentiated
progeny. time:genotype therefore identifies differentiation-specific Flcn targets.
Raw P values were corrected for multiple testing by calculating false discovery rates (FDR). Significant effects in each contrast
were defined as changes with a minimum absolute fold-change of 2 and a FDR less than 0.01.
For visualization in Figure 2A and S2B, calculations of RNA log2 fold changes from edgeRwere used and only significantly deregu-
lated genes in at least one ESC condition (genotype, model (a) and treatment, model (b)) were considered (total: 2,483 genes). For
visualization in Figure 2C, significantly deregulated genes in at least one differentiation condition (time, model (c), treatment, model (d)
and time:genotype, model (e)) were considered (total: 3,370 genes). Read counts were normalized (dividing by the total number of
aligned reads and multiplying with minimal library size, and adding a pseudocount of 8) and log2 transformed. Centered expression
values were generated by calculating differences in log-space of each gene in each sample to its average over all samples. For log2
fold change comparisons shown in Figure S2A and S2B, ESC genes detected in this study (12,478 genes) and annotated in other
datasets (total: 11,770 genes) were considered. Log2 fold changes were calculated using log2-transformed normalized read counts
as described above, averaging biological replicates, and calculating differences (corresponding to fold-changes in linear space)
between conditions. Boxplots (Figures S1D and S2B) were generated using the boxplot function in R with default parameters and
outline = FALSE. Differentially expressed genes upon transient TFEB overexpression in HeLa cells (Sardiello et al., 2009) were con-
verted to mouse homologs using HomoloGene (https://www.ncbi.nlm.nih.gov/homologene) allowing only 1:1 mapping of genes.
Analyses of enriched gene sets (Figure 2C; Table S1) were performed using DAVID (https://david.ncifcrf.gov) for GO terms of biolog-
ical processes, cellular components and molecular functions. Principal component analysis (Figure 2B) was performed on normal-
ized, log2-transformed and mean-centered expression data in R using the prcomp function.
ChIPseq and DHSseq data analysis
Published ChIPseq and DNaseI hypersensitive site sequencing (DHSseq) reads were aligned using qAlign from the Bioconductor
package QuasR (Gaidatzis et al., 2015) (package version 1.16.0) to mouse GRCm38/mm10 genome with default parameters.
H3K4me3 and H3K27me3 ChIP-seq data in ESCs and EpiLCs (Kurimoto et al., 2015) were sequenced on a SOLiD 5500xl platform,
and therefore Bowtie (Langmead et al., 2009) (version 4.4.7) with parameter -C for alignment of reads in colorspace was used. Align-
ments were sorted and indexed using SAMtools (package version 1.2), and quantified with qCount from the Bioconductor package
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QuasR (Gaidatzis et al., 2015) (package version 1.16.0). IP enrichments were calculated using log2((nIP / tIP * c + p) / (nInput / tInput *
c + p), where nIP and nInput are the read counts in a region in IP and input samples, respectively, tIP and tInput are the total number of
aligned reads in the two samples, c is a constant scaling factor (the minimal number of aligned reads in any sample) and p is a pseu-
docount to stabilize enrichments that are based on low numbers of reads (p = 8).
Tfe3 peaks were called on Tfe3 ctrl and shFlcn ChIP in ESCs (Betschinger et al., 2013) using MACS2 (Zhang et al., 2008) (package
version 2.1.1.20160309) with default parameters. Peaks with at least twofold enrichment in IP over IgG in at least one out of the two
Tfe3 ChIP samples were considered (total: 13,512 peaks) (Table S1). Tfe3 peaks were assigned to genes by calculating distance of
peak midpoint to the nearest transcriptional start site (TSS), using a set of non-redundant TSSs with a single start site randomly
selected for each gene. Peaks with a maximum distance less than 2000bp to the nearest TSS were classified as proximal (total:
2,053 peaks) and with a greater distance than 2000bp as distal (total: 11,459). Reads of H3K27ac and H3K4me1 in ESCs and EpiLCs
(Buecker et al., 2014) were counted in Tfe3 peak regions and distal sites with enrichment of H3K27ac in either ESCs or EpiLCs greater
than twofold in IP over input or H3K4me1 in either ESCs or EpiLCs greater than 1.5 fold in IP over input were considered as putative
Tfe3 enhancers (total: 2,387) (Table S1).
Genomic profiles for heatmaps centered on the Tfe3 peakmidpoint (Figure S2E)were generatedwith qProfile from theBioconductor
package QuasR (Gaidatzis et al., 2015) (package version 1.16.0), and visualized using ComplexHeatmap (https://bioconductor.org/
packages/release/bioc/manuals/ComplexHeatmap/man/ComplexHeatmap.pdf) (package version 1.18.1). Except for Tfe3 ChIP and
GROseq samples, averaged replicates are represented.
Enrichment or depletion of specific genes sets in gene clusters (Figure 2D and Figure S2F) were quantified as standardized resid-
uals, calculated using the chisq.test function in R.
Whole exome sequencing (WES)
Genomic DNA from fresh skin, cultured skin fibroblasts, and blood samples was extracted using the Gentra Puregene Blood and
Tissue Extraction Kit (QIAGEN). Genomic DNA integrity and quantity was assessed by agarose gel electrophoresis, NanoDrop spec-
trophotometry, and Qubit fluorometry (Thermo Fisher). Exome capture and sequencing, except for Patients 3 and 4, was performed
at Integragen (Evry, 209 France) from 1 mg of genomic DNA per individual using the Agilent SureSelect Human All Exon V5. Libraries
were sequenced on a HiSeq platform (Illumina) using paired-end 75-bp reads. Sequences were aligned to the human genome refer-
ence sequence (GRCh37/hg19 212 build of UCSC Genome Browser), and single-nucleotide variants and small insertions/deletions
were systematically detected as previously described (Allen et al., 1992). Candidate de novo mutational events were identified by
focusing on protein-altering and splice-site changes: (1) supported by at least three reads and 10% of total reads in the patient;
(2) absent in both parents, as defined by variant reads representing less than 5% of total reads; (3) at base-pair positions covered
by at least four reads in the entire trio; and (4) present at a frequency less than 1% in dbSNP (build 147) and 0.1% in the Exome
Aggregation Consortium (ExAC Browser, exac.broadinstitute.org).
WES for Patient 3 was enriched using the SureSelect XT Human All Exon V6 kit (Agilent) and sequenced (paired end 150bp) on a
NextSeq500 sequencing system (Illumina) at a mean exome depth of 120X. The exomewas defined as all coding exons of UCSC and
Ensembl ± 20bp intron flanks. This coverage was > 99,5% for known intellectual disability genes, and 96.3% of the exome was
covered at least 15X. Reads were aligned to hg19 using BWA (BWA-MEM v0.7.5a) and variants were called using the GATK haplo-
type caller (v3.4.46). Detected variants were annotated, filtered and prioritized using the Bench NGS Lab platform (Cartagenia,
Leuven, Belgium), and confirmed by Sanger sequencing.
Libraries for WES of Patient 4 were prepared using the Kapa HTP kit (Illumina, San Diego, CA, USA) and capture was performed
using the SeqCap EZ MedExome (Roche NimbleGen Madison, WI, USA). Sequencing was done on an Illumina HiSeq2500 HTv4
(Illumina, San Diego, CA, USA) with paired-end 125-bp reads. Read alignment to GRCh37 (hg19) and variant calling were done
with a pipeline based on BWA-MEM0.7 and GATK 3.3.0. The median coverage of the captured target region was at least 100x.
Variant annotation and prioritizing were done using Cartagenia Bench Lab NGS (Agilent Technologies). We excluded variants located
outside the ± 6 nucleotide exons and intron/exon boundaries and variants with a minor allele frequency (MAF) of > 1% in control
databases, including dbSNP137 (https://www.ncbi.nlm.nih.gov/projects/SNP), 1000 Genomes Project (release of February 2012),
and Exome Variant Server (EVS), NHLBI Exome Sequencing ProjectNational Heart, Lung, and Blood Institute GOExome Sequencing
Project (ESP5400 release) (http://evs.gs.washington.edu/EVS/) and our in-house exome controls.
TFE3 sequencing
Regions of interest were amplified using custom intronic primers and long-range polymerase chain reactions with the PrimeSTAR
GXL DNA Polymerase (Takara Bio, Saint-Germain-en-Laye, France). Polymerase chain reaction amplicons were pooled, purified,
and quantified from each affected individual. Sequencing libraries were prepared using the Nextera XT DNA Sample Preparation
kit (Illumina, Paris, France). Paired-end sequencing of 150-bp reads was performed on a MiSeq platform using 300-cycle reagent
kits (v2; Illumina, Paris, France).
Complementary DNA analysis
Complementary DNA was sequenced from the first patient’s fresh skin, and second and fifth patient’s fibroblasts. Total RNA was
isolated with TRIzol Reagent (Life Technologies) from fibroblasts, according to the manufacturer’s instructions. 1mg RNA was tran-
scribed into cDNA with the QuantiTect Reverse Transcription Kit (QIAGEN). Using PCR primers positioned in exons 2 and 6 in TFE3
Cell Stem Cell 24, 257–270.e1–e8, February 7, 2019 e7
gene, complementary DNA was amplified by polymerase chain reaction (PCR) using Prime STAR GXL kit (Takara) according to the
manufacturer’s protocol. The libraries were prepared with the Nextera XT DNA Sample Preparation Kit (Illumina). Generated libraries
were sequenced on a MiSeq instrument (Illumina) according to the manufacturer’s recommendations for paired-end 150 bp reads.
Determination of the X chromosome inactivation pattern at the HUMARA locus
X chromosome inactivation (XCI) pattern was estimated at the HUMARA locus as described previously (Allen et al., 1992) on DNA
extracted from uncultured fibroblasts. Fluorescent PCR products were analyzed by capillary electrophoresis on an ABI3130XL
genetic analyzer (Applied Biosystems) and peak areas were generated with the GeneMapper software (Applied Biosystems). Skew-
ing was defined as greater than 80% of one X allele active.
Details for quantification and statistical analysis in Figures
Details for quantification and statistical analysis are specified in the figure legends, including number of biological or technical
replicates, and statistical tests. Data is presented as the average and standard deviation.
DATA AND SOFTWARE AVAILABILITY
The accession number for the data generated in this paper is Gene Expression OmnibusGEO:GSE108057. All other publicly available
datasets used are specified in Table S3.
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Figure S1, related to Figure 1: Characteristics of lysosomal signaling loss of function 
mutants. 
(A) Model of amino acid-dependent mTORC1 regulation. Activators and inhibitors of 
mTORC1 are indicated in red and blue, respectively.  
(B,C) Resistance to differentiation of O4GIP ESCs transfected with indicated siRNAs after 3 
days of 2i withdrawal. Results were normalized to negative (neg) siRNA cells and are shown 
on a log(10)-scaled axis. Average and SD of 2 technical replicates. (p) denotes pool of 4 
siRNAs. Note that the Tcf7l1, Tsc2, Flcn, Fnip1/2 and Lamtor3 siRNA pools have been 
deconvoluted before  (Betschinger et al., 2013). 
(D) log2 nucleo-cytoplasmic Tfe3 ratios in O4GIP ESCs transfected with indicated siRNAs. 
Significance was determined using a two-tailed unpaired t-test compared to neg control sample. 
(*)<10-15 and (**)<10-30. 
(E) RPKM (reads per kilobase of transcript per million mapped reads) of MiTF/Tfe 
transcription family members in wildtype ESCs. Average and SD of two independent RNA-
Seq experiments. 
(F) Flcn and Lamtor1 KO ESC lines used in this study. Location of gRNAs is indicated with 
blue bars. Top sequence track is the wildtype allele with the ATG start codon underscored. 
Mutant alleles lack the start codon. 
(G) Western blot of indicated genotypes confirms absence/severe reduction of proteins. 
(H) Tfe3 localization in ESCs and after 24 h of differentiation (diff.) in indicated genotypes. 
Scale bar is 20µm. 
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Figure S2, related to Figure 2: Analysis of RNA sequencing data. 
 (A) Pearson’s correlation coefficients of pairwise comparisons between log2 fold expression 
changes of indicated samples. Epiblast (Epi). 
(B) Boxplot of log2 fold changes of genes in clusters 1-8 of indicated genotypes. Fold change 
(FC). 
(C) Log2 fold changes in median fluorescence intensity of DQ-BSA or Lysotracker staining 
relative to untreated (100nM Vacuolin-1, control and Tfe3-ERT2) and sibling wildtype 
genotypes (Lamtor1 and Flcn KO ESC lines). Average and SD of 4 biological replicates. 
Significance was determined using a two-tailed unpaired t-test. (*)<0.1 and (**)<0.05. 
(D) Distance of Tfe3 peaks to the nearest transcriptional start site (TSS). Cut-off for proximal 
and distal binding is shown as red line. 
(E) Heatmap of Tfe3, histone 3 K27 acetylation (H3K27), histone H3 K4 trimethylation 
(H3K4me3), histone H3 K4 monomethylation (H3K4me1) and histone H3 K27 trimethylation 
(H3K27me3) ChIPseq read densities as well as DNAseI hypersensitive sites (DHS) and global 
run-on sequencing (GROseq) read densities across all proximal Tfe3 (top) and distal Tfe3 
(bottom) binding sites. Each row represents a 10-kb window centred on the Tfe3 peak 
midpoint. Rows are sorted for H3K27ac ChIP enrichment in ESCs. Active cis-regulatory 
regions are transcribed (GROseq), in open chromatin (DHS) and negative for H3K27me3. Of 
those, promoters are marked by H3K27ac and H3K4me3, and enhancers by H3K27ac and 
H3K4me1. Reads per million (RPM). 
(F) Enrichment and depletion (standardized residuals) of genes associated with proximal Tfe3 
peaks and CLEAR genes (Sardiello et al., 2009) in indicated clusters. 
  
   
Figure S3. Related to Figure 3
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Figure S3, related to Figure 3: Functional analysis of Rag GTPase signaling in ESCs. 
(A) Subcellular localization of RagC and Lamtor1 in O4GIP ESCs transfected with indicated 
siRNAs. Insets are DNA staining of the field of view. Note cytoplasmic delocalization of RagC 
upon knockdown of Lamtor1, 2 and 3 but not Flcn or Tsc2. Scale bar is 20µm. 
(B) Knockdown of transcripts by indicated siRNAs. Results were normalized to negative 
siRNA transfected cells and are shown on a log(10)-scaled axis. Average and SD of 2 technical 
replicates. 
(C) Resistance to differentiation of O4GIP ESCs transfected with indicated siRNA 
combinations after 3 days of 2i withdrawal. Results were normalized to negative (neg) siRNA 
cells and are shown on a log(10)-scaled axis. Average and standard deviation (SD) of 2 
biological replicates. 
(D,E) Retention of self-renewal relative to empty vector transfected cells after 3 days of 2i 
withdrawal (D) and Tfe3 localization (E) in Flcn KO.1 cells expressing indicated Rag 
transgenes. Average and SD of 2 technical replicates. Scale bar is 20µm. 
(F,G,H) mRNA relative to GAPDH (F), protein expression (G) and subcellular localization 
(H) of indicated transcripts/proteins in Lamtor1KO.1 ESCs expressing indicated constructs. 
Colocalization of lysRag proteins and LAMP1 is indicated by arrowheads (H). Note that RagB 
antibodies failed to recognize endogeneous RagB and that the microscope amplification 
settings for overexpressed RagC proteins did not allow detection of endogeneous RagC 
(Figure 3A). Also note cytoplasmic localization of overexpressed RagC. Average and SD of 
2 biological replicates. Scale bar is 20µm. 
(I) Alkaline phosphatase staining of wildtype cells expressing indicated RagC transgenes that 
were transfected with indicated siRNAs and subjected to clonal self-renewal after 3 days of 2i 
withdrawal. 
(J) Tfe3 localization in wildtype cells expressing indicated RagC transgenes. Scale bar is 
20µm. 
  
   
Figure S4. Related to Figure 4
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Figure S4, related to Figure 4: ESC-specific mTORC1 regulation. 
(A) Depdc5, Wdr24 and Tsc2 KO ESC lines used in this study. Labeling is similar to Figure 
S1F. 
(B,G) Western blot analysis of mTORC1 targets in ESCs and after 48 hours of differentiation 
of indicated genotypes. 20nM Rapamycin was added where indicated. Arrows mark fast 
(unphosphorylated) and slow migrating (phosphorylated) 4EBP1. 
(C,D) Resistance to differentiation in O4GIP ESCs transfected with indicated siRNA 
combinations after 3 days of 2i withdrawal. 20nM Rapamycin and 50nM AZD8055 were added 
where indicated. Results were normalized to neg siRNA cells and are shown on a log(10)-
scaled axis. Average and SD of 2 technical replicates. 
(E) Tfe3 and LAMP1 localization in ESCs treated with 20nM Rapamycin or 50nM AZD8055 
for 24 hours. Arrows indicate colocalization of Tfe3 and LAMP1. Scale bar is 20µm 
(F) Absence of protein in Tsc2 KO ESCs. 
  
   
Figure S5. Related to Figure 5
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Figure S5, related to Figure 5: Catabolic sensing in ESCs. 
(A) Tfe3 localization in wildtype ESCs cultured for 2d in indicated nutrient conditions. Scale 
bar is 20µm. 
(B) Tfe3 KO and Tfe3Dexon4 ESC lines used in this study. Labeling similar to Figure S1F. 
Red bars indicate location of Tfe3 gRNAs recovered in the primary screen and dashed lines 
exon skipping. In frame stop codon is underscored in the Tfe3KO.8 cell lines. 
(C) Absence of Tfe3 protein in in KO cell lines. 
(D) Absence of Tfe3 immunoreactivity in Tfe3KO ESC clones with insets showing DNA 
staining of the field of view (upper). Ectopic nuclear Tfe3 in Tfe3Dexon4 cells (lower). Scale 
bar is 20µm. 
(E) Resistance to differentiation of O4GIP ESCs differentiated for 3 days in the presence of 
AZD8055 (200nM, 100nM, 50nM, 25nM), Rapamycin (Rapa, 80nM, 40nM, 20nM, 10nM), 
BafilomycinA (BafA,  2.5nM, 1.25nM), ConcanamycinA (ConA, 20nM, 10nM, 5nM, 2.5nM), 
Vacuolin-1 (400nM, 200nM, 100nM, 50nM) and Chloroquine (Chloro, 20µM, 10µM, 5µM, 
2.5µM). Results were normalized to control treated cells. Average and SD of 2 technical 
replicates. 
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Figure S6. Related to Figure 6
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Figure S6, related to Figure 6: RagC/DGDP interacts with Tfe3. 
(A) FLAG immunoprecipitates of wildtype ESCs expressing indicated Rag transgenes probed 
for Tfe3 and FLAG. 
  
   
Figure S7. Related to Figure 7
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Figure S7, related to Figure 7: Tfe3 induces a neural differentiation delay. 
(A) In frame Tfe3 mRNA deletions in 13 independent clones derived from differentiation-
resistant Cas9-expressing cells transiently transfected with screen gRNAs targeting exon4 
(Figure S5B). Exon boundaries and translation of wildtype Tfe3 are indicated. 
(B) Retention of self-renewal after 3 days of 2i withdrawal in Tfe3Dexon4 cells. Average and 
SD of 2 technical replicates. 
(C) Amino acid sequence alignment of the exon3-4 boundary in mouse and human MiTF/Tfe 
family members. I-Tasser (Yang et al., 2015) secondary structure prediction including 
confidence values is indicated. Patient mutation homologues are highlighted in red. 
(D) Induction of neural progenitor (left) and neuronal (right) markers upon release from 2i. 
Fold changes relative to ESCs are shown on a log(10)-scaled axis. Average and SD of two 
biological replicates. Days (d). 
(E,F) Self-renewal (E), and Essrb, Oct4 and Nanog expression (F) after 4 days of 2i withdrawal 
in cells of indicated genotypes treated with Tam starting from day 0, 1, 2 or 3 of differentiation. 
Average and SD of two biological replicates. 
(G) Fold mRNA changes of empty vector and Tfe3-ERT2 expressing cells at day 10 of 
neuronal differentiation. Tam was added between day 4 and day 8. Relative changes to 
untreated cells of the same genotype are shown on a log(10)-scaled axis. Average and SD of 
two biological replicates. 
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Abstract
Developmental cell fate specification is a unidirectional process
that can be reverted in response to injury or experimental repro-
gramming. Whether differentiation and de-differentiation trajecto-
ries intersect mechanistically is unclear. Here, we performed
comparative screening in lineage-related mouse naïve embryonic
stem cells (ESCs) and primed epiblast stem cells (EpiSCs), and iden-
tified the constitutively expressed zinc finger transcription factor
(TF) Zfp281 as a bidirectional regulator of cell state interconver-
sion. We showed that subtle chromatin binding changes in dif-
ferentiated cells translate into activation of the histone H3 lysine 9
(H3K9) methyltransferase Ehmt1 and stabilization of the zinc fin-
ger TF Zic2 at enhancers and promoters. Genetic gain-of-function
and loss-of-function experiments confirmed a critical role of
Ehmt1 and Zic2 downstream of Zfp281 both in driving exit from
the ESC state and in restricting reprogramming of EpiSCs. Our
study reveals that cell type-invariant chromatin association of
Zfp281 provides an interaction platform for remodeling the cis-
regulatory network underlying cellular plasticity.
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Introduction
Mammalian development is a hierarchical process that coordinates
organismal growth with increasing cellular differentiation. The
lineage progression of the few pluripotent cells in the blastocyst
toward the many specialized cell types in the mature embryo is by
and large unidirectional. However, fully differentiated cells can be
de-differentiated into induced pluripotent stem cells (iPSCs) by
ectopic expression of the transcription factors (TFs) Oct4, Sox2,
Klf4, and c-Myc (Takahashi & Yamanaka, 2006). Reprogramming of
somatic cells into iPSCs requires erasure of the entire developmental
history of a somatic cell, but whether this depends on the reversal
of developmental hierarchies is unclear (Ladewig et al, 2013; Taka-
hashi & Yamanaka, 2015).
Transcriptional and epigenomic profiling of the reprogramming
process has revealed an ordered series of events that include the
transient and sequential activation of late and early developmental
genes (Takahashi et al, 2014; Cacchiarelli et al, 2015; Amlani et al,
2018). Although the specific trajectory is dictated by the identity of
the starting somatic cell type (Jackson et al, 2016; Nefzger et al,
2017) and the experimental regime (Chantzoura et al, 2015; Stuart
et al, 2019), iPSC formation may involve the reversion of natural
developmental mechanisms (Takahashi & Yamanaka, 2015). Consis-
tent with this possibility, a mesenchymal-to-epithelial transition is
necessary for iPSC formation (Li et al, 2010; Samavarchi-Tehrani
et al, 2010), while the converse epithelial-to-mesenchymal transi-
tion is crucial for embryogenesis, e.g., during gastrulation and
neural crest formation (Acloque et al, 2009). Although it is debated
whether these observations reflect a shared developmental interme-
diate (Raab et al, 2017), they suggest that de-differentiation and dif-
ferentiation employ common mechanisms in opposite directions.
Here, we systematically and functionally examine this concept using
naı¨ve pluripotent embryonic stem cells (ESCs) and primed pluripo-
tent epiblast stem cells (EpiSCs; Smith, 2017).
Embryonic stem cells and EpiSCs are developmentally related
derivatives of mouse embryonic day (E) 3.75–4.5 blastocysts (Boro-
viak et al, 2014) and E5.5–8.0 embryos (Brons et al, 2007; Tesar
et al, 2007; Osorno et al, 2012), respectively. ESCs cultured in the
presence of two inhibitors (2i) resemble naı¨ve pluripotent cells of
the preimplantation epiblast (Boroviak et al, 2014), while primed
pluripotent EpiSCs cultured in the presence of FGF2 and activin A
(FA) resemble cells of the late gastrula (Osorno et al, 2012; Kojima
et al, 2014; Tsakiridis et al, 2014). Upon in vitro differentiation,
ESCs progress through a transient post-implantation epiblast-like
(EpiLC) cell state that is amenable to EpiSC derivation (Zhang et al,
2010; Hayashi et al, 2011). Conversely, activation of just one TF,
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such as Stat3, Klf4, or Esrrb, is sufficient to reprogram EpiSCs into
naı¨ve pluripotent EpiSC-derived iPSCs (Epi-iPSCs) in the presence of
2i (Guo et al, 2009; Yang et al, 2010; Festuccia et al, 2012). The
interconvertibility of ESCs and EpiSCs thus provides an experimen-
tal system to explore whether de-differentiation includes the rever-
sion of differentiation mechanisms.
Using a large-scale loss-of-function reprogramming screen in
sensitized EpiSCs, we identify the zinc finger TF Zfp281 as a promi-
nent bidirectional ESC-EpiSC transition regulator. We show that
Zfp281 exhibits stable chromatin association and drives ESC
progression through differentiation-specific interaction with Ehmt1
and Zic2. Genomic analysis revealed activation of Ehmt1 and
enrichment of Zic2 at Zfp281-bound cis-regulatory elements (CREs)
that are associated with developmental transcription in EpiLCs and
EpiSCs. Zfp281 therefore establishes and stabilizes cell fate commit-
ment to safeguard the unidirectionality of pluripotent state transi-
tions.
Results
Zfp281 is a bidirectional ESC-EpiSC transition regulator
We hypothesized that mechanisms common to differentiation and
de-differentiation may be encoded in genes that both promote exit
from the naı¨ve ESC state and impair reprogramming of EpiSCs. ESC
differentiation drivers have been determined in several genetic loss-
of-function screens (Guo et al, 2011; Westerman et al, 2011;
Betschinger et al, 2013; Leeb et al, 2014; Li et al, 2018), but it is
unknown whether those also inhibit reprogramming of EpiSCs into
naı¨ve pluripotency. We therefore set out to systematically identify
reprogramming roadblocks using a large-scale endoribonuclease-
prepared small interfering RNA (esiRNA) loss-of-function screen
(Ding et al, 2009). We made use of O4GIPGY118F EpiSCs expressing
green fluorescent protein (GFP) and puromycin N-acetyltransferase
under the regulatory sequences of the Oct4 gene (Guo et al, 2009),
and a Stat3-activating receptor (GY118F) responsive to granulocyte
colony-stimulating factor (Gcsf) driven by a constitutive promoter
(Yang et al, 2010). Upon exposure to Gcsf and 2i for 4 days (d),
O4GIPGY118F EpiSCs gave rise to self-renewing Epi-iPSCs at an effi-
ciency of roughly 0.1% (Fig EV1A), thus providing a sensitized
setup to identify reprogramming inhibitors. O4GIPGY118F EpiSCs
were transfected with esiRNAs targeting 9,540 transcripts and
control esiRNAs targeting Luciferase (Luc) and the GY118F down-
stream effector Stat3 in 384-well plates (Fig 1A). The next day,
reprogramming was induced by changing to 2i and Gcsf. After
4 days, we selected Epi-iPSCs in the presence of puromycin and
quantified viability with a fluorescent assay after 3–4 days. The
screen was performed in duplicate, and Z scores were calculated per
plate (Table EV1). Positive (Stat3 esiRNA), but not negative (non-
targeting Luc esiRNA and no esiRNA), controls induced negative Z
scores (Fig EV1B). Screen hits with average Z scores < 2 included
ribosome and proteasome subunits, Stat3 and Oct4 (Fig 1B), and
were strongly enriched for functions associated with RNA matura-
tion and translation using gene ontology (GO) analysis (Fig EV1C).
These therefore contain genes required for reprogramming and/or
cell survival. Screen hits with positive Z scores, conversely, are
expected to inhibit reprogramming and/or proliferation. Among the
146 hits with an average Z score > 2, the zinc finger TF Zfp281 and
the E3 ubiquitin ligase Fbxw7 scored highest. Zfp281 and Fbxw7
have previously been shown to restrict iPSC generation from
somatic cells (Buckley et al, 2012; Fidalgo et al, 2012, 2016; Okita
et al, 2012), thus suggesting successful identification of reprogram-
ming roadblocks.
To determine whether any of the 146 genes also drive ESC dif-
ferentiation, we compared our screen hits with those from two
previous large-scale ESC differentiation loss-of-function studies
(Betschinger et al, 2013; Li et al, 2018; Fig 1C). Zfp281 and the
cytochrome c oxidase subunits Cox5a and Cox6c scored strongest in
all screens. For validation, we depleted each of them by siRNA
transfection in independent GY118F-expressing Oct4 reporter 796.4
EpiSCs (Yang et al, 2010) and also included siRNAs targeting Fbxw7
and Tcf7l1 as controls (Fig 1B and C). Knockdown of Fbxw7 and
Zfp281, but not of Cox5a, Cox6c, or Tcf7l1, increased reprogram-
ming (Fig 1D and Appendix Fig S1A). Therefore, Cox5a and Cox6c
are false-positive or cell line-dependent screen hits, and we focused
our further efforts on Zfp281. Consistent with previous findings
(Fidalgo et al, 2016), Epi-iPSCs derived by Zfp281 depletion
expressed the naı¨ve TFs Esrrb, Klf4, Nr0b1, and Tbx3, and reduced
levels of the primed markers Oct6, Fgf5, Sox3, and Dnmt3b
(Fig EV1D), suggesting successful reversion to the pluripotent
ground state.
To quantify the dynamics of this process, we used self-renewal
in 2i as a proxy for acquisition of Epi-iPSC identity. Compared to
controls, Zfp281 depletion dramatically increased the colony-
forming capacity of single cells after 2 and 4 days of Gcsf addition
(Fig 1E), indicating accelerated and more efficient reprogramming
of EpiSCs. Gcsf supplementation was essential, and co-depletion of
Stat3 abolished Epi-iPSC formation from O4GIPGY118F EpiSCs in the
presence of Gcsf (Fig EV1E). Similarly, Leukemia inhibitory factor
(Lif), which activates Stat3 in EpiSCs (Yang et al, 2010), was
required for reprogramming of Zfp281-depleted OEC2 EpiSCs
(Fig 1F). To test whether Zfp281 acts only in the context of active
Stat3, we used conditional expression of Esrrb or Klf4 in O4GIP
EpiSCs through addition of doxycycline (Dox) to induce reprogram-
ming. In the absence of extrinsic Lif, we observed an increase in
Dox-induced Epi-iPSC colonies upon knockdown of Zfp281
(Fig 1G), suggesting that Zfp281 functions independent of the speci-
fic reprogramming regime. Taken together, these findings demon-
strate that the vast majority of cell state transition regulators act
unidirectionally. Zfp281, in contrast, acts bidirectionally as it drives
ESC differentiation and inhibits reprogramming of EpiSCs. Notably,
this is inverse to the activity of reprogramming TFs, e.g., Klf4 and
Esrrb, that induce and consolidate the naı¨ve ESC state (Guo et al,
2009; Niwa et al, 2009; Festuccia et al, 2012; Martello et al, 2012;
Yamane et al, 2018).
Zfp281 promotes exit from naïve pluripotency independent of
Tet1 and Tet2
To characterize the function of Zfp281 in ESC differentiation, we
inactivated the gene in naı¨ve RGd2 ESCs that contain a destabilized
GFP protein downstream of the Rex1 (Zfp42) promoter
(Appendix Fig S2A and B), which allows near real-time tracking of
cell state transition (Kalkan et al, 2017): GFP is homogeneously
expressed in 2i and up to 16 hours (h) after 2i withdrawal (GFPhigh;
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Kalkan et al, 2017) before becoming progressively downregulated
(GFPlow) as ESCs exit from self-renewal (Fig EV2A). In 2i, reporter
expression in two independent Zfp281 knockout (KO) clones was
similar to the parental wild-type cell line (WT) and an untargeted
wild-type sibling clone (Zfp281 WT) (Fig EV2B). In contrast, 32 and
72 h after 2i withdrawal, 30 and < 1% of WT cells were GFPhigh,
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Figure 1. Zfp281 inhibits reprogramming of EpiSCs.
A Schematic outline of the reprogramming screen. Red indicates O4GiPGY118F EpiSCs and green O4GIPGY118F Epi-iPSCs.
B Average Z scores of the two screen replicates. Note that esiRNAs targeting Mll1 (Zhang et al, 2016a) and Mbd3 (Rais et al, 2013) were not included in our library and
that Otx2 (Acampora et al, 2013) scored below the significance threshold. Screen hits with negative (blue) and positive (red) Z scores (red), and Tcf7l1 (green) are
highlighted.
C Comparison of reprogramming screen hits with two ESC differentiation screens (Betschinger et al, 2013; Li et al, 2018). Empty and full circles indicate genes recovered
in one and both ESC differentiation screens, respectively.
D Number of Epi-iPSC colonies derived from 796.4 EpiSCs transfected with indicated siRNAs, stimulated with Gcsf and 2i for 4 days, and selected with puromycin.
Average and standard deviation (SD) of three experiments performed in duplicates. Negative siRNA (neg).
E Self-renewal of O4GIPGY118F reprogramming intermediates after 2 days or 4 days of stimulation with Gcsf and 2i following transfection with indicated siRNAs.
Average and SD of two experiments performed in duplicates.
F Number of Epi-iPSC colonies derived from OEC2 EpiSCs transfected with indicated siRNAs, treated for 4 days in 2i or 2i/Lif medium, and selected with puromycin.
Average and SD of two experiments performed in duplicates.
G Number of Epi-iPSC colonies derived from O4GIP EpiSCs carrying Dox-inducible Esrrb or Klf4 transgenes after transfection with indicated siRNAs, stimulation with or
without Dox for 2 days, and selection with puromycin. Average and SD of two experiments performed in duplicates.
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while 75 and 10% of Zfp281 KO cells maintained high GFP expres-
sion, respectively. Consistent with impaired exit from the ESC state,
10% of Zfp281 KO cells formed colonies in 2i after 72 h of differenti-
ation (Fig 2A). This phenotype was reverted by transgenic Zfp281
expression (Fig 2B). Resistance to exit self-renewal was also
observed in KO cells generated in a different ESC lines
(Appendix Fig S2A and B, Fig EV2C), and in EpiLC (Hayashi et al,
2011) and embryoid body (EB) differentiation regimes (Figs 2A and
EV2B). Zfp281 mutant cells maintained Rex1 reporter expression
and self-renewal even after lengthy periods in the absence of 2i
(Figs 2A and EV2B), demonstrating that differentiation resistance is
persistent.
Differentiating Zfp281 KO cells expressed varied levels of the
Rex1 reporter (Fig EV2B) and formed colonies in 2i less efficiently
than naı¨ve pluripotent ESCs. For example, 32 h after 2i withdrawal,
mutant cells displayed only 40% of the self-renewal capacity of
ESCs (Fig EV2D). To test whether this reduction is linked to popula-
tion heterogeneity, we purified GFPhigh and GFPlow cells at 32 h
using fluorescence-activated cell sorting. As expected (Kalkan et al,
2017), sorted WT GFPlow cells were largely committed to differentia-
tion and unable to generate clones in 2i (Fig 2C). In contrast,
Zfp281 KO GFPlow cells formed colonies almost as efficiently as
GFPhigh cells. Rex1 downregulation and exit from the ESC state is,
thus, disconnected in Zfp281 mutants. However, the efficiency with
which GFPhigh cells formed colonies after 32 h of 2i withdrawal was
lower than of GFPhigh cells after 24 h (Kalkan et al, 2017) and of
ESCs (Fig 2C). This was irrespective of genotype, suggesting a grad-
ual decline in self-renewal during differentiation both in Zfp281
mutant and in WT GFPhigh cells. The reduced clonogenicity of
Zfp281 KO populations compared to ESCs may therefore be conse-
quential to impaired progression of an advanced cell state with
limited self-renewal capacity and independent of population hetero-
geneity. In fact, GFPlow cells in long-term differentiated Zfp281
mutants re-established GFPhigh expression within a few days
(Fig EV2E), revealing reversibility of the GFPlow state in the absence
of Zfp281. To test sufficiency, we generated naı¨ve RGd2 cells condi-
tionally overexpressing Zfp281 under Dox regulation (Fig EV2F).
Dox treatment in the presence of 2i induced silencing of the Rex1
reporter and loss of self-renewal in a subset of cells (Figs 2D and
EV2G). Zfp281 is therefore required and sufficient for exit from
naı¨ve pluripotency.
A previous study showed that differentiation of Serum/Lif-
cultured ESCs is accompanied by upregulation of Zfp281, which in
turn destabilizes metastable pluripotency by binding to the methyl-
cytosine hydroxylase Tet1 and transcriptionally suppressing Tet2
(Fidalgo et al, 2016). If the same mechanisms were to regulate exit
from naı¨ve pluripotency downstream of Zfp281, loss of Tet1 should
induce the same phenotype as loss of Zfp281, and loss of Tet2, the
opposite. We therefore generated Tet1, Tet2, and Zfp281/Tet2 KO
alleles in naı¨ve RGd2 ESCs (Appendix Fig S2C and D). Strikingly,
the extinction of the Rex1 reporter and self-renewal was similar in
differentiating WT cells and Tet1 and Tet2 mutants, while the
absence of Tet2 in Zfp281/Tet2 KO cells did not revert resistance to
differentiation caused by absence of Zfp281 alone (Figs 2E and
EV2H). We furthermore noted only modest changes in Zfp281
mRNA or protein during ESC differentiation, and across existing
RNA sequencing (RNA-seq) datasets of EpiLC and EpiSC differentia-
tion (Buecker et al, 2014; Factor et al, 2014; Bao et al, 2018) and
epiblast development (Boroviak et al, 2015; Figs 2F and EV2I).
Zfp281 has also been reported to repress Nanog transcription
through interacting with the NuRD complex in Serum/Lif-cultured
ESCs (Fidalgo et al, 2012). However, Nanog mRNA was unchanged
in naı¨ve Zfp281 KO ESCs or EpiSCs depleted of Zfp281 by siRNA
transfection (Fig EV2J and K). Furthermore, knockdown of Nanog
did not restore differentiation in ESCs depleted of Zfp281 while it
partially did so, as expected (Pereira et al, 2006), in ESCs depleted
of Tcf7l1 (Fig EV2L). Taken together, these results suggest that
Zfp281 is expressed fairly constantly during exit from naı¨ve pluripo-
tency and drives differentiation independent of Tet1, Tet2, and
Nanog.
Zfp281 acts independent of cell state-exclusive
chromatin association
To identify the transcriptional defects causing differentiation resis-
tance, we performed RNA-seq of WT and Zfp281 KO cells in 2i, and
16 and 32 h after 2i withdrawal (WT2i,16 h,32 h and Zfp2812i,16 h,32 h;
Table EV2). The expression of several naı¨ve and primed pluripo-
tency markers was perturbed in Zfp28116 h and Zfp28132 h cells
(Fig EV3A), confirming impaired silencing of naı¨ve identity in
Zfp281 mutants. k-means clustering of mRNAs that significantly
changed during WT differentiation or in Zfp281 KO cells (2,495
genes) identified six gene clusters (Fig 3A and B): Clusters 1–4
(1,898 genes) contain the majority of genes that were differentially
transcribed in WT32 h cells and of which a subset was already regu-
lated in WT16 h cells. Comparison with external EpiLC (Buecker
et al, 2014) and EpiSC (Factor et al, 2014; Bao et al, 2018) expres-
sion datasets, which were not employed in the clustering analysis,
revealed persistence of the bulk transcriptional changes established
in WT32 h cells, suggesting that clusters 1–4 contribute to pluripo-
tent cell state progression. Clusters 5 and 6 (597 genes), in contrast,
contain genes that were mostly unchanged in WT32 h cells, but tran-
siently regulated in WT16 h cells and differentially expressed in
EpiSCs. Clusters 5 and 6 may therefore act in gastrulation stage
epiblast development and/or EpiSCs.
Clusters 1 and 2 were largely unaffected in differentiating Zfp281
KO cells, whereas the repression and induction, respectively, of
cluster 3 and 4 genes were blunted in both Zfp28116 h and
Zfp28132 h cells (Fig 3A and B). Cell state-specific comparison
revealed that this was predominantly due to deregulation during dif-
ferentiation (Fig 3C). Although we cannot exclude that the tran-
scriptional defects in Zfp28132 h cells were influenced by cell state
heterogeneity (Fig EV2D), perturbed expression of cluster 3 and 4
genes in Zfp28116 h cells, a time point at which downregulation of
Rex1 reporter expression (Kalkan et al, 2017) and exit from self-
renewal (Fig EV2A and D) has not yet commenced, suggests a direct
role of Zfp281 in regulating these genes. Zfp281 may therefore drive
exit from naı¨ve pluripotency through controlling gene clusters 3 and
4, which contain the naı¨ve pluripotency TFs Klf4, Klf5, and Nr0b1,
and the primed markers Sox3 and Dnmt3b, respectively
(Table EV2), and are enriched for generic developmental terms
using GO analysis (Fig EV3B). Conversely, cluster 5 and 6 genes
were similarly mis-expressed in Zfp2812i, Zfp28116 h, and
Zfp28132 h cells, notably with directionalities that are inverse to the
changes observed in EpiSCs. GO analysis revealed significant enrich-
ment of regulators of cell adhesion, which is critical for cell
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polarization (Ebnet et al, 2018) that initiates lumenogenesis after
exit from naı¨ve pluripotency (Shahbazi et al, 2017). To test whether
Zfp281 controls polarization, we generated spheroids in Matrigel as
described before (Shahbazi et al, 2017). WT ESCs formed polarized
spheroids with expanded lumens that were encircled by apical F-
actin, while Zfp281 KO cells grew as unpolarized and disorganized
cellular aggregates that were morphologically similar to ESCs
(Fig 3D). Although we cannot exclude that this is consequential to
impaired exit from self-renewal, regulation of cluster 5 and 6 genes
by Zfp281 may therefore contribute to cell polarization and cavity
formation during ESC differentiation.
Oct4, similar to Zfp281, is expressed at equal levels in ESCs and
EpiLCs, but occupies distinct CREs in the two cell states (Buecker
et al, 2014). To determine whether Zfp281 acts through cell state-
specific chromatin association, we profiled its genome localization
in WT2i and WT32 h cells using chromatin immunoprecipitation
(ChIP) coupled to deep sequencing (ChIP-seq) (Table EV2). De novo
motif finding identified the consensus CCCCTCCCCC motif in 82.4%
of 23,756 peaks (Fig EV3C), which is similar to results obtained in
Serum/Lif ESCs (Fidalgo et al, 2016). Surprisingly, Zfp281 occu-
pancy in WT2i and WT32 h cells was as highly correlated (Pearson’s
correlation coefficient R = 0.81) as between replicates (R = 0.84 and
R = 0.85, respectively), with only few peaks exclusively detected in
any of the two cell states (Figs 3E and EV3D). A lower correlation
was observed between WT32 h cells and published data for EpiSCs
(Huang et al, 2017; R = 0.69) and trophoblast stem cells (TSCs; Ishi-
uchi et al, 2019; R = 0.55), but binding at peaks associated with
cluster 1–6 genes was largely unchanged (Fig EV3E and F), suggest-
ing stable chromatin association also during later pluripotency
progression and in lineage-unrelated TSCs. To determine whether
Zfp281 binds to CREs, we profiled histone H3 lysine 27 acetylation
(H3K27ac), a chromatin mark associated with active promoters and
enhancers. Comparison of our Zfp281 and H3K27ac with published
histone mark ChIP-seq data (Kurimoto et al, 2015; Buecker et al,
2014; Fig EV3G) identified 7,697 Zfp281 peaks proximal to tran-
scriptional start sites (TSSs), of which 54% were at active promoters
(co-localization with H3K27ac and H3K4 tri-methylation), and
16,059 distal Zfp281 peaks of which 62% were at putative enhan-
cers (co-localization with H3K4 mono-methylation). 38% of the
latter were also enriched for H3K27ac, qualifying them as active
enhancers. Notably, peaks with slightly increased Zfp281 binding in
WT32 h cells gained H3K27ac and expression of associated genes
during differentiation, while decreased binding was associated with
reduced H3K27ac and transcription (Fig 3F). Despite stable occu-
pancy of target sites, quantitative binding changes in Zfp281 at these
sites therefore parallel differences in CRE activity. However, this
was similar at peaks linked to Zfp281-insensitive cluster 1/2 and
Zfp281-sensitive cluster 3/4 genes (Fig 3G), showing that differen-
tial binding strength at CREs correlates with differentiation-specific
gene expression, but only partially with transcriptionally regulated
targets.
Zfp281 interacts with Ehmt1 and Zic2 during ESC differentiation
Since chromatin occupancy was largely unchanged, we reasoned
that Zfp281 may control transcription through cell state-specific
protein interaction partners. To test this, we performed Zfp281
immunoprecipitations (IPs) coupled to semi-quantitative mass spec-
trometry (MS) in nuclear extracts of WT2i and WT40 h cells, includ-
ing Zfp281 KO lysates to control for antibody specificity
(Table EV3). Stringent selection criteria identified the previously
reported interactor Nanog (Fidalgo et al, 2012) in WT2i cells and
several proteins specifically enriched in WT40 h cells (Fig 4A). Strik-
ingly, the latter were transcriptionally induced and the former
repressed during differentiation (Fig 4B), suggesting that differential
binding to Zfp281 may, at least in part, be driven by protein abun-
dance. To determine functional downstream effectors, we decided
to probe genetic interaction of differentiation-specific interactors
with Zfp281 in our conditionally overexpressing ESCs (Fig 2D). To
this end, we depleted selected binding partners using siRNA trans-
fection, induced Zfp281 by Dox treatment, and quantified Rex1
reporter distribution after 32 h in 2i (Fig 4C). As controls, we
included siRNAs targeting Zfp281 itself and Tcf7l1. Transfection of
Zfp281 but not Tcf7l1 siRNAs blocked emergence of GFPlow cells
(76% reduction) (Figs 4C and EV4A), thus confirming suitability for
identifying genetic Zfp281 interactors. Of all candidates tested indi-
vidually, only knockdown of Ehmt1 and Zic2 reduced the fraction of
GFPlow cells (34 and 32%, respectively), an effect enhanced by
simultaneous depletion of both (63%). Conversely, conditional
overexpression of Ehmt1 and Zic2 in RGd2 ESCs (Fig EV4B and C),
similar to Zfp281, induced downregulation of the Rex1 reporter in a
subset of cells (Fig EV4D). The de novo DNA methyltransferases
Dnmt3a and Dnmt3b have overlapping functions during embryogen-
esis (Okano et al, 1999) and, hence, may act redundantly. However,
simultaneous depletion of Dnmt3a and Dnmt3b by siRNAs or in
compound Dnmt3a/3b KO cells (Appendix Fig S2E and Fig EV4E)
did not impair Zfp281-induced reporter repression (Figs 4C, and
EV4A and F), demonstrating that Zfp281 drives differentiation inde-
pendent of Dnmt3a and Dnmt3b.
Zic2 is a zinc finger TF that represses poised developmental
enhancers in Serum/Lif ESCs (Luo et al, 2015). Ehmt1 (GLP) is a
methyltransferase that can be found in a complex with Ehmt2
◀ Figure 2. Zfp281 drives exit from naïve pluripotency independent of Tet enzymes.A, B Self-renewal in RGd2 ESCs of specified genotypes expressing indicated transgenes (B) after differentiation in indicated conditions (A) or 72 h in N2B27 (B). Average
and SD of two experiments performed in duplicates. Note that control cells were lost during continuous passaging in N2B27 (A). Not determined (n.d.).
C Representative flow cytometry profiles of WT and Zfp281 KO.1 cells after 32 h of 2i withdrawal before (unsorted) and after purification of cells with indicated GFP
expression (top panel). Self-renewal of undifferentiated (2i) and sorted GFPhigh,sort and GFPlow,sort cells of indicated genotypes (bottom panel). Average and SD of
three experiments performed in duplicates.
D Representative flow cytometry profiles of control and Zfp281-inducible ESCs (top panel) and quantification of GFPlow cells (bottom panel) after 2 days in 2i and in
the presence (green) or absence (black) of Dox. Average and SD of two experiments.
E Self-renewal in RGd2 ESCs of specified genotypes after 72 h in N2B27. Average and SD of two experiments performed in duplicates.
F Zfp281 mRNA changes during ESC differentiation detected by quantitative PCR (left) and extracted from published RNA-seq datasets (Buecker et al, 2014; Factor
et al, 2014; Boroviak et al, 2015; Bao et al, 2018) (right). Average and SD of two technical replicates (left).
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(G9a), which both mediate mono- and di-methylation of histone H3
lysine 9 (H3K9me1 and H3K9me2; Tachibana et al, 2005). The
genetic interactions in naı¨ve ESCs (Fig 4C) together with the prefer-
ential binding during differentiation observed in both nuclear
extracts using IP-MS (Fig 4A) and in whole-cell lysates using IP–
Western blot (Fig EV4G) suggest that Ehmt1 and Zic2 are functional
downstream effectors of Zfp281.
Ehmt1 and Zic2 regulate ESC differentiation and reprogramming
of EpiSCs
We therefore generated individual and compound Ehmt1 and Zic2
KO RGd2 ESCs (Appendix Fig S2F and G). In contrast to wild-type
or Zic2 KO cells, Ehmt1 and Ehmt1/Zic2 KO cells were spindle-
shaped (Fig EV4H) and proliferated slowly (Fig EV4I). They were
not arrested at a specific cell cycle stage (Fig EV4J) and did not
exhibit downregulation of the Rex1 reporter in 2i (Fig EV4K). After
2i withdrawal for 32 h (or 72 h), 75% (9%) of Ehmt1 and 55%
(7%) of Zic2 KO cells maintained GFP expression, increasing to
90% (35%) in Ehmt1/Zic2 compound KO cells (Fig EV4K), while
30% (1%) of cells from untargeted sibling clones (Zic2 WT and
Ehmt1 WT) were GFPhigh. Correspondingly, 5, 4, and 12% of Zic2,
Ehmt1, and Ehmt1/Zic2 KO cells retained self-renewal after 72 h of
differentiation (Fig 5A). Ehmt1 and Ehmt1/Zic2, but not Zic2 KO
ESCs, were unable to form polarized spheroids in Matrigel (Fig 5B).
Quantification of this effect was similar to Zfp281 mutants
(Fig EV4L). We therefore conclude that Ehmt1 is required for polar-
ization and that Ehmt1 and Zic2 promote exit from self-renewal
independently of each other.
In the absence of Ehmt1, H3K9me2 was limited to DAPI-rich
speckles (Fig EV4M), which is reminiscent of the depletion of
euchromatic H3K9me2 and its enrichment at pericentric heterochro-
matin in Ehmt2 mutants (Tachibana et al, 2002). Since exposure to
the Ehmt inhibitors A-366 and UNC0642 induced dose-dependent
cell lethality (data not shown), we decided to test Ehmt1’s enzy-
matic activity by expressing specific loss-of-function alleles in Ehmt1
KO cells: An Ehmt1 protein with mutations in the ankyrin domain
(Ehmt1ank), responsible for binding to methylated H3K9 in vitro
(Collins et al, 2008), reverted nuclear H3K9me2 distribution
(Fig EV4M) and resistance to Rex1 downregulation (Figs 5C and
EV4N) to a similar extent as the wild-type protein did. In contrast,
substitutions in the SET domain (Ehmt1NH-LE) that perturb Ehmt1
methyltransferase in vitro (Tachibana et al, 2008) rescued only
partially and a small deletion in the SET domain (Ehmt1DNHHC) that
additionally ablates binding to Ehmt2 completely abolished rescue.
Therefore, both catalytic activity of Ehmt1 and formation of a larger
methyltransferase protein complex are implicated in ESC transition.
Chemical inhibition and knockdown of Ehmt enzymes in somatic
cells enhances reprogramming (Shi et al, 2008; Sridharan et al,
2013; Rodriguez-Madoz et al, 2017). Consistently, depletion of
Ehmt1 but also of Zic2 in 796.4 and O4GIPGY118F EpiSCs increased
Epi-iPSC formation in the presence of Gcsf (Fig 5D and
Appendix Fig S1B). The effect was modest, but enhanced by the
combined knockdown of both. Taken together, these results suggest
that Ehmt1 and Zic2, similar to Zfp281, drive exit from naı¨ve
pluripotency and restrain reprogramming of EpiSCs. Notably,
phenotypes induced by co-depletion of Zic2 and Ehmt1 were weaker
than elimination of Zfp281, suggesting the existence of additional
Zfp281 effectors that may include other histone-modifying
complexes (Huang et al, 2017; Zhou et al, 2017; Ishiuchi et al,
2019).
Overlapping transcriptional functions of Zfp281 and Ehmt1/Zic2
To test whether the biochemical and functional interaction with
Zfp281 is reflected in similar transcriptional outputs, we profiled
mRNA expression in Ehmt1, Zic2, and Ehmt1/Zic2 KO cells in 2i
and after 32 h of differentiation (Table EV2). Principal component
(PC) analysis, including Zfp281 KO, EpiLC (Buecker et al, 2014),
and EpiSC (Bao et al, 2018) datasets, of changes relative to WT
ESCs identified PC1 to discriminate developmental timing and to
separate differentiated cells from ESCs (Fig 6A). Mutant and wild-
type ESCs projected similarly onto PC1 and expressed pluripotency
marker genes at similar levels (Fig EV5A), confirming their naı¨ve
identity. PC2, in contrast, segregatedWT from Zfp281 and, in partic-
ular, Ehmt1 KO genotypes. We, indeed, observed 1,274 deregulated
genes in Ehmt12i cells that were unchanged in Zfp2812i cells
(Fig EV5B). These were enriched for homeostatic and cell adhesion
GO terms (Fig EV5B) and likely contribute to the cellular and polar-
ization phenotypes in Ehmt1 KO cells.
Progression of Zfp28116 h/32 h, Ehmt132 h, and Ehmt1/Zic232 h
cells along PC1 was impaired when compared to matching WT
controls (Fig 6A), which we also observed in PC analysis using blas-
tocyst development datasets (Boroviak et al, 2015; Fig 6B). In fact,
alterations in Ehmt1 and Zfp281 KO cells correlated during differen-
tiation (Fig EV5C), suggesting similar defects in developmental
◀ Figure 3. Zfp281 directs sequential gene expression despite stable occupancy of target sites.A mRNA log2 fold changes (log2FC) in WT16 h, WT32 h, Zfp28116 h, and Zfp28132 h samples relative to WT2i cells, and in EpiSCs relative to WT2i/Lif cells (Factor et al,
2014; Bao et al, 2018). Zfp2812i, Zfp28116 h, and Zfp28132 h and WT16 h and WT32 h samples were used for k-means clustering.
B, C Quantification of (A) including mRNA log2FC in EpiLCs relative to WT
2i/Lif (Buecker et al, 2014) and as indicated (C). (B) Dots represent the median, and shades, the
lower and upper quartile. (C) Middle line represents median; notches, 95% confidence interval of the median; box, interquartile range; and whiskers, 1.5 times the
interquartile range. Number of datapoints: 477 (cluster 1), 397 (cluster 2), 534 (cluster 3), 490 (cluster 4), 337 (cluster 5), and 260 (cluster 6).
D Representative immunofluorescence staining of spheroids in Matrigel derived from WT or Zfp281 KO.1 ESCs grown in 2i or N2B27 for 3 days. Blue: DNA. Red:
F-actin. Scale bar is 10 lm.
E Scatter plot comparing Zfp281 log2 ChIP enrichment relative to matched inputs in WT
2i and WT32 h cells.
F Same as in (E) with dots colored according to H3K27ac ChIP log2FC at the same peaks (top left), and to gene expression log2FC associated with peaks by nearest
distance to TSS (bottom left) in WT32 h relative to WT2i cells. Quantification of H3K27ac ChIP (top right) and mRNA (bottom right) log2FC at top 1,000 Zfp281 peaks
with increased (red) or decreased (blue) Zfp281 binding during ESC differentiation. Boxes as in Fig 3C for 1,000 datapoints each.
G Quantification of Zfp281 (left) and H3K27ac (right) ChIP log2FC in WT
32 h compared to WT2i cells at Zfp281 peaks assigned to gene clusters 1–6. Boxes and number
of datapoints as in Fig 3C.
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transcription. This correlation was not strong (R = 0.44), but
increased (R = 0.57) when only considering cluster 1–6 gene expres-
sion (Fig EV5D). Although we also noted slight deregulation of clus-
ters 1 and 2, transcriptional defects in clusters 3–6 were similar in
Ehmt132 h and Zfp28132 h cells (Fig 6C and D). Ehmt2-dependent
H3K9 di-methylation is associated with gene silencing (Zylicz et al,
2015), consistent with the majority of genes showing increased RNA
levels in Ehmt12i cells (Fig EV5B). Nevertheless, 38% of target
genes were downregulated. Changes in the absence of Ehmt1 are
therefore likely consequential to both direct and indirect effects and
may also include the contribution of non-histone Ehmt1 substrates
(Sim et al, 2017) to transcription.
Based on mRNA levels, Zic232 h cells were not separated from
matching control cells (Fig 6A–D). This was surprising, since Zic2
KO cells appeared similarly impaired in exiting self-renewal as
Ehmt1 KO cells (Fig 5A). However, loss of Zic2 in Ehmt132 h cells
enhanced the deregulation of clusters 1–4 during differentiation
(Fig 6D) and induced a shift along PC1 (Fig 6A and B). Linear
regression revealed that perturbations in Ehmt1/Zic2 KO cells were
predominantly the sum of alterations in single mutants rather than
synergistic (Fig EV5E), implying subtle, but functionally relevant,
changes in Zic2 KO cells. Ehmt1 and Zic2 therefore regulate tran-
scription independently of each other, aligning with their additive
loss-of-function phenotypes in differentiation and reprogramming
(Fig 5A and D). Taken together, this analysis demonstrates
connected functions of Zfp281 and Ehmt1/Zic2 in gene expression
during cell state transition.
Ehmt1 and Zic2 act downstream of Zfp281 on chromatin
To identify direct targets and to explore how those relate to the
physical interaction with Zfp281 in differentiated cells, we
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performed Zic2 and Ehmt1 ChIP-seq, and profiled H3K9me2 as a
proxy for Ehmt1 activity. Due to absence of ChIP-seq compatible
Ehmt1 antibodies, we inserted an N-terminal Flag-Avi tag at both
Ehmt1 alleles in ESCs expressing the BirA biotin ligase (Fig EV5F).
This did not perturb exit from self-renewal (Fig EV5G), indicating
expression of a functional Ehmt1 fusion protein (Bio-Ehmt1).
ChIP-seq using Streptavidin beads identified broad Ehmt1-occupied
chromatin domains that, consistent with an enzyme–substrate rela-
tionship, scaled with H3K9me2 genome-wide (Fig EV5H). To deter-
mine overlap with Zfp281, we quantified Ehmt1 and H3K9me2
enrichment at Zfp281-bound and matching unbound control
windows (see Materials and Methods for details). Ehmt1 localiza-
tion at both sets of regions was unchanged during differentiation or
in Zfp281 KO cells (Fig EV5I and J), indicating that Zfp281 is not
required for Ehmt1 localization on chromatin. In contrast to Ehmt1,
H3K9me2 increased in WT32 h cells and EpiLCs (Kurimoto et al,
2015), with a more pronounced increase at Zfp281-occupied loci
than control windows (Fig 7A). To test whether these dynamics
require Zfp281, we performed immunofluorescence staining, which
revealed that mutant cells failed to gain H3K9me2 by 32 h after 2i
withdrawal (Fig EV5K). H3K9me2 ChIP-seq in Zfp281 mutants
confirmed that H3K9me2 levels were unaffected in Zfp2812i cells
but did not increase in Zfp28132 h cells (Figs 7A and EV5J).
Impaired gain of H3K9me2 was observed at both Zfp281-bound
and Zfp281-unbound sites, suggesting that Zfp281 is a differentia-
tion-specific pervasive activator of Ehmt1 during ESC transition.
Zic2 ChIP-seq identified 28,495 peaks, of which approximately 30%
overlapped with Zfp281 (Fig 7B). These were closer to promoters
and enriched for H3K27ac compared to Zic2-only and Zfp281-only
peaks (Fig EV5L and M), suggesting co-localization of Zfp281 and
Zic2 at CREs. In WT32 h cells, Zic2 increased predominantly at co-
bound peaks (Fig 7B). Although we noted a general reduction of
Zic2 on chromatin in Zfp281 mutants, Zic2 localization was
particularly perturbed at co-bound sites in Zfp28132 h cells (Figs 7B
and EV5N). Our findings therefore suggest that Zfp281 engages
Ehmt1 and Zic2 during ESC differentiation through chromatin
co-occupancy-dependent and chromatin co-occupancy-independent
mechanisms.
0
20
40
60
80
100
WT
Eh
mt1
WT
.1
Eh
mt1
ank
.1
Eh
mt1
ank
.2
Eh
mt1
WT
.2
Eh
mt1
ΔN
HH
C.2
Eh
mt1
NH
-LE
.1
Eh
mt1
NH
-LE
.2
Eh
mt1
ΔN
HH
C.1
G
FP
hi
gh
 c
el
ls
 (%
)
32h N2B272i
Ehmt1 KO.1 
-
WT
2i
N
2B
27
Ehmt1
KO.1
Zic2
KO.1
Ehmt1/Zic2
KO.1
DNAF-Actin
0
5
10
15
20
25
Zfp
281
 KO
.1
Zic
2 W
T
Zic
2 K
O.2
Ehm
t1 W
T
Ehm
t1/Z
ic2 
KO
.1
Ehm
t1/Z
ic2 
KO
.2
Ehm
t1 K
O.1
Ehm
t1 K
O.2
Zic
2 K
O.1
*
*
se
lf-
re
ne
w
al
 (%
)
*
*
*
C
BA
D
0
50
100
150
200
neg Zfp281 Ehmt1 Zic2 Ehmt1+Zic2
- + - +Gcsf:
siRNA:
E
pi
-iP
S
C
 c
ol
on
ie
s
- + - + - +
*
*
*
*
*
*
*
*
*
*
*
*O4GiPGY118F 
796.4 
Figure 5. Ehmt1 and Zic2 drive exit from the ESC state and restrict reprogramming of EpiSCs.
A Self-renewal in cells with indicated genotypes 3 days after 2i withdrawal. Significance was determined using a Wilcoxon–Mann–Whitney rank sum test comparing
the specified genotype groups. *P < 0.05. Average and SD of two experiments performed in duplicates.
B Representative immunofluorescence staining of spheroids in Matrigel derived from indicated genotypes in 2i or N2B27 for 4 days. Blue: DNA. Red: F-actin. Scale bar is
10 lm.
C Quantification of GFPhigh cells in WT cells or Ehmt1 KO clones expressing indicated transgenes in 2i (black) or 32 h after 2i withdrawal (pink). Average and SD of two
experiments.
D Number of Epi-iPSC colonies derived from 796.4 (gray) and O4GIPGY118F (black) EpiSCs transfected with indicated siRNAs, stimulated with Gcsf and 2i for 4 days, and
selected with puromycin. Significance was determined using a Wilcoxon–Mann–Whitney rank sum test compared to neg control sample of the respective cell line, or
comparing Zic2 and Ehmt1 to Ehmt1/Zic2 depletion. *P < 0.05. Average and SD of five experiments performed in duplicates.
10 of 22 The EMBO Journal e102591 | 2019 ª 2019 Friedrich Miescher Institute for Biomedical Research
The EMBO Journal Daniela Mayer et al
At Zfp281-bound peaks, the gain of H3K9me2 and Zic2
occurred mostly at mutually exclusive sets of genomic loci with
reduced and increased Zfp281 binding during differentiation,
respectively (Fig 7C and D), indicating that these are sites of
direct physical interaction that control transcription of nearby
genes. We therefore stratified H3K9me2 and Zic2 binding dynam-
ics at Zfp281 peaks by gene cluster association. H3K9me2
increased predominantly at peaks linked to repressed clusters 1
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C, D Quantification of cell state-specific mRNA log2FC of gene clusters 1–6 between indicated genotypes in 2i (C) and 32 h after 2i withdrawal (D). Boxes and number of
datapoints as in Fig 3C.
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and 3, and Zic2 at peaks belonging to induced clusters 2 and 4
(Fig 7E). Surprisingly, the gain in WT32 h cells and reduction in
Zfp28132 h cells were indistinguishable between clusters 1 and 3
(for H3K9me2) and clusters 2 and 4 (for Zic2). Hence, Zfp281
catalyzes H3K9me2 and Zic2 deposition at transition-associated
CREs genome-wide and without any qualitative or quantitative
specificity for its transcriptional targets in clusters 3 and 4. Why
cluster 1 and 2 gene expression is insensitive to perturbation of
H3K9me2 and Zic2 dynamics in Zfp281 KO cells (Figs 3C and 7E)
remains to be determined. Additional chromatin regulators may
be involved, since transcription of clusters 1 and 2 is also less
sensitive to Ehmt1 depletion than of clusters 3 and 4 (Fig 6D).
We therefore propose that Zfp281 drives and stabilizes transition-
specific transcription, at least in part, through activation of Ehmt1
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at cluster 3 CREs and recruitment or stabilization of Zic2 at clus-
ter 4 CREs.
Discussion
Cellular plasticity in response to injury in vivo or TF overexpression
in vitro is frequently accompanied by the reversal of cellular special-
ization (Merrell & Stanger, 2016). Although single-cell profiling has
shown that this process is not a strict inversion of natural develop-
ment (Treutlein et al, 2016; Gerber et al, 2018), differentiation and
de-differentiation trajectories may mechanistically intersect. We
aimed to uncover such plasticity regulators in pluripotent cells and
performed loss-of-function screening for genes that both drive exit
from ESC self-renewal and shield EpiSCs from reprogramming into
the pluripotent ground state. Within the experimental limitations of
this approach, we identified only one gene, the TF Zfp281. Such
exclusivity suggests a prominent role in establishing and maintain-
ing the unidirectionality of pluripotent cell state progression in vitro.
The former is consistent with perturbed epiblast maturation in
Zfp281 mutant embryos (Huang et al, 2017), but whether Zfp281
protects cellular identities against de-differentiation in vivo remains
to be determined. We, however, note that Zfp281 restrains iPSC
formation from fibroblasts at a late pre-iPSC stage (Fidalgo et al,
2012), supporting the notion that resetting of EpiSCs into naı¨ve
pluripotency recapitulates a late phase of somatic cell reprogram-
ming (Dunn et al, 2019). Other factors that, similar to Zfp281, drive
differentiation and inhibit de-differentiation of cell states not repre-
sented in our ESC-EpiSC conversion system are likely to exist.
We showed that Zfp281 is important for robust ESC differentia-
tion. This is reminiscent of lineage-specifying TFs that are specifi-
cally expressed in the lineages they instruct (Graf & Enver, 2009). In
adult mice, Zfp281 is indeed transcribed strongest in heart tissue
and its overexpression in fibroblasts enhances cardiac reprogram-
ming (Zhou et al, 2017). During ESC differentiation, however,
Zfp281 neither changes expression nor occupies distinct genomic
sites, indicating a facilitating, rather than specifying, function. Using
biochemical, genetic, and genomic experiments, we provide
evidence that Zfp281 directs sequential gene expression through
permissive and instructive mechanisms involving physical interac-
tion with Ehmt1 and Zic2. Cluster 5 and 6 genes are differentially
expressed in EpiSCs, but transcriptionally primed by Zfp281
throughout differentiation, including in the naı¨ve pluripotent start-
ing cell state. Cluster 5 contains modulators of cell adhesion that
may contribute to polarization of post-implantation epiblast cells.
However, although Zfp281 null embryos degenerate during
gastrulation, they do form an epithelial egg cylinder (Huang et al,
2017), suggesting operation of compensatory mechanisms in vivo.
Cluster 3 and 4 genes are, in contrast, regulated by Zfp281 predomi-
nantly during transition, enriched for developmental functions, and
therefore likely responsible for extinguishing ESC identity. Strik-
ingly, Zfp281 quantitatively decreases at CREs associated with
repressed cluster 3 genes and, vice versa, increases at CREs associ-
ated with induced cluster 4 genes. Concomitant gain of H3K9me2
and Zic2 at cluster 3 and 4 CREs, respectively, suggests that subtle
Zfp281 chromatin binding differences are converted into CRE activ-
ity changes by reciprocal activation of Ehmt1 and Zic2. Consistently,
embryonic arrest in Ehmt1 and Ehmt2 mutant mouse embryos
(Tachibana et al, 2002, 2005) has been attributed to reduced
H3K9me2 deposition at and impaired silencing of developmental
enhancers (Zylicz et al, 2015), while Zic2 triggers neural plate gene
expression in EpiSCs through enhancer activation (Iwafuchi-Doi
et al, 2012). The molecular mechanisms inducing differential bind-
ing of Zfp281 to Ehmt1 and Zic2 remain to be elucidated. Because of
similar overexpression phenotypes in ESCs, we surmise that protein
ratios are rate-determining. Zic2 protein levels, despite unchanged
mRNA (Fig 4B), indeed increase during differentiation, while Ehmt1
persists (Fig EV4G). However, Ehmt1 and Ehmt2 interact with addi-
tional zinc finger TFs (Shinkai & Tachibana, 2011) that may
compete with Zfp281 for binding to Ehmt1 specifically in ground
state ESCs. Taken together, we suggest that Zfp281 promotes stable
cell state transition by permissively marking cluster 5 and 6 genes
for forthcoming developmental regulation, and instructing cluster 3
and 4 gene expression for elimination of naı¨ve pluripotency, the
latter through differential engagement with Ehmt1 or Zic2 at CREs.
Zfp281 drives differentiation to and inhibits reprogramming of
EpiSCs, and therefore qualifies as a bidirectional cell state regulator
with antipodal functions during developmental progression and
reversion. Whether this is because Zfp281-Ehmt1/Zic2 control the
same cell state transition and act through the same target genes in
mutual directions remains to be determined. We showed that Zfp281
KO cells exposed to differentiation-promoting conditions are less
clonogenic than ESCs and give rise to an equilibrium of Rex1high and
Rex1low cell states that features defective coupling of Rex1 downreg-
ulation with exit from self-renewal. It is therefore conceivable that
Zfp281 acts after an initial commitment step to induce and stabilize
irreversible silencing of naı¨ve identity. During reprogramming,
Zfp281 may inversely antagonize induction of naı¨ve pluripotency
prior to formation of a Rex1high state, which has recently been shown
to mark transition intermediates with full ESC self-renewal activity
and destined to give rise to Epi-iPSCs (Stuart et al, 2019). Acting at a
late stage of reprogramming also reconciles our finding of Zfp281
◀ Figure 7. Zfp281 engages with Ehmt1 and Zic2 at developmental CREs.A H3K9me2 ChIP log2FC between indicated cell states and genotypes at 10-kb windows surrounding Zfp281-bound (purple) or matching DNase-hypersensitive site
(DHS) control peaks (gray). Boxes as in Fig 3C for 23,756 datapoints each.
B Overlap of Zfp281 and Zic2 ChIP peaks (left) and Zic2 ChIP log2FC between specified cell states and genotypes at indicated peak subsets (right). Boxes as in Fig 3C
for 15,659 (Zfp281-only), 20,183 (Zic2-only), and 8,312 (Zfp281/Zic2) datapoints.
C, D Same as in Fig 3F. Coloring is according to H3K9me2 ChIP log2FC between WT
32 h and WT2i cells (C, top left) and between EpiLCs and WT2i/Lif cells (C, bottom left)
at Zfp281 peaks extended to 10-kb windows, and according to Zic2 ChIP log2FC between WT
32 h and WT2i cells (D, left). Quantification of corresponding ChIP
changes at top 1,000 Zfp281 peaks with increased (red) or decreased (blue) Zfp281 binding during ESC differentiation (right). Boxes and number of datapoints as in
Fig 3F.
E H3K9me2 (top) and Zic2 (bottom) ChIP log2FC between indicated cell states and genotypes at all Zfp281 peaks extended to 10-kb windows (top) or Zfp281/Zic2 co-
bound peaks (bottom) associated with nearest TSSs of cluster 1–6 genes. Boxes and number of datapoints as in Fig 3C.
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impairing Epi-iPSC formation by STAT3 activation and Esrrb overex-
pression (Figs 1G and EV1E) with the notion that both regimes
proceed along distinct transcriptional trajectories before converging
on a Rex1high cell state (Stuart et al, 2019). However, Zfp281 deple-
tion in EpiSCs also causes cell cycle arrest and apoptosis (Fidalgo
et al, 2016), but not upregulation of naı¨ve pluripotent TFs such as
Nanog (Fig EV2K), and is not alone sufficient for reprogramming to
Epi-iPSCs in the presence of 2i (Fig 1F). Zfp281 activates transcrip-
tion of Nodal signaling components, such as the cluster 5 genes
Lefty1 and Lefty2, in ESCs, EpiSCs, and the post-implantation
epiblast (Huang et al, 2017). Nodal signaling is required for EpiSC
maintenance (Vallier et al, 2009), but dispensable for exit from ESC
self-renewal (Mulas et al, 2017) and somatic cell reprogramming
(Ruetz et al, 2017). We therefore speculate that Zfp281 controls the
EpiSC state and reprogramming through different effector genes, the
former through regulation of cluster 5/6 genes, e.g., Lefty1, Lefty2 or
cell polarity regulators, and the latter through stabilization of cell
state transition-specific cluster 3/4 genes.
In metastable serum/Lif ESCs, Zfp281 is reported to promote
DNA methylation and differentiation by recruiting Tet1 and silenc-
ing Tet2 (Fidalgo et al, 2016). Upon exit from the naı¨ve ESC state,
Zfp281 binds to Dnmt3a, Dnmt3b, and Dnmt3l (Fig 4A), suggesting
that Zfp281 controls 5-methylcytosine turnover through regulating
DNA methylating and demethylating enzymes. Furthermore,
Dnmt1, Dnmt3a, and Dnmt3b interact with the Ehmt1-Ehmt2
heterodimer (Este`ve et al, 2006; Epsztejn-Litman et al, 2008),
H3K9me2 and 5-methylcytosine marks overlap genome-wide (von
Meyenn et al, 2016), and DNA is hypomethylated upon depletion or
catalytic inhibition of Ehmt2 in ESCs (Zhang et al, 2016b). We,
however, showed that Zfp281 drives exit from naı¨ve pluripotency
independent of Dnmt3a, Dnmt3b, Tet1, and Tet2. Although the
specific contributions of 5-methylcytosine, H3K9me2, and other
Ehmt substrates (Sim et al, 2017) to pluripotent cell plasticity
remain to be determined, our findings suggest that resolution of
naı¨ve pluripotency in vitro is masked or mechanistically distinct in
heterogeneous Serum/Lif ESC cultures. Similarly, Zic2 has previ-
ously been reported to act as a repressor in metastable serum/Lif
ESCs (Luo et al, 2015), but we detect only minor transcriptional
defects in naı¨ve Zic2 KO ESCs.
Using the paradigm of pluripotent cell state conversion in vitro,
we here identify, in Zfp281, a regulator of cellular plasticity that
modulates CRE activity and transcription without reliance on cell
type-restricted expression or chromatin occupancy. We propose that
the persistence of Zfp281 at developmental CREs throughout cell
state transition provides a molecular platform for ordered remodel-
ing of the cis-regulatory architecture and further consolidation by
lineage-specifying TFs. These findings demonstrate that differential
gene expression is not a necessary criterion of cellular plasticity
regulators, and we suggest that this feature may not be limited to
pluripotent cells.
Materials and Methods
Cell culture
Embryonic stem cells (male and female RGd2 cells containing a
Rex1:GFPd2-IRES-blasticidin (Wray et al, 2011), male O4GIP ESCs
containing a GFP-IRES-puromycin transgene under control of an
Oct4 regulatory element (Betschinger et al, 2013), and male E14
cells) were cultured on plastic coated with gelatin or laminin
(Sigma) in N2B27 medium [DMEM/F12 (Life Technologies),
Neurobasal (Gibco) supplemented with N2 (homemade) and B-27
serum-free supplement (Gibco), 2 mM L-glutamine (Gibco), and
0.1 mM 2-mercaptoethanol (Sigma)] with 2i [3 lM CHIR99021 and
1 lM PD0325901 (Steward Lab, Dresden)] and, where indicated,
with 1 lg/ml doxycycline (Sigma). EpiSCs [O4GIP and OEC2 (Guo
et al, 2009) and 796.4 (Yang et al, 2010)] were cultured on plastic
coated with fibronectin (Millipore) in N2B27 with bFGF (12 ng/ml)
and activin A (20 ng/ml) (FA) (Smith Lab, Cambridge).
For monolayer differentiation, ESCs were seeded on gelatin-
coated plates at 1.5 × 104 cells/cm2 in 2i, and the following day, 2i
was withdrawn. Cells were incubated in N2B27 for 32 h or 72 h, or
continuously passaged on laminin-coated plates, as indicated. For
EpiLC differentiation for 48 h (Hayashi et al, 2011), medium was
adjusted to FA and 1% knockout serum replacement (Thermo
Fisher). For embryoid body (EB) differentiation, ESCs were seeded
at 2.5 × 104 cells/cm2 on ultra-low attachment plates (Corning) in
serum media [GMEM (Sigma) supplemented with 10% fetal bovine
serum (Sigma), 1 mM sodium pyruvate (Gibco), 2 mM L-glutamine
(Gibco), 0.1 mM non-essential amino acids (Gibco), and 0.1 mM 2-
mercaptoethanol (Sigma)] for 72 h. Exit from pluripotency was
quantified by measuring GFP fluorescence in RGd2 cells on a LSRII
SORP Analyzer (Becton Dickinson) and analyzed using FlowJo
(FlowJo, LLC), and by performing self-renewal and commitment
assays as described before (Betschinger et al, 2013). Briefly, dif-
ferentiated RGd2 and E14 cells at indicated time points were plated
at clonal density on laminin-coated plates in 2i medium, and result-
ing colonies were stained for alkaline phosphatase activity (Sigma)
according to the manufacturer’s instruction and counted. RGd2 cells
were additionally selected with 10 lg/ml blasticidin (Thermo
Fisher). O4GIP cells were differentiated for 72 h and treated with 2i
medium containing 1 lg/ml puromycin (Gibco), and uncommitted
cells were quantified after 3 days by adding 1:10 diluted Alamar
Blue (Invitrogen) in 2i medium, following by readout on a Spec-
traMax Gemini EM (Molecular Devices) microplate reader. For cell
cycle analysis, cells were fixed in cold 70% ethanol for 30 min at
4°C, washed twice with PBS and 0.1% BSA (Sigma), treated with
5 lg RNaseA (Thermo Fisher) for 15 min at room temperature (RT),
and stained with 10 lg propidium iodide (Sigma). Cells were
analyzed on a LSRII SORP Analyzer, and cell cycle distributions
were determined using FlowJo.
siRNA transfections were performed as described (Betschinger
et al, 2013) using 16.7 nM siRNA (detailed in Table EV4) and trans-
fection mixes in OptiMEM (Invitrogen) containing Lipofectamine
2000 or RNAiMAX (Thermo Fisher) for ESCs or EpiSCs, respec-
tively.
For EpiSC reprogramming, cells were plated at 1.5 × 104 cells/
cm2 on fibronectin-coated plates in N2B27 with FA. The next day,
medium was changed to 2i and, as indicated, supplemented with
30 ng/ml granulocyte colony-stimulating factor (Gcsf) (PeproTech),
10 ng/ml Lif (Smith lab, Cambridge), or 1 lg/ml doxycycline. After
4 days (d), medium was changed to 2i with 1 lg/ml puromycin,
and Epi-iPSC colonies were stained for alkaline phosphatase activity
and counted. For experiments shown in Figs 1E and EV1A, cells
were subjected to self-renewal assays in 2i after 2 and 4 days of Gcsf
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supplementation. For experiments shown in Fig EV1D, individual
Epi-iPSC colonies were picked and expanded in 2i with puromycin
for further experiments.
Spheroid formation of ESCs was performed as described before
(Shahbazi et al, 2017). Briefly, ESCs grown in 2i medium were
washed in N2B27, and 7.5 × 103 cells were resuspended in 25 ll
ice-cold growth factor reduced Matrigel (Corning, 356231), plated
dropwise on uncoated 96-well glass plates (Greiner Bio-One), and
aggregated in N2B27 with or without 2i for 3 or 4 days.
EpiSC screen
O4GIPGY118F EpiSCs were reverse-transfected in fibronectin-coated
384-well plates using mixtures of 50 ng esiRNA and 0.075 ll Lipo-
fectamine 2000 in 10 ll OptiMEM. EpiSCs were plated at a density
of 5,000 cells/well in 80 ll N2B27 with FA. Each plate included
three negative (Luciferase esiRNA) and two positive (Stat3 esiRNA)
control wells. The next day, medium was changed to 2i containing
30 ng/ml Gcsf and 4 days later to 2i containing 1 lg/ml puromycin.
After 3–4 days, medium was changed to 2i containing 1/10 vol
Alamar Blue (Invitrogen) and cell survival quantified on a Spec-
traMax M2 (Molecular Devices).
Genome editing
CRISPR/Cas9 genome editing was performed by transient co-trans-
fection of hCas9 and U6-gRNA plasmids (Mali et al, 2013) (Addgene
plasmids 41,815 and 41,824) and a dsRed expression plasmid into
E14 or female RGd2 ESCs. Two days later, single dsRed-positive
cells were sorted into gelatin-coated 96-well plates containing serum
media supplemented with 10 ng/ml Lif and 2i. Clones were geno-
typed by sequencing amplified target loci and by confirming protein
absence in Western blots. For generation of knockout (KO) cell
lines, two independent KO clones (specified in Appendix Fig S2)
and, in the case of Zfp281, Ehmt1, and Zic2 targeting, one untar-
geted wild-type sibling clone were kept for further analysis.
N-terminal Flag-Avi tagging of Ehmt1 was performed in WT or
Zfp281 KO ESCs constitutively expressing the BirA biotin ligase (see
below). The recombination template was generated by cloning
homology arms (548 bp upstream and 618 bp downstream of the
Ehmt1 transcription start site) into pDONR221 using Gateway tech-
nology (Thermo Fisher) and inserting the Flag-Avi sequence by
Seamless Cloning (Thermo Fisher). Targeting was performed as
above with hCas9, U6-gRNA, and dsRed expression plasmids, but
included co-transfection of the recombination template. Targeting
was confirmed by sequencing the target locus and by the expression
of biotinylated Ehmt1 in Western blots.
gRNA sequences, genotyping primers, and the Ehmt1 recombina-
tion template are specified in Table EV4. gRNA sequences targeting
Tet1 and Tet2 (Wang et al, 2013) and Dnmt3a and Dnmt3b (Dom-
cke et al, 2015) have been described.
Immunostaining
Cells seeded on laminin-coated 96-well glass plates were fixed with
4% paraformaldehyde (Electron Microscopy Sciences) for 10 min
and spheroids grown in Matrigel for 20 min at RT. Samples were
blocked for 1 h in blocking solution (PBS, 0.1% Triton X-100
(Sigma), 3% donkey serum (Sigma), and 1% BSA) and incubated
overnight with primary antibodies [Ehmt1 (Abcam, ab41969, 1:300)
and H3K9me2 (Abcam, ab1220, 1:300)] at 4°C. After three washes
in washing solution (PBS, 0.1% Triton X-100), secondary antibodies
were added, DNA was stained with Hoechst33342 (Life Technolo-
gies) and, where indicated, incubated with Alexa Fluor 488 Phal-
loidin (Life Technologies, A12379, 1:40) for 20 min at RT. Images
were acquired using a LSM 710 scanning head confocal microscope
(Zeiss) at 20× magnification and handled using Fiji and Adobe
Photoshop (Adobe). Imaging of spheroids used for quantification in
Fig EV4L was performed with a Yokogawa CV7000S high-
throughput confocal microscope at 20× magnification. Images were
acquired in confocal mode as z-stack multiplane images over z
distance of 50 lm with a 5 lm step size, and maximum intensity
projections were stored, representatives of which are shown in
Fig 5B.
Molecular biology
Coding sequences for Ehmt1, Esrrb, Klf4, and Zfp281 were amplified
from ESC complementary DNA (cDNA) and for BirA biotin ligase
from a plasmid (gift of Matyas Flemr, Friedrich Miescher Institute,
Basel). For Zic2, the coding sequence was synthesized as a double-
stranded gBlock (IDT). Polynucleotides were recombined into
pDONR221 using Gateway technology. Ehmt1 point mutations
[Ehmt1DNHHC: NHHC1198-1201del (Tachibana et al, 2008),
Ehmt1NH-LE: NH1198-1199LE (Tachibana et al, 2008), and Ehmt1ank:
W872A, W877A, and E880A (Collins et al, 2008)] were introduced
by polymerase chain reaction (PCR). Expression destination vectors
were pPB-CAG-DEST-pgk-hph (Betschinger et al, 2013) and pPB-
TRE-DEST-rTA-pgk-hph (Villegas et al, 2019), and GY118F expres-
sion vector as described (Yang et al, 2010). Stable integration into
ESCs or EpiSCs after co-transfection with pBASE (Betschinger et al,
2013) was selected in the presence of 150 lg/ml hygromycin B
(Thermo Fisher).
For relative mRNA quantification, total RNA was isolated from
indicated samples using RNeasy Mini Kit (Qiagen) and cDNA
prepared using SuperScript III reverse transcriptase (Invitrogen).
Quantitative PCR was performed using TaqMan Fast Universal PCR
Master Mix (Applied Biosystems) with gene-specific primers, using
either the universal probe library (UPL, Roche) or TaqMan system
(Applied Biosystems), and a GAPDH probe (Applied Biosystems) for
normalization. Oligonucleotide sequences and probes are listed in
Table EV4.
Protein methods
Cell lysates for Western blotting were generated in RIPA buffer
(50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
and 0.1% SDS). Primary antibodies were anti-GAPDH (Sigma,
G8795, 1:5,000), anti-Ehmt1 (Abcam, ab41969, 1:500), anti-Tet1
(Millipore, 09-872, 1:1,000), anti-Tet2 (Abcam, ab124297, 1:300),
anti-Zic2 (Abcam, ab150404, 1:500), anti-Zfp281 (Bethyl Laborato-
ries, A303-118A, 1:500), and anti-Streptavidin coupled to HRP
(Sigma, EV2438, 1:1,000).
Nuclear immunoprecipitations (IPs) for Zfp281 were performed
in three biological replicates using WT2i, Zfp2812i, WT40 h, and
Zfp28140 h cells. Cells were washed with cold PBS, resuspended in
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five packed cell volume (pcv) of buffer A (10 mM HEPES pH 7.9,
1.5 mM MgCl2, and 10 mM KCl), incubated for 10 min on ice, and
broke open using a Dounce homogenizer. Nuclei were pelleted at
3,300 g for 15 min at 4°C, resuspended in 3 pcv of buffer B
(20 mM HEPES pH 7.9, 1.5 mM MgCl2, 0.2 mM EDTA, and 20%
glycerol) supplemented with 420 mM NaCl, Complete Mini
protease, PhosSTOP phosphatase inhibitors (Roche), and 250 U/ml
Benzonase (Sigma), and incubated for 30 min at 4°C on a rotating
wheel. Insoluble material was pelleted at 25,000 g for 30 min at
4°C, and the supernatant diluted with buffer B to a final concentra-
tion of 150 mM NaCl and including 0.02% NP40. 1% of the super-
natant was kept as input sample and the remainder incubated with
10 ll Dynabeads Protein G (Invitrogen) and 1 lg Zfp281 antibody
(Bethyl Laboratories, A303-118A) for 1 h at 4°C on a rotating
wheel. Beads were collected on a magnetic rack for 2–3 min to
remove the supernatant, and washed four times in 1 ml buffer B
containing 150 mM NaCl and 0.02% NP40 for 10 min each at 4 °C
on a rotating wheel. For mass spectrometry, proteins were digested
on the beads as described before (Villegas et al, 2019).
Whole-cell lysate IPs using 1 lg Zfp281 antibody (Bethyl Labora-
tories, A303-118A) were performed as described before (Villegas
et al, 2019) using Dynabeads.
Chromatin immunoprecipitation
For ChIP of endogenous proteins or histone modifications, 8 × 106
cells per IP were fixed for 10 min with 1.1% formaldehyde in fix-
ing solution (0.1 M NaCl, 1 mM EDTA, 0.5 mM EGTA, and
50 mM HEPES pH 7.5) at RT on a rotating wheel, and neutralized
with glycine to a final concentration of 0.125 M for 5 min at RT.
Cells were washed three times with ice-cold PBS by spinning at
1,600 g for 5 min at 4°C, incubated for 10 min at 4°C on a rotat-
ing wheel with 1 ml lysis buffer 1 (50 mM HEPES pH 7.5,
140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, and
0.25% Triton X-100), pelleted, and incubated for a further 10 min
at 4°C in 1 ml lysis buffer 2 (10 mM Tris pH 8.0, 200 mM NaCl,
1 mM EDTA, and 0.5 mM EGTA). Nuclei were pelleted, resus-
pended in 140 ll shearing buffer (50 mM Tris pH 8.0, 10 mM
EDTA, and 1% SDS), and sonicated in Diagenode 15-ml Falcon
tubes for 25 cycles (30 s ON, 30 s OFF) in ice-cold water using a
Bioruptor Plus (Diagenode). 10% of sonicated DNA was kept as
input sample. Lysates were further pelleted at 14,000 g for 10 min
at 4°C, and the supernatant diluted 1:10 with ChIP dilution buffer
(50 mM Tris pH 8.0, 167 mM NaCl, 1.1% Triton X-100, and
0.11% Na-deoxycholate). Lysates were precleared over 10 ll
Dynabeads for 2 h and incubated overnight at 4°C on a rotating
wheel with the following antibodies: 2 lg H3K27ac (Active Motif,
39135), 2 lg H3K9me2 (Abcam, ab1220), 2 lg Zic2 (Abcam,
ab150404), or 2 lg Zfp281 (Bethyl Laboratories, A303-118A). The
next day, 10 ll Dynabeads were added and incubated with lysates
for 1 h at 4°C on a rotating wheel. Beads were washed with 1 ml
of the following buffers for 5 min each at 4°C: twice with wash
buffer 1 (50 mM Tris pH 8.0, 0.1% SDS, 0.1% Na-deoxycholate,
1% Triton X-100, 150 mM NaCl, 1 mM EDTA, and 0.5 mM
EGTA), once with wash buffer 2 (50 mM Tris pH 8.0, 0.1% SDS,
0.1% Na-deoxycholate, 1% Triton X-100, 500 mM NaCl, 1 mM
EDTA, and 0.5 mM EGTA), once with wash buffer 3 (50 mM Tris
pH 8.0, 250 mM LiCl, 0.5% Na-deoxycholate, 0.5% NP40, 1 mM
EDTA, and 0.5 mM EGTA), and twice with wash buffer 4 (50 mM
Tris pH 8.0, 10 mM EDTA, and 5 mM EGTA). Finally, beads were
eluted twice with 100 ll elution buffer (0.1 M NaHCO3, and 1%
SDS) for 15 min at RT in a shaker at maximum speed, and
combined supernatants de-crosslinked overnight by supplementa-
tion to 200 mM NaCl and continuous shaking at maximum speed
at 65°C. The same procedure was followed for input samples by
adjusting the total volume of elution buffer to 200 ll and 200 mM
NaCl. The next day, DNA was purified using MinElute PCR Purifi-
cation Kit (Qiagen).
Bio-ChIP for Flag-Avi-tagged Ehmt1 was performed as described
before (Ostapcuk et al, 2018) with minor modifications. Briefly,
8 × 106 cells per IP were fixed for 8 min with 1% formaldehyde in
PBS at RT on a rotating wheel, and neutralized with adjusting
glycine to a final concentration of 0.125 M and incubation for
1 min at RT and for 5 min on ice. Cells were washed three times
with ice-cold PBS and pelleted at 1,000 g for 5 min at 4°C. Cells
were lysed in lysis buffers 1 and 2 as described above. Nuclei
were washed once in 5 ml NUC buffer (15 mM HEPES pH 7.5,
60 mM KCl, 15 mM NaCl, and 0.32 mM sucrose) and resuspended
in 1 ml NUC buffer supplemented with Complete Mini protease
inhibitors, 3.3 ll 1 M CaCl2, and 2–3 ll Micrococcal Nuclease (Cell
Signaling, 10011S). Enzymatic activity was induced for 15 min at
37°C and shaking at 1,000 rpm, and stopped by addition of 50 ll
of STOP solution (250 mM EDTA and 500 mM EGTA) and 110 ll
of 10× ChIP buffer (167 mM Tris pH 8.0, 1.67 M NaCl, 12 mM
EDTA, 10% Triton X-100, and 0.1% SDS) with a further incuba-
tion for 5 min on ice. Nuclei were gently disrupted by sonication
in Diagenode 15-ml Falcon tubes for eight cycles (5 s ON, 5 s
OFF) in ice-cold water using a Bioruptor Plus. Lysates were centri-
fuged at 14,000 g for 5 min at 4°C, 5% of the supernatant was
kept as input sample, and the remaining supernatant precleared
for 2 h over 10 ll Dynabeads at 4°C on a rotating wheel. Chro-
matin was incubated for 1 h with M-280 Streptavidin-coupled
Dynabeads (Invitrogen) at 4°C on a rotating wheel, and washed
with 1 ml of the following buffers for 5 min each at 4°C: twice
with TE buffer (10 mM Tris pH 8.0, and 1 mM EDTA) supple-
mented with 2% SDS, once with high-salt buffer (50 mM HEPES
pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 0.1%
Na-deoxycholate), once with wash buffer 3 (see above), and twice
with TE buffer. Beads were eluted in 60 ll elution buffer (see
above) supplemented with 2 ll RNaseA (10 mg/ml stock) and
incubated for 30 min at 37°C while mixing. After supplementation
to 10 mM EDTA, 10 mM Tris pH 8.0, and 2 ll proteinase K
(10 mg/ml, Promega), the bead suspension was further incubated
for 3 h at 55°C and overnight at 65°C while shaking. The same
procedure was followed for input samples, including RNaseA and
proteinase K digestion. DNA was purified using AMPure XP beads
(Beckman Coulter).
Sequencing libraries
RNA from ESCs grown in 2i and 16 and 32 h after 2i withdrawal
was isolated using RNeasy kit (Qiagen). For Zfp281 KO and corre-
sponding WT cells, total RNA was subjected to ribosomal RNA
depletion using Ribozero removal kit (Illumina) followed by library
construction using ScriptSeq V2 library preparation kit (Illumina).
For Ehmt1, Zic2, Ehmt1/Zic2 KO, and corresponding WT cells,
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RNA-seq libraries were prepared using TruSeq mRNA Library
Preparation Kit (Illumina). ChIP-seq libraries were prepared using
NEBNext Ultra kit (New England BioLabs) following the
manufacturer’s recommendations. Sequencing was performed on an
Illumina HiSeq2500 machine (50-bp single-end reads).
Screen analysis
For the EpiSC reprogramming screen, Z scores were calculated for
each plate, excluding the two outer most columns and rows
(Table EV1). Screen replicates are presented in Fig EV1B. Average Z
scores > 2 were considered as screen hits, identifying 146 genes
(Fig 1B). We quantified their role in exit from the ESC state by
extracting primary data for these 146 genes from two previous ESC
differentiation studies (Betschinger et al, 2013; Li et al, 2018), and
computing Z scores on this subset (Table EV1). Sixty-seven and 129
of the 146 genes were mapped on results from Betschinger et al
(2013) and Li et al (2018), respectively, resulting in mapping of 130
genes in total. Average Z scores from both ESC differentiation
screens are presented in Fig 1C.
Quantification of immunostaining
Quantification of H3K9me2 was performed in CellProfiler3 (Broad
Institute). Nuclei were identified using Hoechst33342 staining and
average H3K9me2 and DNA fluorescence intensity per nucleus
determined: WT2i (453 cells), Zfp2812i (574 cells), WT32 h (465
cells), Zfp28132 h (792 cells).
For quantification of d3 and d4 spheroids from two biological
replicates, images were stitched to generate a single image per
channel and per well, and used for object segmentation with
MATLAB (MathWorks). Segmented object outlines were exported
and used for feature extraction with software package CellProfiler3.
Extracted features (84 features) describing object area, shape, and
intensity were normalized within corresponding assay plates using
Z score transformation and unified into a cross-comparable dataset.
Normalized features were used to extract 10 principal components
(PC), which were further used for unsupervised clustering with the
software package PhenoGraph (Levine et al, 2015). Unsupervised
clustering returned 13 clusters, and objects belonging to the two
sparsest clusters were discarded as outliers based on extreme vari-
ance in measured features in the respective classes. To describe
radial distribution of F-actin signal intensity, segmented objects
were divided into 20 concentric regions of same width. Distribution
of F-actin staining intensity was described as mean fraction of
intensity per region (MeanFrac) whereby the total intensity in the
given region was normalized to the fraction of object area corre-
sponding to the region. Mean fractions of intensity per region were
not Z scored as these values were normalized per object ad initio.
Visualization in Fig EV4L shows the mean of F-actin signal in a
given concentric ring of all d4 spheroids per genotype and medium
condition: WT2i (559 spheroids), Ehmt12i (349 spheroids), Zic22i
(292 spheroids), Ehmt1/Zic22i (164 spheroids), Zfp2812i (324 spher-
oids), WT96 h (437 spheroids), Ehmt196 h (228 spheroids), Zic296 h
(202 spheroids), Ehmt1/Zic296 h (233 spheroids), Zfp28196 h (547
spheroids). Heatmap was generated using aheatmap function from
the Bioconductor package NMF (Gaujoux & Seoighe, 2010) (pack-
age version 0.21.0).
Protein identification and quantification
Relative quantification of mass-spec data from three biological repli-
cates (Table EV3) was performed with MaxQuant (version 1.5.3.8)
using Andromeda as search engine and label-free quantification as
described (Villegas et al, 2019). Briefly, the mouse subset of the
UniProt version 2015_01 combined with the contaminant DB from
MaxQuant was searched, and the protein and peptide FDR were set
to 0.01. For Fig 4A and B, proteins were considered, which passed
an interaction threshold of an at least twofold enrichment in IPs
from WT2i or WT40 h lysates compared to matched Zfp281 KO
lysates with a significant P-value < 0.1, and were quantifiable with
at least two unique razor peptides.
RNA-seq and GRO-seq analysis
RNA-seq reads from wild-type and mutant cells in 2i, and 16 and
32 h after 2i withdrawal were aligned to the mouse GRCm38/mm10
genome using qAlign from the Bioconductor package QuasR (Gai-
datzis et al, 2015) (package version 1.22.0) with default parameters
except for splicedAlignment=TRUE. Published RNA-seq from ESCs
cultured in 2i/Lif and EpiLC (Buecker et al, 2014) was 36-bp reads,
and therefore, no spliced alignment could be performed. RNA-seq
from ESCs cultured in 2i/Lif and EpiSCs (Factor et al, 2014; Bao
et al, 2018), and global run-on sequencing (GRO-seq) data from
2i/Lif-cultured ESCs (Dorighi et al, 2017) were 100-bp and 50-bp
paired-end reads, respectively, and therefore, paired=“fr” was used.
For in vivo embryo data (Boroviak et al, 2015), preexisting align-
ments to mouse GRCm38/mm10 genome were downloaded from
ArrayExpress (E-MTAB-2958) and used. Alignments were quantified
for known UCSC genes obtained from the TxDb.Mmuscu-
lus.UCSC.mm10.knownGene package (package version 3.4.4) using
qCount from the Bioconductor package QuasR with default parame-
ters (Table EV2).
Only transcripts with at least three counts per million in at least
two biological samples from this study were considered as
expressed genes (total: 13,096 genes). For identification of signifi-
cantly deregulated genes, edgeR (Robinson & Oshlack, 2010; pack-
age version 3.24.0) was used and detected genes were fitted to two
generalized linear models:
(a) ~ time + genotype + time:genotype: This model uses WT2i,
WT16 h, WT32 h, Zfp2812i, Zfp28116 h, and Zfp28132 h expres-
sion datasets. Genes with a significant time coefficient are
genes that change either between WT2i and WT16 h or WT2i
and WT32 h cells, genes with a significant genotype coefficient
are differentially expressed between Zfp2812i and WT2i cells,
and genes with a significant interaction term time:genotype are
deregulated in Zfp281 KO cells specifically during 16-h or 32-h
differentiation.
(b) ~ genotype: This model identifies genes that differ between
Ehmt12i and WT2i cells.
Raw P-values were corrected for multiple testing by calculating
false discovery rates (FDR). Significant genes were identified as
genes with an absolute log2 fold change > 1.0 and an FDR of
< 0.01.
For visualization of RNA-seq data, except principal component
analysis (PCA) in Fig 6A and B and heatmap of selected markers in
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Fig EV5A, log2 fold-change values were used that were obtained
from edgeR by fitting the indicated datasets to the following models:
(c) ~ time (EpiLCs or EpiSCs): EpiLCs (Buecker et al, 2014) or
EpiSCs (Factor et al, 2014) compared to WT2i/Lif (Buecker et al,
2014) and EpiSC compared to WT2i/Lif (Bao et al, 2018; used
for Fig 3A and B).
(d) ~ genotime: Zfp28116 h or Zfp28132 h compared to WT2i (used
for Figs 3A and B, and EV3A), where genotime is the combina-
tion of genotype and time.
(e) ~ genotype (cell state-specific): KO cells in 2i compared to
WT2i, or KO cells 16 h or 32 h after 2i withdrawal compared to
WT16 h or WT32 h, respectively (used for Figs 3C and 6C and
D, and EV5B–E).
For heatmap visualization in Fig 3A, only significantly deregulated
genes in at least one condition were considered (model (a): time,
genotype, or time:genotype; total: 2,495 genes) and the following
log2 contrast was used for clustering: WT
16 h-WT2i, WT32 h-WT2i,
Zfp2812i-WT2i, Zfp28116 h-WT2i, Zfp28132 h- WT2i, Zfp28116 h-
WT16 h, and Zfp28132 h-WT32 h. For heatmap visualization in
Fig EV5A, RNA-seq read counts were normalized (divided by the
total number of aligned reads (library size), multiplied with minimal
library size, and added with a pseudocount of 8) and log2-trans-
formed, and the mean of biological replicates was plotted. For visu-
alization in Fig EV5B, significantly deregulated genes in Ehmt12i
(model (b): genotype) but not Zfp2812i (model (a): genotype) are
highlighted. In Fig 3B, dots represent the median, and shades, the
lower and upper quartile of indicated samples. Boxplots were gener-
ated using the boxplot function in R with default parameters except
outline=FALSE. Correlation plots (Fig EV5C and D) were generated
using corrplot function from the Bioconductor package corrplot
(https://github.com/taiyun/corrplot) (package version 0.84). Heat-
maps (Figs 3A and EV3A, and EV5A) were generated using
aheatmap function from the Bioconductor package NMF. For PCA
represented in Fig 6A, normalized (see above) and log2-transformed
read counts were centered by subtracting the average of WT ESCs
within each of the following four RNA-seq datasets: (i) Zfp281 KO
and corresponding WT samples from this study; (ii) Ehmt1, Zic2,
Ehmt1/Zic2 KO, and corresponding WT samples from this study;
(iii) WT2i/Lif cells and EpiLCs (Buecker et al, 2014); and (iv) WT2i/Lif
cells and EpiSCs (Bao et al, 2018). For PCA represented in Fig 6B,
normalized (see above) and log2-transformed read counts were
centered by subtracting the average over all samples within each of
the following three RNA-seq datasets: (i) Zfp281 KO and corre-
sponding WT samples from this study; (ii) Ehmt1, Zic2, Ehmt1/Zic2
KO, and corresponding WT samples from this study; and (iii) WT2i/
Lif cells and embryo samples (Boroviak et al, 2015). Centered read
counts for each PCA are provided in Table EV2, and the detailed R
code is provided in Dataset EV1. PCA was performed using the
prcomp function in R. Analyses of enriched gene sets (Figs EV1C,
EV3B and EV5B) were performed using DAVID (Huang et al, 2009)
(version 6.8) for GO terms of biological processes.
The linear model to estimate synergistic transcriptional effects in
Ehmt1 and Zic2 KO cells (Fig EV5E) takes into account all (13,096)
expressed genes, and was fitted using lm function in R:
ΔEhmt1/Zic2i ~ bEΔEhmt1i + bZΔZic2i + bintΔEhmt1:Zic2i
Δ: transcriptional difference (KO—WT) of gene i
b: regression coefficient:
E: Ehmt1
Z: Zic2
int: non-additive interaction
ChIP-seq and DHS-seq analysis
ChIP-seq data from this study, published datasets (Buecker et al,
2014; Huang et al, 2017; Ishiuchi et al, 2019), and DNase I hyper-
sensitive site sequencing (DHS-seq) (Encode; accession number:
ENCSR000CMW) reads were aligned to mouse GRCm38/mm10
genome using qAlign from the Bioconductor package QuasR with
default parameters. Published H3K4me3, H3K27me3, and H3K9me2
ChIP-seq data (Kurimoto et al, 2015) were aligned using Bowtie
(Langmead et al, 2009) (version 4.4.7) with parameter -C in color-
space. Alignments were sorted and indexed using SAMtools (pack-
age version 1.2), and all ChIP-seq data were quantified with qCount
from the Bioconductor package QuasR. Read counts were normal-
ized (divided by the total number of aligned reads (library size),
multiplied with minimal library size, and added with a pseudocount
of 8) and log2-transformed. For DHS-seq, reads per million (RPM)
were calculated by dividing the total number of aligned reads, multi-
plying with one million, adding a pseudocount of 8, and log2 trans-
forming the data.
We observed a non-linear relationship in Zfp281 ChIP-seq data
when comparing read counts in Zfp281 peaks between ChIP-seq
replicates in WT2i, and therefore performed loess regression using
normalizeBetweenArrays function of the Bioconductor package
limma (Ritchie et al, 2015) (package version 3.38.2) with
method = cyclingloess.
In Ehmt1 ChIP-seq data, we detected a variable dependency of
read counts in genomic tiles on the tile’s GC composition (GC bias),
which was most pronounced in input samples. In order to reduce
this bias, we used a loess-based normalization method: First, reads
were counted in each sample in 10-kb windows (either genome-
tiling windows or windows centered on Zfp281 peaks and corre-
sponding control windows; see below). The counts were then scaled
[divided by the total number of aligned reads (library size)], multi-
plied with minimal library size, added with a pseudocount of 8, and
log2-transformed. A loess curve was fit to the log2-transformed
counts as a function of the fraction of G+C bases in the window
using the R function loess with span = 0.3. This fit robustly captures
the global signal dependency on the underlying GC composition.
GC-corrected log2 read counts were then obtained by subtracting the
values predicted by the loess fit from the observed log2 read counts
(residuals of the fit).
Zfp281 peaks were called on Zfp281 ChIP-seq reads in WT2i
and WT32 h cells using Macs2 (Zhang et al, 2008; version
2.1.1.20160309) with default parameters. Peaks that were at least
twofold enriched (IP over respective inputs) in at least one of the
four Zfp281 ChIP samples were considered (total: 23,756 peaks;
Table EV2). For comparison of Zfp281 ChIP samples from this
study to ChIP in EpiSCs (Huang et al, 2017) and TSCs (Ishiuchi
et al, 2019), peaks were called on Zfp281 ChIP-seq reads in WT2i,
WT32 h, EpiSCs, and TSCs. Peaks that were at least twofold
enriched (IP over respective inputs) in at least one of the four
Zfp281 ChIP samples from this study, in the one Zfp281 ChIP
sample in EpiSCs, or in one of the two Zfp281 ChIP samples in
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TSCs were considered (total: 27,435 peaks) and used for plotting
(Fig EV3E and F). Zic2 peaks were called on Zic2 ChIP-seq reads
in WT2i, WT32 h, Zfp2812i, and Zfp28132 h cells. To quantitatively
compare Zfp281 and Zic2 binding, both peak sets were combined
and overlapping peak regions were merged using the function
reduce from Bioconductor package GenomicRanges (Lawrence
et al, 2013) (package version 1.34.0). Fused peaks were classified
into single- or co-bound as follows: Peaks that were enriched at
least twofold (IP over respective inputs) in at least one of the four
Zfp281 ChIP samples and in at least one of the eight Zic2 ChIP
samples were considered as co-bound (total: 8,312 peaks), while
those if detected only in Zfp281 ChIP or only in Zic2 ChIP samples
were considered as Zfp281-only (total: 15,659 peaks) or Zic2-only
(total: 20,183 peaks), respectively (Table EV2). Reads of H3K27ac
ChIP-seq datasets were counted in Zfp281, Zic2, or Zfp281/Zic2
co-bound peaks and normalized as described above.
Zfp281 or Zfp281/Zic2 co-bound peaks were assigned to genes
by calculating the distances of peak midpoint to the nearest tran-
scriptional start site (TSS) using a set of non-redundant TSSs with
a single start site randomly selected for each gene. Zfp281 peaks
were classified as proximal if the distance to the nearest TSS was
less than 2,000 bp (7,697 peaks) and as distal otherwise (16,059
peaks; Fig EV3G). H3K27ac reads in WT2i and WT32 h cells, and
H3K4me1 (Buecker et al, 2014) and H3K4me3 (Kurimoto et al,
2015) reads in WT2i/Lif and EpiLCs were counted in Zfp281 peak
regions and normalized as described above. Proximal Zfp281
binding sites with at least 1.5-fold enrichment of H3K27ac over
respective inputs in either WT2i or WT32 h cells and with at least
twofold enrichment of H3K4me3 over respective inputs in either
WT2i/Lif cells or EpiLCs were considered as associated with active
promoters (54% of proximal peaks; total: 4,128). Distal Zfp281
binding sites with at least 1.5-fold enrichment of H3K4me1 over
respective inputs in either WT2i/Lif cells or EpiLCs were consid-
ered as putative enhancers (62% of distal peaks; total: 9,990), of
which sites additionally enriched at least 1.5-fold over respective
inputs in H3K27ac in either WT2i or WT32 h cells were classified
as active enhancers (38% of putative enhancers; total: 3,818). For
quantification at target sites differentially bound by Zfp281 during
differentiation (Figs 3F, and 7C and D), the 1,000 binding sites
with strongest increase (Zfp281 UP) and decrease (Zfp281
DOWN) in Zfp281 ChIP signal in WT32 h compared to WT2i were
considered.
Due to the broad chromatin distribution of Ehmt1 and H3K9me2,
ChIP-seq reads were first quantified in genome-tiling windows of
10 kb, which were generated using tileGenome function from
Bioconductor package GenomicRanges with tilewidth=10000 and
cut.last.tile.in.chrom=TRUE. In Fig EV5H, all 10-kb genome-tiling
windows were separated in five bins with equal number of tiles but
increasing Ehmt1 ChIP log2 enrichment over respective input in
WT2i cells. To quantify Ehmt1 and H3K9me2 enrichment at Zfp281
binding sites, Zfp281 peak regions were extended to 10 kb centered
on the peak midpoint using the function resize from the Bioconduc-
tor package GenomicRanges. As a control set, DHS-seq peaks (peak
annotation downloaded from ENCODE; accession number:
ENCSR000CMW) were extended to 10 kb centered on the peak
midpoint and only regions non-overlapping with 10-kb extended
Zfp281 peaks were considered. The final set of control regions was
obtained by randomly sampling one DHS 10-kb peak per Zfp281
10-kb peak, such that the distributions of DHS-seq signal (log2 RPM)
and GC content between Zfp281 10-kb extended peaks and the
selected control regions matched closely.
Boxplots were generated using the boxplot function in R with
default parameters except outline=FALSE. Genomic profiles for heat-
maps centered on the Zfp281 peak midpoint (Fig EV3G) were gener-
ated with qProfile from the Bioconductor package QuasR, and
visualized using ComplexHeatmap (package version 1.20.0) (Gu
et al, 2016). Except for Zfp281 ChIP-seq and GRO-seq (Dorighi et al,
2017), the averages of two replicates are shown.
Details for quantification and statistical analysis
Details of experiments are specified in figure legends, including the
number of biological or technical replicates and the number of data-
points, and are further detailed in the respective Materials and Meth-
ods sections. In brief, experimental data quantification is represented
as the mean and standard deviation (SD). Significances in Figs 4C,
and 5A and D were determined using a Wilcoxon–Mann–Whitney
rank sum test using R function wilcox_test. In Fig 2B, the computa-
tional analysis shows dots as the median and shades as the lower
and upper quartile. In Figs 3C, F, G, 6C, D, and 7A–E, and EV5H–K
and M, N, the computational analysis shows the median as middle
line, the 95% confidence interval of the median as notches, the
interquartile range as box, and 1.5 times the interquartile range as
whiskers. In Fig EV5E, the estimated regression coefficients and
standard errors are derived from the computational linear model.
Data availability
Next-generation sequencing data reported in this study have been
deposited at the Gene Expression Omnibus with accession number
GSE131017; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE131017.
Expanded View for this article is available online.
Acknowledgements
We would like to thank S. Dessus-Babus, K. Jacobeit, E. Pandini Figueiredo
Moreno, T. Roloff, and S. Smallwood (FMI) for processing sequencing samples;
L. Gelman, S. Bourke, and M. Zinner (FMI) for imaging assistance; H. Kohler
(FMI) for cell sorting; M. Flemr and P. Knuckles (FMI) for advice on genome
editing and ChIP; and P.A. Ginno, L. Hoerner, and A.H.F.M. Peters (FMI) for
providing reagents. We are grateful to S. Gasser, M. Michalski, F. Mohn, and
A.H.F.M. Peters (FMI), and S. Stricker (Helmholtz Centre) for comments on the
manuscript. This work was supported by the EU Seventh Framework
Programme Integrated Project SyBoSS (to A.S. and F.B.) and the Novartis
Research Foundation (to J.B.). A.S is a Medical Research Council Professor.
Author contributions
DM, MR, and JB performed experiments. DM and MBS performed bioinformati-
cal analysis. DH performed mass spectrometry. IL performed spheroid image
analysis. MW, AS, and FB assisted the esiRNA screen. DM and JB wrote the
paper.
Conflict of interest
The authors declare that they have no conflict of interest.
ª 2019 Friedrich Miescher Institute for Biomedical Research The EMBO Journal e102591 | 2019 19 of 22
Daniela Mayer et al The EMBO Journal
References
Acampora D, Di Giovannantonio LG, Simeone A (2013) Otx2 is an intrinsic
determinant of the embryonic stem cell state and is required for
transition to a stable epiblast stem cell condition. Development 140:
43 – 55
Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009)
Epithelial-mesenchymal transitions: the importance of changing cell state
in development and disease. J Clin Invest 119: 1438 – 1449
Amlani B, Liu Y, Chen T, Ee L-S, Lopez P, Heguy A, Apostolou E, Kim SY,
Stadtfeld M (2018) Nascent induced pluripotent stem cells efficiently
generate entirely iPSC-derived mice while expressing differentiation-
associated genes. Cell Rep 22: 876 – 884
Bao S, Tang WW, Wu B, Kim S, Li J, Li L, Kobayashi T, Lee C, Chen Y, Wei M
et al (2018) Derivation of hypermethylated pluripotent embryonic stem
cells with high potency. Cell Res 28: 22 – 34
Betschinger J, Nichols J, Dietmann S, Corrin PD, Paddison PJ, Smith A (2013)
Exit from pluripotency is gated by intracellular redistribution of the bHLH
transcription factor Tfe3. Cell 153: 335 – 347
Boroviak T, Loos R, Bertone P, Smith A, Nichols J (2014) The ability of inner-
cell-mass cells to self-renew as embryonic stem cells is acquired following
epiblast specification. Nat Cell Biol 16: 516 – 528
Boroviak T, Loos R, Lombard P, Okahara J, Behr R, Sasaki E, Nichols J, Smith A,
Bertone P (2015) Lineage-specific profiling delineates the emergence and
progression of naive pluripotency in mammalian embryogenesis. Dev Cell
35: 366 – 382
Brons IGM, Smithers LE, Trotter MWB, Rugg-Gunn P, Sun B, Chuva de Sousa
Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA et al
(2007) Derivation of pluripotent epiblast stem cells from mammalian
embryos. Nature 448: 191 – 195
Buckley SM, Aranda-Orgilles B, Strikoudis A, Apostolou E, Loizou E, Moran-
Crusio K, Farnsworth CL, Koller AA, Dasgupta R, Silva JC et al (2012)
Regulation of pluripotency and cellular reprogramming by the ubiquitin-
proteasome system. Cell Stem Cell 11: 783 – 798
Buecker C, Srinivasan R, Wu Z, Calo E, Acampora D, Faial T, Simeone A,
Tan M, Swigut T, Wysocka J (2014) Reorganization of enhancer patterns
in transition from naive to primed pluripotency. Cell Stem Cell 14:
838 – 853
Cacchiarelli D, Trapnell C, Ziller MJ, Soumillon M, Cesana M, Karnik R,
Donaghey J, Smith ZD, Ratanasirintrawoot S, Zhang X et al (2015)
Integrative analyses of human reprogramming reveal dynamic nature of
induced pluripotency. Cell 162: 412 –424
Chantzoura E, Skylaki S, Menendez S, Kim S-I, Johnsson A, Linnarsson S,
Woltjen K, Chambers I, Kaji K (2015) Reprogramming roadblocks are
system dependent. Stem Cell Reports 5: 350 – 364
Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR, Cheng X
(2008) The ankyrin repeats of G9a and GLP histone methyltransferases are
mono- and dimethyllysine binding modules. Nat Struct Mol Biol 15:
245 – 250
Ding L, Paszkowski-Rogacz M, Nitzsche A, Slabicki MM, Heninger A-K, de
Vries I, Kittler R, Junqueira M, Shevchenko A, Schulz H et al (2009) A
genome-scale RNAi screen for Oct4 modulators defines a role of the
Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4:
403 – 415
Domcke S, Bardet AF, Adrian Ginno P, Hartl D, Burger L, Schübeler D (2015)
Competition between DNA methylation and transcription factors
determines binding of NRF1. Nature 528: 575 – 579
Dorighi KM, Swigut T, Henriques T, Bhanu NV, Scruggs BS, Nady N, Still CD,
Garcia BA, Adelman K, Wysocka J (2017) Mll3 and Mll4 facilitate enhancer
RNA synthesis and transcription from promoters independently of H3K4
monomethylation. Mol Cell 66: 568 – 576.e4
Dunn S-J, Li MA, Carbognin E, Smith A, Martello G (2019) A common
molecular logic determines embryonic stem cell self-renewal and
reprogramming. EMBO J 38: e100003
Ebnet K, Kummer D, Steinbacher T, Singh A, Nakayama M, Matis M (2018)
Regulation of cell polarity by cell adhesion receptors. Semin Cell Dev Biol 81:
2 – 12
Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J,
Deplus R, Fuks F, Shinkai Y, Cedar H et al (2008) De novo DNA
methylation promoted by G9a prevents reprogramming of embryonically
silenced genes. Nat Struct Mol Biol 15: 1176 – 1183
Estève P-O, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, Carey
MF, Pradhan S (2006) Direct interaction between DNMT1 and G9a
coordinates DNA and histone methylation during replication. Genes Dev 20:
3089 – 3103
Factor DC, Corradin O, Zentner GE, Saiakhova A, Song L, Chenoweth JG,
McKay RD, Crawford GE, Scacheri PC, Tesar PJ (2014) Epigenomic
comparison reveals activation of ‘seed’ enhancers during transition from
naive to primed pluripotency. Cell Stem Cell 14: 854 – 863
Festuccia N, Osorno R, Halbritter F, Karwacki-Neisius V, Navarro P, Colby D,
Wong F, Yates A, Tomlinson SR, Chambers I (2012) Esrrb is a direct Nanog
target gene that can substitute for Nanog function in pluripotent cells.
Cell Stem Cell 11: 477 – 490
Fidalgo M, Faiola F, Pereira C-F, Ding J, Saunders A, Gingold J, Schaniel C,
Lemischka IR, Silva JCR, Wang J (2012) Zfp281 mediates Nanog
autorepression through recruitment of the NuRD complex and inhibits
somatic cell reprogramming. Proc Natl Acad Sci USA 109: 16202 – 16207
Fidalgo M, Huang X, Guallar D, Sanchez-Priego C, Valdes VJ, Saunders A, Ding
J, Wu W-S, Clavel C, Wang J (2016) Zfp281 coordinates opposing functions
of Tet1 and Tet2 in pluripotent states. Cell Stem Cell 19: 355 – 369
Gaidatzis D, Lerch A, Hahne F, Stadler MB (2015) QuasR: quantification and
annotation of short reads in R. Bioinformatics 31: 1130 – 1132
Gaujoux R, Seoighe C (2010) A flexible R package for nonnegative matrix
factorization. BMC Bioinformatics 11: 367
Gerber T, Murawala P, Knapp D, Masselink W, Schuez M, Hermann S, Gac-
Santel M, Nowoshilow S, Kageyama J, Khattak S et al (2018) Single-cell
analysis uncovers convergence of cell identities during axolotl limb
regeneration. Science 362: eaaq0681
Graf T, Enver T (2009) Forcing cells to change lineages. Nature 462: 587 – 594
Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and
correlations in multidimensional genomic data. Bioinformatics 32:
2847 – 2849
Guo G, Yang J, Nichols J, Hall JS, Eyres I, Mansfield W, Smith A (2009) Klf4
reverts developmentally programmed restriction of ground state
pluripotency. Development 136: 1063 – 1069
Guo G, Huang Y, Humphreys P, Wang X, Smith A (2011) A PiggyBac-based
recessive screening method to identify pluripotency regulators. PLoS One 6:
e18189
Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M (2011) Reconstitution of
the mouse germ cell specification pathway in culture by pluripotent stem
cells. Cell 146: 519 – 532
Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res 37: 1 – 13
20 of 22 The EMBO Journal e102591 | 2019 ª 2019 Friedrich Miescher Institute for Biomedical Research
The EMBO Journal Daniela Mayer et al
Huang X, Balmer S, Yang F, Fidalgo M, Li D, Guallar D, Hadjantonakis A-K,
Wang J (2017) Zfp281 is essential for mouse epiblast maturation through
transcriptional and epigenetic control of Nodal signaling. Elife 6: 243
Ishiuchi T, Ohishi H, Sato T, Kamimura S, Yorino M, Abe S, Suzuki A,
Wakayama T, Suyama M, Sasaki H (2019) Zfp281 shapes the
transcriptome of trophoblast stem cells and is essential for placental
development. Cell Rep 27: 1742 – 1754.e6
Iwafuchi-Doi M, Matsuda K, Murakami K, Niwa H, Tesar PJ, Aruga J, Matsuo I,
Kondoh H (2012) Transcriptional regulatory networks in epiblast cells and
during anterior neural plate development as modeled in epiblast stem
cells. Development 139: 3926 – 3937
Jackson SA, Olufs ZPG, Tran KA, Zaidan NZ, Sridharan R (2016) Alternative
routes to induced pluripotent stem cells revealed by reprogramming of
the neural lineage. Stem Cell Reports 6: 302 – 311
Kalkan T, Olova N, Roode M, Mulas C, Lee HJ, Nett I, Marks H, Walker R,
Stunnenberg HG, Lilley KS et al (2017) Tracking the embryonic stem cell
transition from ground state pluripotency. Development 144: 1221 – 1234
Kojima Y, Kaufman-Francis K, Studdert JB, Steiner KA, Power MD, Loebel DAF,
Jones V, Hor A, de Alencastro G, Logan GJ et al (2014) The transcriptional
and functional properties of mouse epiblast stem cells resemble the
anterior primitive streak. Cell Stem Cell 14: 107 – 120
Kurimoto K, Yabuta Y, Hayashi K, Ohta H, Kiyonari H, Mitani T, Moritoki Y,
Kohri K, Kimura H, Yamamoto T et al (2015) Quantitative dynamics of
chromatin remodeling during germ cell specification from mouse
embryonic stem cells. Cell Stem Cell 16: 517 – 532
Ladewig J, Koch P, Brüstle O (2013) Leveling Waddington: the emergence of
direct programming and the loss of cell fate hierarchies. Nat Rev Mol Cell
Biol 14: 225 – 236
Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome.
Genome Biol 10: R25
Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R,
Morgan MT, Carey VJ (2013) Software for computing and annotating
genomic ranges. PLoS Comput Biol 9: e1003118
Leeb M, Dietmann S, Paramor M, Niwa H, Smith A (2014) Genetic exploration
of the exit from self-renewal using haploid embryonic stem cells. Cell
Stem Cell 14: 385 – 393
Levine JH, Simonds EF, Bendall SC, Davis KL, Amir E-AD, Tadmor MD, Litvin O,
Fienberg HG, Jager A, Zunder ER et al (2015) Data-driven phenotypic
dissection of AML reveals progenitor-like cells that correlate with
prognosis. Cell 162: 184 – 197
Li R, Liang J, Ni S, Zhou T, Qing X, Li H, He W, Chen J, Li F, Zhuang Q et al
(2010) A mesenchymal-to-epithelial transition initiates and is required for
the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7: 51 – 63
Li M, Yu JSL, Tilgner K, Ong SH, Koike-Yusa H, Yusa K (2018) Genome-wide
CRISPR-KO screen uncovers mTORC1-mediated Gsk3 regulation in naive
pluripotency maintenance and dissolution. Cell Rep 24: 489 – 502
Luo Z, Gao X, Lin C, Smith ER, Marshall SA, Swanson SK, Florens L, Washburn
MP, Shilatifard A (2015) Zic2 is an enhancer-binding factor required for
embryonic stem cell specification. Mol Cell 57: 685 – 694
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013)
RNA-guided human genome engineering via Cas9. Science 339: 823 – 826
Martello G, Sugimoto T, Diamanti E, Joshi A, Hannah R, Ohtsuka S, Göttgens
B, Niwa H, Smith A (2012) Esrrb is a pivotal target of the Gsk3/Tcf3 axis
regulating embryonic stem cell self-renewal. Cell Stem Cell 11: 491 – 504
Merrell AJ, Stanger BZ (2016) Adult cell plasticity in vivo: de-differentiation
and transdifferentiation are back in style. Nat Rev Mol Cell Biol 17:
413 – 425
von Meyenn F, Iurlaro M, Habibi E, Liu NQ, Salehzadeh-Yazdi A, Santos F,
Petrini E, Milagre I, Yu M, Xie Z et al (2016) Impairment of DNA
methylation maintenance is the main cause of global demethylation in
naive embryonic stem cells. Mol Cell 62: 848 – 861
Mulas C, Kalkan T, Smith A (2017) NODAL secures pluripotency upon
embryonic stem cell progression from the ground state. Stem Cell Reports
9: 77 – 91
Nefzger CM, Rossello FJ, Chen J, Liu X, Knaupp AS, Firas J, Paynter JM,
Pflueger J, Buckberry S, Lim SM et al (2017) Cell type of origin dictates the
route to pluripotency. Cell Rep 21: 2649 – 2660
Niwa H, Ogawa K, Shimosato D, Adachi K (2009) A parallel circuit of LIF
signalling pathways maintains pluripotency of mouse ES cells. Nature 460:
118 – 122
Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a
and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99: 247 – 257
Okita Y, Matsumoto A, Yumimoto K, Isoshita R, Nakayama KI (2012) Increased
efficiency in the generation of induced pluripotent stem cells by Fbxw7
ablation. Genes Cells 17: 768 – 777
Osorno R, Tsakiridis A, Wong F, Cambray N, Economou C, Wilkie R, Blin G,
Scotting PJ, Chambers I, Wilson V (2012) The developmental dismantling
of pluripotency is reversed by ectopic Oct4 expression. Development 139:
2288 – 2298
Ostapcuk V, Mohn F, Carl SH, Basters A, Hess D, Iesmantavicius V,
Lampersberger L, Flemr M, Pandey A, Thomä NH et al (2018) Activity-
dependent neuroprotective protein recruits HP1 and CHD4 to control
lineage-specifying genes. Nature 557: 739 – 743
Pereira L, Yi F, Merrill BJ (2006) Repression of Nanog gene transcription by
Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol 26:
7479 – 7491
Raab S, Klingenstein M, Möller A, Illing A, Tosic J, Breunig M, Kuales G, Linta L,
Seufferlein T, Arnold SJ et al (2017) Reprogramming to pluripotency does not
require transition through a primitive streak-like state. Sci Rep 7: 16543
Rais Y, Zviran A, Geula S, Gafni O, Chomsky E, Viukov S, Mansour AA, Caspi I,
Krupalnik V, Zerbib M et al (2013) Deterministic direct reprogramming of
somatic cells to pluripotency. Nature 502: 65 – 70
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma
powers differential expression analyses for RNA-sequencing and
microarray studies. Nucleic Acids Res 43: e47
Robinson MD, Oshlack A (2010) A scaling normalization method for
differential expression analysis of RNA-seq data. Genome Biol 11: R25
Rodriguez-Madoz JR, San Jose-Eneriz E, Rabal O, Zapata-Linares N, Miranda
E, Rodriguez S, Porciuncula A, Vilas-Zornoza A, Garate L, Segura V et al
(2017) Reversible dual inhibitor against G9a and DNMT1 improves human
iPSC derivation enhancing MET and facilitating transcription factor
engagement to the genome. PLoS One 12: e0190275
Ruetz T, Pfisterer U, Di Stefano B, Ashmore J, Beniazza M, Tian TV, Kaemena
DF, Tosti L, Tan W, Manning JR et al (2017) Constitutively active SMAD2/3
are broad-scope potentiators of transcription-factor-mediated cellular
reprogramming. Cell Stem Cell 21: 791 – 805.e9
Samavarchi-Tehrani P, Golipour A, David L, Sung H-K, Beyer TA, Datti A,
Woltjen K, Nagy A, Wrana JL (2010) Functional genomics reveals a BMP-
driven mesenchymal-to-epithelial transition in the initiation of somatic
cell reprogramming. Cell Stem Cell 7: 64 – 77
Shahbazi MN, Scialdone A, Skorupska N, Weberling A, Recher G, Zhu M,
Jedrusik A, Devito LG, Noli L, Macaulay IC et al (2017) Pluripotent state
transitions coordinate morphogenesis in mouse and human embryos.
Nature 552: 239 – 243
ª 2019 Friedrich Miescher Institute for Biomedical Research The EMBO Journal e102591 | 2019 21 of 22
Daniela Mayer et al The EMBO Journal
Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, Ding S (2008) Induction of
pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4
with small-molecule compounds. Cell Stem Cell 3: 568 – 574
Shinkai Y, Tachibana M (2011) H3K9 methyltransferase G9a and the related
molecule GLP. Genes Dev 25: 781 – 788
Sim Y-J, Kim M-S, Nayfeh A, Yun Y-J, Kim S-J, Park K-T, Kim C-H, Kim K-S
(2017) 2i maintains a naive ground state in ESCs through two distinct
epigenetic mechanisms. Stem Cell Reports 8: 1312 – 1328
Smith A (2017) Formative pluripotency: the executive phase in a
developmental continuum. Development 144: 365 – 373
Sridharan R, Gonzales-Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel
S, Lopez D, Mishra N, Pellegrini M et al (2013) Proteomic and genomic
approaches reveal critical functions of H3K9 methylation and
heterochromatin protein-1c in reprogramming to pluripotency. Nat Cell
Biol 15: 872 – 882
Stuart HT, Stirparo GG, Lohoff T, Bates LE, Kinoshita M, Lim CY, Sousa EJ,
Maskalenka K, Radzisheuskaya A, Malcolm AA et al (2019) Distinct
molecular trajectories converge to induce naive pluripotency. Cell Stem
Cell 25: 388 – 406
Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M,
Takeda N, Niida H, Kato H et al (2002) G9a histone methyltransferase
plays a dominant role in euchromatic histone H3 lysine 9 methylation
and is essential for early embryogenesis. Genes Dev 16: 1779 – 1791
Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H, Sakihama T,
Kodama T, Hamakubo T, Shinkai Y (2005) Histone methyltransferases G9a
and GLP form heteromeric complexes and are both crucial for
methylation of euchromatin at H3-K9. Genes Dev 19: 815 – 826
Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y (2008) G9a/GLP
complexes independently mediate H3K9 and DNA methylation to silence
transcription. EMBO J 27: 2681 – 2690
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors. Cell
126: 663 – 676
Takahashi K, Tanabe K, Ohnuki M, Narita M, Sasaki A, Yamamoto M,
Nakamura M, Sutou K, Osafune K, Yamanaka S (2014) Induction of
pluripotency in human somatic cells via a transient state resembling
primitive streak-like mesendoderm. Nat Commun 5: 3678
Takahashi K, Yamanaka S (2015) A developmental framework for induced
pluripotency. Development 142: 3274 – 3285
Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL,
McKay RDG (2007) New cell lines from mouse epiblast share defining
features with human embryonic stem cells. Nature 448: 196 – 199
Treutlein B, Lee QY, Camp JG, Mall M, Koh W, Shariati SAM, Sim S, Neff NF,
Skotheim JM, Wernig M et al (2016) Dissecting direct reprogramming from
fibroblast to neuron using single-cell RNA-seq. Nature 534: 391 – 395
Tsakiridis A, Huang Y, Blin G, Skylaki S, Wymeersch F, Osorno R, Economou C,
Karagianni E, Zhao S, Lowell S et al (2014) Distinct Wnt-driven primitive
streak-like populations reflect in vivo lineage precursors. Development 141:
1209 – 1221
Vallier L, Mendjan S, Brown S, Chng Z, Teo A, Smithers LE, Trotter MWB, Cho CH-
H, Martinez A, Rugg-Gunn P et al (2009) Activin/Nodal signalling maintains
pluripotency by controlling Nanog expression. Development 136: 1339 – 1349
Villegas F, Lehalle D, Mayer D, Rittirsch M, Stadler MB, Zinner M, Olivieri D,
Vabres P, Duplomb-Jego L, De Bont ESJM et al (2019) Lysosomal signaling
licenses embryonic stem cell differentiation via inactivation of Tfe3. Cell
Stem Cell 24: 257 – 270
Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch
R (2013) One-step generation of mice carrying mutations in multiple
genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910 – 918
Westerman BA, Braat AK, Taub N, Potman M, Vissers JHA, Blom M, Verhoeven
E, Stoop H, Gillis A, Velds A et al (2011) A genome-wide RNAi screen in
mouse embryonic stem cells identifies Mp1 as a key mediator of
differentiation. J Exp Med 208: 2675 – 2689
Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R, Smith A
(2011) Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression
of the pluripotency network and increases embryonic stem cell resistance
to differentiation. Nat Cell Biol 13: 838 – 845
Yamane M, Ohtsuka S, Matsuura K, Nakamura A, Niwa H (2018) Overlapping
functions of Krüppel-like factor family members: targeting multiple
transcription factors to maintain the naïve pluripotency of mouse
embryonic stem cells. Development 145: dev162404
Yang J, van Oosten AL, Theunissen TW, Guo G, Silva JCR, Smith A (2010) Stat3
activation is limiting for reprogramming to ground state pluripotency. Cell
Stem Cell 7: 319 – 328
Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C,
Myers RM, Brown M, Li W et al (2008) Model-based analysis of ChIP-Seq
(MACS). Genome Biol 9: R137
Zhang K, Li L, Huang C, Shen C, Tan F, Xia C, Liu P, Rossant J, Jing N (2010)
Distinct functions of BMP4 during different stages of mouse ES cell neural
commitment. Development 137: 2095 – 2105
Zhang H, Gayen S, Xiong J, Zhou B, Shanmugam AK, Sun Y, Karatas H, Liu L,
Rao RC, Wang S et al (2016a) MLL1 inhibition reprograms epiblast stem
cells to naive pluripotency. Cell Stem Cell 18: 481 – 494
Zhang T, Termanis A, Özkan B, Bao XX, Culley J, de Lima Alves F,
Rappsilber J, Ramsahoye B, Stancheva I (2016b) G9a/GLP complex
maintains imprinted DNA methylation in embryonic stem cells. Cell Rep
15: 77 – 85
Zhou H, Morales MG, Hashimoto H, Dickson ME, Song K, Ye W, Kim MS,
Niederstrasser H, Wang Z, Chen B et al (2017) ZNF281 enhances cardiac
reprogramming by modulating cardiac and inflammatory gene expression.
Genes Dev 31: 1770 – 1783
Zylicz JJ, Dietmann S, Günesdogan U, Hackett JA, Cougot D, Lee C, Surani
MA (2015) Chromatin dynamics and the role of G9a in gene regulation
and enhancer silencing during early mouse development. Elife 4: 717
22 of 22 The EMBO Journal e102591 | 2019 ª 2019 Friedrich Miescher Institute for Biomedical Research
The EMBO Journal Daniela Mayer et al
Expanded View Figures
0 10 20 30 40 50
translation
antigen proc. and pres. of antigens via MHC
RNA splicing
form. of transl. preinit. complex
mRNA processingZ 
sc
or
e 
< 
-2
0 10 20 30 40 50
histone H2A acetylation
histone H4 acetylation
covalent chromatin modification
neg. regul. of proteasomal ubiqui.-dep.proc.
pos. regul. of substrate adhesion-dep. cell spread.
-log10 p-value
Z 
sc
or
e 
> 
2
se
lf-
re
ne
w
al
 (%
)
0
0.05
0.1
0.15
0.2
0.25
2d 4d
+ Gcsf
- Gcsf
E 120
0
20
40
60
80
100
O4GiPempty O4GiPGY118F
- -+ +
neg + Zfp281
neg + Stat3
neg + neg
E
pi
-iP
S
C
 c
ol
on
ie
s
Gcsf:
Stat3 + Zfp281
0.0001
0.001
0.01
0.1
1
10 O
4G
iP
GY
118
F
O4
GiP
Ep
i-iP
SC
.1
796
.4
796
.4
Ep
i-iP
SC
.1
ES
C
2i
O4
GiP
Ep
i-iP
SC
.2
O4
GiP
Ep
i-iP
SC
.3
796
.4
Ep
i-iP
SC
.2
796
.4
Ep
i-iP
SC
.3
Nr0b1
Tbx3Klf4
Esrrb
n.
d.
n.
d.
n.
d.
m
R
N
A
 re
l. 
to
 E
S
C
 (l
og
10
)
CA
D
0.0001
0.001
0.01
0.1
1
10
0.00001
n.
d.
n.
d.
n.
d.
n.
d.
n.
d.
n.
d.
n.
d.
m
R
N
A
 re
l. 
to
 E
pi
S
C
 (l
og
10
)
Sox3
Dnmt3bFgf5
Oct6
B
4 60 2
-4
-2
0
2
4
Z score replicate 1
Z 
sc
or
e 
re
pl
ic
at
e 
2 6
8
-4 -2
R = 0.51
8
no esiRNA
Luc esiRNA
Stat3 esiRNA
Figure EV1. Enhanced reprogramming of EpiSCs in the absence of Zfp281.
A Self-renewal of O4GIPGY118F reprogramming intermediates after 2 or 4 days in 2i in the presence or absence of Gcsf. Average and SD of 2 experiments performed in
duplicates.
B Scatter plot of Z scores between screen replicates. Negative controls (no esiRNA and non-targeting Luc esiRNA) are marked in yellow and green, respectively, and
positive controls (Stat3 esiRNA) in blue. Pearson’s correlation coefficient (R).
C Top 5 GO terms enriched in screen hits with Z scores > 2 (top) and < 2 (bottom).
D Induction of naïve (top) and repression of primed (bottom) pluripotency markers in Epi-iPSCs derived from Zfp281-depleted and Gcsf-stimulated O4GIPGY118F and
796.4 EpiSCs. mRNA fold changes relative to ESCs (top) and EpiSCs (bottom) are shown on a log(10)-scaled axis. Average and SD of two technical replicates. Not
detected (n.d.).
E Epi-iPSC colonies derived from O4GIPempty and O4GiPGY118F EpiSCs transfected with indicated siRNAs, incubated for 4 days in 2i in the presence or absence of Gcsf,
and selected with puromycin. Average and SD of two technical replicates.
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▸Figure EV2. Characterization of Zfp281 and Tet enzymes in ESC differentiation.A Self-renewal in RGd2 cells at indicated time points of 2i withdrawal. Average and SD of two experiments performed in duplicates.
B Representative flow cytometry profiles of RGd2 ESCs of specified genotypes, at indicated time points and in indicated conditions. Numbers are average and SD of
GFPhigh cells in two experiments.
C, D Self-renewal in RGd2 cells of indicated genotypes after 3 days (C) or indicated time points (D) of 2i withdrawal. Average and SD of two experiments performed in
duplicates. E denotes E14 parental cell line origin.
E Flow cytometry profiles (left panel) of long-term differentiated Zfp281 KO.2 cells in N2B27 and indicating GFP sorting gates (left), and of unsorted or sorted
GFPlow,sort and GFPhigh,sort cells after an additional 2–3 days of culture in N2B27 and indicating gates used for quantification of GFP distribution (right). Please note
that profiles shown on the right were recorded on a different instrument than the profile presented on the left. Quantification of GFP distribution (right panel) in
N2B27 cultures derived from indicated sorted cells of specified genotypes. Average and SD of 2 experiments.
F Zfp281 transcription relative to untreated WT2i cells in Zfp281-inducible ESC clones after 48 h in 2i and in the presence or absence of Dox. Average and SD of two
technical replicates.
G Self-renewal of sorted GFPhigh,sort and GFPlow,sort populations of indicated genotypes after exposure to Dox (green) or control conditions (black) for 48 h. Green
circles on x-axis mark Dox-treated non-self-renewing samples. Average and SD of two technical replicates.
H Representative flow cytometry profiles of RGd2 ESCs of specified genotypes at indicated time points and in indicated conditions. Numbers are average and SD of
GFPhigh cells in two experiments.
I Western blot showing Zfp281 protein levels during ESC progression.
J, K Nanog (J, K) and Zfp281 (K) mRNA levels relative to WT2i cells in ESCs of specified genotypes (J) and in indicated EpiSCs 24 h after transfection of neg and Zfp281
siRNAs (K). Average and SD of 5 (J) and 2 (K) experiments performed in duplicates.
L Resistance to differentiation in O4GIP ESCs transfected with indicated siRNA combinations after 3 days of 2i withdrawal relative to untransfected cells. Average
and SD of two experiments performed in duplicates.
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▸Figure EV3. Genomics of Zfp281.A mRNA log2FC relative to WT2i cells of selected core, naïve, and primed pluripotency markers in differentiating between WT and Zfp281 KO cells at indicated time
points.
B Top 5 enriched GO terms in clusters 1–6.
C Sequence logo from the de novo identified binding motif in 82.4% of 23,756 Zfp281 peaks.
D Scatter plot comparing log2 Zfp281 peak ChIP enrichment over matched inputs between replicates in WT
2i (top) and WT32 h (bottom) cells.
E, F Scatter plot comparing log2 Zfp281 ChIP enrichment over matched inputs in WT
32 h cells and EpiSCs (Huang et al, 2017) (E) and TSCs (Ishiuchi et al, 2019) (F). Peaks
were assigned to closest transcriptional start sites (TSSs) and colored according to association with gene clusters 1–6.
G Heatmap of Zfp281, H3K27ac, histone H3K4 tri-methylation (H3K4me3), H3K4 mono-methylation (H3K4me1), and histone H3K27 tri-methylation (H3K27me3) ChIP-
seq, DNase-hypersensitive sites (DHS), and global run-on sequencing (GRO-seq) read densities across all proximal ( 2 kb of TSS) Zfp281 (top) and distal Zfp281
(bottom) peaks. Each row represents a 10-kb window centered on the peak mid of Zfp281. Rows are sorted for H3K27ac ChIP read densities in ESCs. Reads per
million (RPM).
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▸Figure EV4. Characterization of Ehmt1 and Zic2 downstream of Zfp281.A Representative flow cytometry profiles of Zfp281-inducible RGd2 ESCs transfected with indicated siRNAs after 32 h in 2i and in the presence (green) or absence
(black) of Dox.
B, C FC Ehmt1 (B) and Zic2 (C) transcription relative to untreated WT2i cells in indicated ESC clones after 32 h in 2i in the presence or absence of Dox. Average and SD of
two technical replicates.
D Representative flow cytometry profiles of RGd2 ESCs with conditional Ehmt1 and Zic2 expression after 32 h in 2i and in the presence (green) or absence (black) of
Dox. Numbers are the average and SD of GFPlow cells in two experiments.
E Zfp281 transcription relative to untreated WT2i cells in indicated ESC clones after 32 h in 2i in the presence or absence of Dox. Average and SD of two technical
replicates.
F Representative flow cytometry profiles of Dnmt3a/3b compound KO RGd2 ESCs with conditional Zfp281 expression after 32 h in 2i and in the presence (green) or
absence (black) of Dox. Significance was determined using a Wilcoxon–Mann–Whitney rank sum test compared to WTind. Zfp281.1 Dox-treated cells. Not significant
(n.s.) ≥ 0.05. Numbers are the average and SD of GFPlow cells in four experiments.
G Whole-cell lysate Zfp281 IPs in WT and Zfp281 KO cells in 2i or 40 h after 2i withdrawal, and probed for indicated proteins. Input (left) and Zfp281 IP (right). (*) Ig
heavy chain.
H–J Cell morphologies (H), growth curves (I), and cell cycle analyses using propidium iodide staining (J) of indicated genotypes in 2i. Average and SD of three
experiments (I, J). Scale bar is 50 lm (H).
K Representative flow cytometry profiles of indicated genotypes in 2i, and after 32 and 72 h of 2i withdrawal. Numbers are the average and SD of GFPhigh cells in two
experiments.
L Quantification and hierarchical clustering of normalized F-actin intensity in 20 concentric rings (from center to circumference) in spheroids derived from ESCs with
indicated genotypes in 2i or N2B27 for 4 days. Intensity is color-coded and illustrates central F-actin accumulation and, hence, polarization of WT and Zic2 KO cells
during differentiation.
M Representative immunofluorescence staining of WT or Ehmt1 KO ESCs expressing the indicated transgenes. Top: H3K9me2 and DAPI. Bottom: Ehmt1. Co-localization
of H3K9me2 with DAPI-rich speckles in Ehmt12i cells expressing no transgene, the ΔNHHC, or NH-LE alleles is indicated by arrowheads. Please note the absence of
nuclear Ehmt1 staining in Ehmt12i cells and restoration by Ehmt1 transgenes. Scale bar is 10 lm.
N Representative flow cytometry profiles of indicated genotypes in 2i and 32 h after 2i withdrawal.
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▸Figure EV5. Ehmt1 and Zic2 transcriptomics and genomics.A Log2-normalized read counts of selected core, naïve, and primed pluripotency markers in ESCs of indicated genotypes.
B Scatter plot of mRNA log2FC in Zfp281
2i and Ehmt12i cells (left). Top 5 GO terms enriched in genes upregulated (red) and downregulated (blue) specifically in
Ehmt12i cells (right).
C, D Pairwise Pearson correlation coefficients of mRNA changes between indicated differentiated cells considering all detected transcripts (C) or gene cluster 1–6
transcripts (D).
E Estimated regression coefficients and standard errors for the contribution of Ehmt1 (DEhmt1), Zic2 (DZic2), and their interaction (DEhmt1:Zic2) to cell state-specific
gene expression changes in Ehmt1/Zic2 compound KO cells. All expressed genes (13,096) are taken into account.
F Western blot confirming Ehmt1 biotinylation [probed with Streptavidin (Strep)] in ESCs of indicated genotypes expressing the BirA ligase.
G ESC self-renewal of indicated genotypes after 3 days of 2i withdrawal. Average and SD of three experiments performed in duplicates.
H Log2 Ehmt1 and H3K9me2 ChIP enrichment in ESCs over matched inputs at five classes of 10-kb genome-wide windows binned by increasing Ehmt1 chromatin
association. Boxes as in Fig 3C for 42,887 datapoints each.
I, J Ehmt1 (I, J) and H3K9me2 (J) ChIP log2FC between indicated cell states and genotypes at Zfp281 peaks (purple) or matching and non-overlapping DHS control
peaks (gray) extended to 10-kb windows. Boxes and number of datapoints as in Fig 7A.
K Representative immunofluorescence staining of H3K9me2 (left) and quantification relative to DNA (right) in indicated genotypes and conditions. Scale bar is 10 lm.
Boxes as in Fig 3C for 453 (WT2), 465 (WT32 h), 574 (Zfp2812), and 792 (Zfp28132 h) datapoints.
L Density plot showing distance of Zfp281-only (pink), Zic2-only (blue), and Zfp281/Zic2 co-bound peaks (yellow) to nearest TSS.
M Zfp281 (left), Zic2 (middle), and H3K27ac (right) log2 ChIP enrichment over matched inputs in ESCs at Zfp281-only (pink), Zic2-only (blue), and Zfp281/Zic2 co-
bound (yellow) peaks. Boxes and number of datapoints as in Fig 7B.
N Cell state-specific Zic2 ChIP log2FC between indicated genotypes and cell states at Zfp281-only (pink), Zic2-only (blue), and Zfp281/Zic2 co-bound (yellow) peaks.
Boxes and number of datapoints as in Fig 7B.
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Appendix Figure S1: Deconvolution of siRNA pools (related to Figures 1 and 5). 
(A, B) Epi-iPSC colonies derived from 796.4 EpiSCs transfected with indicated siRNAs (individual 
siRNAs or pools), stimulated for 4d with Gcsf and 2i, and selected with Puromycin. Average and SD 
of 3 experiments performed in duplicates. 
 
Appendix Figure S2: Details of genome-edited ESC lines (related to Figures 2 and 5, and EV4). 
(A, B) Sequence of genome-edited Zfp281 locus (A) and absence of protein (B) in KO cells. E denotes 
E14 parental cell line origin. 
(C, D) Sequence of genome-edited Tet1 and Tet2 loci (C) and absence of proteins (D) in KO cells. 
(E) Sequences of genome-edited Dnmt3a and Dnmt3b loci in WTind. Zfp281.1 ESCs. 
(F, G) Sequence of genome-edited Ehmt1 and Zic2 loci (F) and absence of proteins (G) in KO cells. 
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